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SUMMARY
The intimate interplay between gut microbiota, host, and nutrient flow is crucial in defining the health 
status of the host. During microbial conventionalization of germfree mice, tightly regulated molecular 
responses assure the establishment of homeostasis and immune tolerance towards the microbiota. To 
decipher the temporal and regional dynamics of host-microbiota communication during the process 
of conventionalization, a combination of transcriptomics, (immune-)histology, metabonomics (tissue, 
urine, and plasma), as well as MITChip (Mouse Intestinal Tract Chip) based microbiota profiling was 
employed. To this end, C57/BL 6 J germfree mice were conventionalized with mouse fecal microbiota 
and responses were followed in a time-resolved manner for thirty days. The colonizing microbiota 
was characterized by a shift from low towards higher diversity of its composition, over the period 
of conventionalization. Microbial colonization was rapidly (after one day) reflected by increased 
concentrations of specific urine and jejunal metabolites as well as by biologically relevant changes 
in jejunal tissue transcriptome profiles. Conversely, ileal and colonic transcriptome responses could 
be measured later, after four days post-conventionalization, and led towards stable molecular profiles 
at sixteen and thirty days of conventionalization, albeit with region-specific differences. The major 
molecular responses included strong induction of innate immune response followed by stimulation 
of adaptive and regulatory immune functions, as well as modulation of metabolic pathways involved 
in lipid, carbohydrate, and anabolic metabolism. Conventionalization was characterized by two 
stages separated by one stage of a single day which, particularly in the colon, resembled a transient 
stage of inflammation, based on transcriptomes, histology and transiently elevated levels of specific 
plasma markers. This state coincided with temporal domination of specific microbial groups that have 
previously been identified as “pathobionts”, suggestive of a transient state of dysbiosis. Extensive 
transcriptome profile analyses throughout the GI tract enabled the identification of central gene 
regulatory networks that govern the molecular responses during conventionalization and are proposed 
to serve as genetic signatures for the control of intestinal homeostasis in mice. Nearly all genes in 
these regulatory networks have human orthologues, suggesting that the biological findings of this 
study is also relevant for human intestinal biology. In support of this hypothesis, in the jejunum, 
the identified gene regulatory network appeared to be strongly associated with human metabolic 
disorders. This notion also suggests that at least in mice, possibly also in human, there is a prominent 
role of the proximal small intestine in systemic metabolic control. 
This thesis exemplifies the pivotal role of the dynamic molecular interactions between the microbiota 
and the intestinal mucosa, in the establishment and maintenance of mucosal homeostasis in healthy 
mice. The molecular signatures obtained from these studies in mice may provide novel diagnostic 
tools and/or therapeutic targets in humans for specific disorders associated with intestinal dysbiosis 
and loss of mucosal homeostasis.
KEYWORDS: C57/BL6 J mice, conventionalization, transcriptomics, (immune-)histology,  
                           metabonomics, microbiota.   
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CHAPTER 1
GENERAL INTRODUCTION
Gut Microbiota and the Balance between Health and Disease
Sahar El Aidy and Michiel Kleerebezem                                                                                            
In preparation
2CHAPTER 1
Overview of the Mammalian Gastrointestinal Tract, its Cellular Architecture and Renewal 
The gastrointestinal (GI) tract of an adult human consists of a muscular tube that starts from 
the oral cavity, where the food enters through the mouth, passes through the pharynx, the upper 
GI-tract, which consists of the oesophagus, stomach, and the first part of the small intestine 
(duodenum), the lower GI tract, which consists of the rest of the small intestine (jejunum and 
ileum), and the large intestine (cecum to which the appendix is attached, and the colon (ascending, 
transverse, descending, and sigmoid flexure)) to end with the anus and rectum, where the food 
waste is expelled (Martini 2001). Each part of the intestine has a different function. During 
swallowing, the food passes from the oral cavity to the stomach via the oesophagus. The main 
function of the stomach is the secretion of digestive enzymes and acids to help food digestion. 
From the duodenum onward, the dietary components are in close contact with the intestinal 
mucosa that fulfills the most important absorptive function and provide a barrier between the 
luminal contents and the rest of the body. The duodenum is the site where stomach acids are 
neutralized, and where the dietary materials are mixed together with the digestive enzymes 
mixture that catalyzes the break-down of the food into proteins and fats to facilitate their 
absorption. The main function of the jejunum is the passive transport of monosaccharides and 
active transport of amino acids, small peptides, vitamins, lipids, and glucose (Wilson 2004). 
The ileum absorbs the digestive products that were not absorbed by jejunum and secretes the 
enzymes required for the final stages of protein digestion (Sheehy 1964). The digested nutrients 
absorbed via the small intestine represent nearly 90% of the energy uptake from the diet (Walter 
and Ley 2011). The small intestine (terminal ileum) is separated from the large intestine (colon) 
by the ileocecal valve. The colon reabsorbs water and inorganic salts from the solid wastes 
before they are excreted from the body. Unlike the small intestine, no digestive enzymes are 
secreted in the colon. Instead, the colon is home to trillions of intestinal commensal microbes 
which break down unabsorbed material and produce fermentation products in the form of short 
chain fatty acids (SCFAs) which, in turn, are used by colonocytes as a major source of energy 
(Cummings and MacFarlane 1997). 
The three segments of the small intestine have the same basic histological organization, mucosa 
and submucosa (Figure 1.1B). The mucosa is composed of the lumen-exposed monolayer of 
epithelium that covers the gastrointestinal wall and overlays the lamina propria (a layer of 
connective tissue) and the muscularis mucosae (a thin layer of smooth muscle). The entire 
mucosa has finger like projections (known as villi) which extrude into the lumen and cover the 
inner surface and are much longer in the jejunum than in the duodenum or ileum. The villi are 
lined with epithelial cells which in their turn have a large number of microvilli at the apical side, 
the brush border region, whereby the surface area of mucosa that is in contact with the intestine 
lumen is maximized (see also below). Such structural features of the mucosa support the main 
function of the small intestine, the absorption of digested food. The ileal villi contain large 
number of capillaries that transport the amino acids and glucose as end products of digestion 
to the hepatic portal vein. Crypts of Lieberkühn (simple tubular glands) are found between the 
intestinal villi and extend down to the muscularis mucosae through the lamina propria which 
is rich with lymphocytes and other immune cells. Together, the crypt-villus units (also known 
as crypt-to-villus axis) play an important role in control of cell proliferation, differentiation, 
migration, and apoptosis (Ahuja, Dieckgraefe et al. 2006). Conversely, the surface of the 
large intestine is relatively smooth with no extruding villi and longer and straighter crypts 
of Lieberkühn as compared to the small intestine (Stappenbeck, Hooper et al. 2002). Only a 
limited lamina propria is present in the large intestine, which is located between the crypts. 
C
H
A
PT
E
R
 1
Gut Microbiota  and the Balance between Health and Disease
C
H
A
PT
E
R
 1
The submucosa is comprised of connective tissue, blood and lymphatic vessels, and nerves to 
supply and support the intestinal mucosa (Barrett 2006).
Under physiological, healthy conditions, the gut is covered by the largest epithelial surface in 
the body (Tlaskalova-Hogenova, Stepankova et al. 2011), which in humans equals the size of 
a tennis-court (approximately 200 m2 in humans). This single layer consists of interconnected, 
polarized cells reinforced together by associated areas of protein strands known as the tight 
junctions, to form the major barrier of the intestinal mucosa.  Tight junctions participate in 
determining the shape and structure of epithelial cells (Fasano 2008) . Epithelial cells are 
continuously shed and generated de novo by multipotent stem cells located at the base of crypts 
of Lieberkühn (Figure 1.1C). Each active stem cell differentiates into progenitor cells which 
give rise to two cell-populations, (i) the absorptive enterocytes, and (ii) the secretory epithelial 
cells, including goblet, enteroendocrine, and Paneth cells (Bjerknes and Cheng 1981) (Figure 
1.1C). Enterocytes are the most abundant cells present in both the small and large intestine. 
They are involved in water and electrolyte absorption and form an important physical barrier to 
the luminal microbes (Ahuja, Dieckgraefe et al. 2006). Goblet cells are present in both the small 
and large intestine but are relatively more abundant in the large intestine. They help protect the 
mucosal surface by secreting mucins (glycosylated proteins) that form a protective layer that 
lies over the epithelial surface and prevents or restricts direct contact between the epithelial 
cells and gut content, particularly in the large intestine. Moreover, the mucus layer acts as a 
lubricant to facilitate the peristaltic movement of the intestine and its luminal content. The 
thickness of the secreted mucus increases along the GI tract (150-300 μm in the small intestine 
up to 800 μm in the large intestine) (Medema and Vermeulen 2011). Enterendocrine cells are 
a complex and specialized population of intestinal epithelial cells that can produce a variety of 
gut hormones and neurotransmitters such as serotonin, cholecystokinin (CCK), and glucagon-
like peptides 1, 2 (GLP-1,-2) (Liddle 2010). Enteroendocrine cells are positioned in the mucosa 
in a way that allows them to sense luminal signals, including microbial metabolites, which 
can elicit cellular responses that in their turn function as signals to modulate other mucosal 
cells (Bienenstock and Collins 2010). The signals derived from enteroendocrine cells play an 
important role in the modulation of host energy metabolism,  mucus secretion and intestinal 
motility (Cani and Delzenne 2009). The three cell lineages described above complete their 
differentiation by migrating out of the crypt to a cellular extrusion zone located near the tip 
of each villus which takes 2 to 5 days to be completed (Stappenbeck, Hooper et al. 2002). 
The fourth cell lineage, Paneth cells (Barker, van de Wetering et al. 2008), are essential in the 
antimicrobial defense and are located at the base of the small intestinal crypts (Figure 1.1C), 
while they appear to be absent from the large intestinal mucosa. Paneth cells contain secretory 
granules in which different antimicrobial peptides such as α-defensins, lysozymes, RegIIIγ, and 
phospolipase A2 are present. The vital role that these humoral components of the innate (non-
specific) immune response play in mucosal barrier function is now well-recognized (Tlaskalova-
Hogenova, Stepankova et al. 2011; Vaishnava, Yamamoto et al. 2011). Defensins (also known 
as cryptidins) are the principle defense molecules of Paneth cells (Wilson, Ouellette et al. 1999), 
they interact with phospholipids in bacterial cell membranes and form pores that disrupt the 
membrane function and cause cell lysis (Ayabe, Satchell et al. 2000).  In order to maintain the 
protective function of the mucosal epithelia, the cellular turn-over needs to be tightly controlled 
without disrupting the epithelial cell-cell tight-junctions, to prevent breaches in the epithelial 
barrier function (Mentor-Marcel, Bobe et al. 2009). 
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The Immune System of the Gastrointestinal Tract
The enormous surface area of the GI tract that is exposed to the environment requires a balanced 
defense system to prevent the translocation of antigens from the lumen (Mestecky 2005). 
A multitude of activities contribute to defense, including the innate and adaptive (specific) 
immune system, as well as detoxification enzymes, and bile salts which have bactericidal effect 
(Cummins 1911). Collectively, the immune system of the GI tract is largely organized in the 
gut-associated lymphoid tissue (GALT), which is the largest mass of lymphoid tissue in the 
human body (Isolauri, Sutas et al. 2001). The GALT comprises different types of lymphoid 
tissues including the Peyer’s patches (Mestecky 2005). Only the ileum has abundant Peyer’s 
patches that contain large numbers of lymphocytes and other immune cells. Peyer’s patches 
are aggregations of lymphoid tissue which appear as elongated thickenings of the ileal tissue 
(Figure 1.1A) and play a major role in the development and maintenance of the immune system. 
The Peyer’s patches are located in the lamina propria layer of the mucosa and are covered by 
microfold cells (M cells), which sample antigens from the GI tract lumen that are processed 
by antigen presenting cells located in the Peyer’s patches such as macrophages, dendritic cells, 
natural killer cells, B-and T-lymphocytes (Brandtzaeg, Kiyono et al. 2008) (Figure 1.2). M cells 
are absent from the isolated lymphoid follicles of the large intestine. In addition, sampling of 
antigens from the intestinal lumen can also be carried out by a subset of dendritic cells that 
have been reported to sample directly by dendrites that penetrate between the epithelial cells 
and protrude into the lumen (Rescigno, Urbano et al. 2001). Dendritic cells and macrophages 
Figure 1.1. Schematic representation of the mammalian 
GI tract and its bacterial load (A). Cross section of 
the intestinal tube (B), and crypt and adjoining villus 
epithelium illustrating the different epithelial cell lineages 
((C), adapted from (Shroyer, Wallis et al. 2005)).
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represent important members of the innate immune system; they internalize partially degraded 
luminal compounds and present them to cells of the adaptive immune system. In particular, 
antigens are presented to naive and memory T cells leading to their activation in a process 
known as antigen-processing and presentation (Lee, Starkey et al. 1985) (Figure 1.2). Naive T 
cells can differentiate into T helper (Th) cells (Th1, Th2, and Th17), which are co-regulated with 
regulatory T cells  (Tregs) (Hooper and Macpherson 2010). The differentiation of B cells leads 
to cells that produce immunoglobulin A (IgA), which plays a vital role in mucosal immunity 
and is produced extensively in mucosal linings. Epithelia express the polymeric IgA receptor 
(pIgA) to transport IgA across the epithelial cells to be released into the lumen where the IgA 
are involved in neutralization of luminal antigens (Macpherson and Uhr 2004). The mesenteric 
lymph nodes are part of the intestinal lymphatic system and lie in the peritoneal membrane that 
separates the jejunum and ileum from the abdomen. The mesenteric lymph nodes prevent the 
translocation of the luminal antigens to the systemic immune compartment to avoid eliciting 
damaging immune responses to the harmless luminal antigens (Macpherson and Harris 2004). 
Microbiota of the (human) Gastrointestinal Tract in Health and Disease
There is an intimate contact of the microbes (collectively known as microbiota) that live in 
and on the surface areas of mammalian bodies, including the mucosal surfaces of the GI tract. 
Colonization of the GI tract is initiated during and after birth (Hallstrom, Eerola et al. 2004). 
Typically, a high degree of variation in the gut microbiota composition during the first few days 
to weeks after birth is observed (Harmsen HJ 2000; Palmer, Bik et al. 2007).  In healthy adults, 
the colonizing microbiota reaches a climax community with a total number of approximately 
1014 microbial cells that collectively weigh more than 1kg.    
A typical microbe includes archaea, fungi, viruses, and protozoa, but is largely predominated by 
bacteria. This number of microbial cells is several orders of magnitude larger than the estimated 
1012 parenchymal cells in an average human body (excluding the blood cells and neurons) 
(Todar 2004). The very low pH of the stomach allows the survival of very limited number 
of microbiota (101-102 cells/g, with Helicobacter pylori as the most well-known example) 
(O’Hara and Shanahan 2006) (Figure 1.1A). In the proximal small intestine the luminal pH is 
neutralized so that the number of residing bacteria can increase gradually along the GI tract. In 
the small intestine, the rapid luminal flow and the secretion of bile salts limit the bacterial density 
(between 103-105 cells/g in the proximal part of the small intestine; duodenum and jejunum). 
Figure 1.2. Schematic diagram of the 
intestinal mucosal immune system. The 
effector compartment consists of lamina 
propria and epithelial cells. M cells act as an 
entry port to facilitate the uptake of luminal 
antigens and their subsequent processing by 
the lymphoid tissues, particularly involving 
dendritic cells and macrophages. Antigen 
presentation and processing leads to the 
activation and differentiation of naive T and 
B cells into T helper (Th), T regulatory (Tregs), 
and IgA-producing B-cells, respectively.
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Such low number of colonizing microbiota allows the host to limit direct competition with the 
microbiota for the absorption of ingested nutrients which is the main function of the proximal 
small intestine (Walter and Ley 2011). In contrast, the distal part of the small intestine and the 
large intestine have significantly slower luminal flow, which allows for the colonization by a 
more dense microbiota (nearly  107 -1012 bacterial cell/g) (Figure 1.1A) (O’Hara and Shanahan 
2006). 
 Despite the high microbial population density, a peaceful coexistence (homeostasis) is 
maintained between the intestinal microbiota and its (healthy) host. The molecular basis of this 
partnership involves bacterial signals that are recognized by host receptors to mediate host’s 
tolerance towards the commensal microbiota, which facilitates beneficial outcomes for both 
the microbiota and host (Lee and Mazmanian 2010). The microbiota contributes to diverse 
mammalian processes that include the defense against pathogens, thereby enhancing the barrier 
function of the gut mucosa. In addition, the microbiota ensures de novo synthesis of essential 
nutrients and the fermentation of non-digestible dietary materials, which result in enhanced 
recovery of energy from the diet by the host (Hooper, Bry et al. 1998; Xu and Gordon 2003). 
Only microbial population that are capable of establishing a mutualistic relation with the host 
can be maintained in the gut ecosystem (Bäckhed, Ley et al. 2005), creating a habitat that exerts 
restrictive selection on its microbial inhabitants. This restrictive selection of specific microbial 
groups is illustrated clearly by the relatively low phylum-level diversity observed in the 
microbiota of the GI tract of many mammalian organisms, including mice and humans, which 
is dominated by the phyla of the Bacteroidetes (e.g., the genus Bacteroides), the Firmicutes 
(e.g., the genera Clostridium and Eubacterium), (Bäckhed, Ley et al. 2005; Eckburg, Bik et al. 
2005; Ley, Hamady et al. 2008) and Actinobacteria. The actual number of the latter group are 
probably under-estimated by PCR based approaches but appear to make up a high proportion 
of the gut microbiota based on Florescent in situ hybridization (FISH) approaches (Zoetendal, 
Vaughan et al. 2006) . Notwithstanding the relatively low diversity of the gut microbiota at the 
phylum level, the diversity at the genus and species levels is enormous and is shaped by the host 
genotype, the variation in early-life environmental exposure that includes the mode of delivery 
(Zoetendal 2001; Hallstrom, Eerola et al. 2004) and nourishing regime of neonates (Dai D 
1999), and later in life by factors like dietary habits, antibiotic therapy, hygiene and infection 
(Fanaro, Chierici et al. 2003). 
Molecular strategies to create inventories of the human intestine microbiota species composition 
commonly target the universal 16 S ribosomal RNA (16 S rRNA) gene as a universal marker 
to discriminate bacterial species. These studies have demonstrated strikingly high variability 
within and between the individuals (Zoetendal 1998; Eckburg, Bik et al. 2005). In an attempt to 
define a common core of microbiota members in the fecal samples of healthy individuals, Tap 
and colleagues reported that  2.1% of the identified bacterial groups were encountered in more 
than 50% of the individuals (designated “core microbiota”), while the rest were individual-
specific (Tap, Mondot et al. 2009). However, more recent studies have debated the concept 
of a common core microbiota that can be recognized at the phylogenetic level, pointing out 
that the depth of analysis may play an important role in the differences in the outcomes of 
these analyses (Turnbaugh, Hamady et al. 2009; Jalanka-Tuovinen, Salonen et al. 2011). The 
molecular profiling of microbiota community composition in healthy volunteers in comparison 
to cohorts of diseased individuals show associations between diseases and aberrations in the 
intestinal microbiota composition (Zoetendal, Vaughan et al. 2006). While these associations 
are highly intriguing and postulate that there is potential for health management through the 
C
H
A
PT
E
R
 1
Gut Microbiota  and the Balance between Health and Disease
7
(targeted) modulation of the microbiota composition, in many cases the exact causal relations 
within these associations remain to be established. More recently, metagenomic approaches 
allowed in depth insight in the functional diversity of the dominant microbial composition and 
its genetic potential (Gill, Pop et al. 2006; Qin, Li et al. 2010) and have revealed that despite 
the variation of species composition, the microbial communities encompass a relatively similar 
set of (metabolic) functions in healthy individuals, which is referred to as “core microbiome” 
(Turnbaugh, Hamady et al. 2009; Qin, Li et al. 2010). Subsequent function-based comparative 
analysis of the function-microbiome of individual humans has allowed the detection of distinct 
subgroups of people that can be classified on basis of their microbiome composition, so-called 
enterotypes (Arumugam, Raes et al. 2011). The three enterotypes detected could be discriminated 
on basis of a single discriminating genus (Bacteroides [enterotype 1], Prevotella [enterotype 
2], or Ruminococcus [enterotype 3]) (Arumugam, Raes et al. 2011), and did not appear to 
correlate with particular host properties like body mass index (BMI), gender, age or dietary 
habits. Moreover, distinct abundances of specific functional markers (microbiome functions) 
could be correlated with either the enterotype classification or with some of the host-phenotype 
data like age and BMI. These microbiome functional markers may provide diagnostic tools 
for detecting (enterotype specific) markers for specific health aberrations within the intestinal 
microbiome (Arumugam, Raes et al. 2011).  A recent study suggested that enterotypes could 
be specifically linked to long-term dietary pattern, although only two enterotypes could be 
discriminated (Wu, Chen et al. 2011). Taken together, the human microbiome studies confirm 
the significant difference in the microbial composition of healthy and diseased individuals and 
highlight the importance of the human gut microbiome in human (and animal) health and disease. 
Despite these advances, the molecular mechanisms by which the microbiota may influence 
human health remain largely unknown, and it will require a substantial effort to unravel these 
mechanisms to a level that enables the use of this knowledge for the definition of species- or 
functional- microbiome-markers for diagnostic purposes or as targets for therapeutic and/or 
dietary interventions that aim at maintaining or may be even improving host health. 
In Vivo Animal Models as Simplified Host Models                                    
Simplified in vivo and in vitro models have been instrumental in the first steps towards unraveling 
the molecular basis of the complex and dynamic interrelations underlying the healthy homeostatic 
relation between the microbiota and the intestinal mucosa, as well as the deviations in these 
interrelations that may lead to dysbiosis and disease. In vitro and ex vivo models frequently 
employ animal and human cell culture systems such as cell-line models, Ussing chambers, 
organotypic models (which include all intestinal cell types), and isolated and perfused intestinal 
segments. These models have been widely used to study host-microbe interactions, particularly, 
the functioning of the intestinal epithelium and its role in absorption, metabolism, drug 
detoxification, and microbial recognition (Le Ferrec, Chesne et al. 2001). These approaches 
provide relatively simple models, but the extrapolation of the results obtained in these in vitro 
and ex vivo systems to real life is far from trivial. These simplified models consistently lack the 
systemic in vivo interplay that is found within a complete organism, but in most cases also fail 
to accurately mimic the in vivo anatomical and biochemical characteristics. For instance, the 
use of tumor-derived cell lines (e.g.; Caco-2 and HT-29) may introduce artifacts due to the 
hyperproliferative nature of the tumor cells employed. Therefore, in vivo models are crucial to 
better understand the molecular bases by which the microbiota shapes the host’s physiology. 
However, it is virtually impossible to perform such molecular studies in vivo in human subjects 
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due to the experimental and ethical limitations. To overcome this, (ex-) germfree, gnotobiotic, 
and genetically modified animals provide attractive and genetically defined, simplified models 
to study the in vivo responses to commensal bacteria. The most frequently employed animal 
models in such studies are zebra fish, Drosophila spp., and rodents, with the largest number of 
published studies on germfree mice. Germfree (and genetically modified) mice have allowed 
the study of the role of specific genes and functions in the interplay between (specific) microbial 
species and the mouse physiology, and these models have been extensively used to study the 
relations between microbiota and different hosts, including healthy hosts and models for 
diseases like obesity, diabetes, and cardiovascular dyslipidaemia (Bäckhed, Ding et al. 2004; 
Turnbaugh, Ley et al. 2006; Cani, Amar et al. 2007; Cani, Neyrinck et al. 2007). The basic 
studies on germfree life were initiated in the United States by J.A. Reyniers at the Lobund 
laboratories-University of Notre Dame in 1928 (Wiseman 1965). Germfree animals are bred 
and maintained without exposure to bacteria of any kind (Gordon 1968), they live in flexible-
film isolators that are essentially plastic bubbles inflated with sterile filtered air using elevated 
atmospheric pressure. All food, water, and bedding are autoclaved and introduced to the isolator 
using aseptic protocols. Initiator animals for a germfree colony must be aseptically delivered by 
Caesarean section, but later they can be interbred within the sterile environment (Gordon 1968; 
Smith, McCoy et al. 2007). If colonized with single microbial species (mono-association), or a 
microbiota of low or high complexity, the animals will allow the establishment of a bacterial 
community in the intestine and other body surfaces within days. This process can be considered 
to share similarities with the process encountered by a conventionally born mammal that 
becomes rapidly colonized by microbial communities after leaving the uterus (Macpherson and 
Uhr 2004). Histological and molecular experiments performed on germfree animals illustrated 
that the presence of the microbiota causes extensive changes in the host biology that includes 
altered epithelial cell gene expression, changes in the composition and activity of the mucosal 
immune system, metabolism, angiogenesis, bile acid cycle, intestinal motility, and overall 
animal behavior (Heneghan 1963; Evrard, Charlier et al. 1964; Dahlqvis.A, Bull et al. 1965; 
Reddy, Pleasant et al. 1969; Yolton, Stanley et al. 1971; Cebra 1999; Hooper 2001; Hooper, 
Wong et al. 2001; Stappenbeck, Hooper et al. 2002; DiBaise, Zhang et al. 2008) (Table 1.1). 
For example, the intestinal mucosal morphology of the germfree animals differs from that of 
their conventional counterparts in several ways, including the total mass of the intestine 
(Levenson and Tennant 1963) and the total surface area of the small intestine, both of which are 
decreased in germfree animals (Gordon and Brucknerkardoss 1961; Meslin and Guenet 1973). 
Simplified and defined microbiotas composed of single or several bacterial species and/or 
strains  have been used in germfree mice to define the impact of a specific member of the 
bacterial community on the host functions. Mono- and bi-association are attractive models of 
gnotobiotic animals based on their high degree of definition and consistency. Bacteroides 
thetaiotaomicron, an abundant, genetically tractable member of the normal human and mouse 
microbiota (Salyers, Bonheyo et al. 2000) represents the most widely used mono-associated 
model in mice. B. thetaiotaomicron was used to study the microbial polysaccharide metabolism 
in the gut (Bry, Falk et al. 1996; Hooper, Xu et al. 1999; Xu, Bjursell et al. 2003) and showed 
to be able to degrade a wide variety of host-derived glycans (glycoconjugates) that provided a 
nutrient source for the initial colonization of the neonate intestine (Salyers, Vercellotti et al. 
1977; Karlsson 1989; Falk, Roth et al. 1994; Hooper, Midtvedt et al. 2002). In a pioneering 
study, Hooper and co-workers showed how the mono-association of germfree mice with B. 
thetaiotaomicron modulated the cellular, kinetic, and spatial features of fucosylated glycans in 
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a way that bears similarity to the effects of total microbial communities in conventionally raised 
animals during weaning (Hooper, Wong et al. 2001). Interestingly, the metabolic activity of 
B. thetaiotamicron in situ in the intestine of mice as well as the mouse immune responses were 
shown to be significantly influenced by the presence of specific additional members of the 
microbiota (Sonnenburg, Chen et al. 2006; Sonnenburg, Zheng et al. 2010), illustrating the 
importance of microbial interplay in the interaction with the host system. Mono-association of 
mice with Bacteroides fragilis demonstrated the strong impact of this microbe on mucosal 
immune responses, in particular its role in the stimulation of anti-inflammatory T regulatory 
cell development (Mazmanian, Round et al. 2008). Another intriguing example was provided 
by mono-association experiments using segmented-filamentous bacteria (SFB). SFB are strictly 
anaerobic, gram-positive bacterial groups that inhabits the intestinal tracts of many species 
(Klaasen, Koopman et al. 1992). Mono-association studies of SFB in mice illustrated the potent 
role of this bacteria in the stimulation of the gut mucosal immune system including  the induction 
of germinal center reactions and activation of effector T cells in Peyer’s patches (Talham, Jiang 
et al. 1999; Gaboriau-Routhiau, Rakotobe et al. 2009). Besides mono-associations, colonization 
of mice by multiple groups has also been performed. Schaedler and co-workers developed a 
reduced standardized microbiota (referred to as altered Schaedler flora or ASF) (Orcutt, Gianni 
et al. 1987) to colonize germfree mice in order to avoid the variations in the microbial 
composition among conventionally raised mice purchased from different sources (Gaboriau-
Routhiau, Rakotobe et al. 2009; Ivanov and Manel 2010). Unfortunately, even such a standardized 
microbial community is unlikely to provide an accurate representation of the complexity of the 
total microbial community. These examples highlight the usefulness of simplified (ex-) germfree 
animal models for the study of molecular interactions between the intestinal mucosa and the 
colonizing bacteria. Notably, without such animal model studies it is virtually impossible to 
decipher molecular interaction models that accurately describe host microbe interactions in the 
mammalian intestine. However, it remains essential that mechanisms of interaction deduced 
from these simplified animal models are translated to hypotheses for the molecular basis of 
human host-microbe homeostasis in the intestine that can be verified in vivo in human 
intervention studies. Importantly, recent controlled dietary interventions in healthy human 
volunteers have illustrated the feasibility of the accurate measurement of mucosal transcriptional 
responses after consumption of probiotics (van Baarlen, Troost et al. 2011). 
Gut Microbiota Shapes the Host Immune System in Health and Disease
In healthy individuals, the gut epithelia are in continuous contact with different kinds of 
stressors, including the gut microbiota, but succeed to maintain homeostasis. During early 
and later stages of life, the gut microbiota shapes the molecular profile of the gastrointestinal 
immune system (Lee and Mazmanian 2010). The beneficial and adverse interactions between 
the immune system and microbiota (Macpherson and Harris 2004; Garrett, Gordon et al. 2010) 
have been extensively studied in in vivo animal models. These studies showed that the host 
intestinal immune system requires the presence of commensal microbes for its development 
and proper functioning. The first line of defense for the intestinal mucosa (GALT) is defective 
in germfree mice that have smaller Peyer’s patches and reduced cellularity of the lamina 
propria with lower Cd4+ and Cd8+ T cells (Glaister 1973; Falk, Hooper et al. 1998). Plasma 
cells and intraepithelial lymphocytes are rare in the small intestine mucosa of germfree mice 
and secretory IgA levels are significantly lower (Fahey and Sell 1965; Crabbe, Nash et al. 
1970; Moreau, Ducluzeau et al. 1978) (Table 1.1). Germfree mice exhibit reduced expression 
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Table 1.1. Selected examples of germfree animal associated characteristics (adapted from (Norin E. 2000; Smith, 
McCoy et al. 2007; Round and Mazmanian 2009)).
Parameter Germfree associated characteristics ReferenceIntestinal motility -Increased transit time of contents-Altered myenteric neurons-Increased muscular tissue (Abrams, Sprinz et al. 1963)(Dupont, Jervis et al. 1965)(Gordon 1968)Intestinal function -Altered absorption rate of  ingested material-Decreased fatty acids in intestinal content-Excrete largely unsaturated fatty acids-Excrete large amount of mucin in feces -Increased bilirubin in feces
(Heneghan 1963)(Evrard, Charlier et al. 1964)(Evrard, Charlier et al. 1964)(Carlstedtduke, Hoverstad et al. 1986)(Gustafsson and Lanke 1960)Absorption function -Increased absorption of vitamins and minerals (Heneghan 1963)Intestinal morphology -Decreased intestinal total mass-Decreased total surface area of small intestine-Altered villus and crypt length-Larger cecum with thinner cecal wall-Thinner lamina propria with less cellularity
(Levenson and Tennant 1963)(Gordon and Brucknerkardoss 1961)(Glaister 1973)(Jervis and Biggers 1964; Gordon 1968)(Glaister 1973)
Intestinal epithelium -More uniform with longer microvilli-Slower rate of turn over-Decreased cellular renewal rate in Peyer’s patch-Reduced expression of antimicrobial peptides in Paneth cells
(Abrams, Sprinz et al. 1963)(Lesher, Sacher et al. 1964)(Abrams, Sprinz et al. 1963)(Round and Mazmanian 2009)Mucosal immunity -Decreased IgA-Very few plasma cells in small intestine-Decreased expression of activation markers on immune cells-Decreased histamine and increased 5-HT in small intestine-Decreased MHC II on epithelial cells of small intestine- Fewer CD8+T cells in intestinal epithelial lymphocytes with reduced cytotoxicity-Fewer CD4+T cells in lamina propria
(Fahey and Sell 1965)(Glaister 1973)(Mikkelsen, Garbarsch et al. 2004)(Beaver and Wostmann 1962)(Umesaki, Okada et al. 1995)(Glaister 1973; Round and Mazmanian 2009)(Round and Mazmanian 2009)Metabolism -Increased nitrogen in feces and cecal content-Little ammonia and more urea in intestinal content-Decreased basal metabolic rate
(Evrard, Charlier et al. 1964)(Evrard, Charlier et al. 1964)(Wostmann, Bruckner.E et al. 1968)Nutritional differences -Requires Vitamin B and K in diet-Decreased body fat percentage (Wostmann 1981)(Levenson and Tennant 1963)
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of activation markers of intestinal macrophages (Mikkelsen, Garbarsch et al. 2004), Toll-like 
receptors (TLRs), and major histocompatibility complex II (MHC II) which are involved in 
microbial sensing and antigen presentation (Matsumoto, Setoyama et al. 1992; Lundin, Bok et 
al. 2008). Reconstitution of germfree animals leads to re-localization of intestinal immune cells 
to both inductive sites (e.g.; Peyer’s patches, colonic patches, and mesenteric lymph nodes) and 
effector sites (epithelia and lamina propria) (Ley, Hamady et al. 2008).
Commensal and pathogenic bacteria share the same conserved molecular patterns (designated 
microbe associated molecular patterns or MAMPs) that are recognized by and bind to host 
receptors of the innate immune system (known as pattern recognition receptors or PRRs), 
involved in bacterial recognition (Falk, Hooper et al. 1998; Bäckhed and Hornef 2003). PRRs 
are classified according to their function into signaling (such as TLRs and NOD-like receptors) 
and endocytic pattern recognition receptors which are found on phagocytic cells and promote 
attachment, engulfment, and destruction of microorganisms without depending on intracellular 
signaling (Mestecky 2005). Binding of MAMPs to PRRs activates a cascade of reactions that 
control the expression of genes that are associated with defense mechanisms including the 
production of anti-microbial peptides and the expression of pro- and anti-inflammatory genes, 
but also influence cell migration, proliferation, and apoptosis (Falk, Hooper et al. 1998; Cario, 
Rosenberg et al. 2000; Bäckhed and Hornef 2003). It remains obscure how the microbial sensing 
by the host immune system discriminates between the development of tolerance that is stimulated 
by the commensal gut microbiota and other benign luminal antigens, and mounting of cytotoxic 
responses towards undesired pathogens. The role of adaptive immune response in mounting 
balanced pro- and anti-inflammatory responses depending on the nature or subcellular position 
of a particular antigen could be a mechanism by which the host immune system tolerates or 
defends against the microbiota and pathogens, respectively. Surface expression of receptors by 
dendritic cell populations that can activate regulatory T cells (Tregs) may determine the direction 
of the mucosal immune response either towards inflammatory responses or tolerance (Coombes 
and Powrie 2008). For example, pathogenic bacteria induces the maturation of dendritic cell 
populations that activate the effector T cell subpopulation and results in strong cytotoxic, 
inflammatory responses (Rescigno and Di Sabatino 2009). Ignorance of recognition is another 
suggested mechanism that could underlie tolerance development, and it has been shown that 
the gut epithelium can inactivate some TLRs ligands via their delocalization (Bates, Erwin et 
al. 2002). The gut microbiota itself (e.g., Bacteroides species (Ley, Hamady et al. 2008)) may 
play a role in TLR inactivation, providing a mechanism by which inappropriate inflammatory 
responses could be avoided. One of the suggested mechanisms by which the microbiota shapes 
the immune balance during health is via the induction of Tregs activity, including the production 
of transforming growth factor beta (Tgfβ) , interleukin 10 (Il-10), and forkhead box P3 (Foxp3) 
(Round and Mazmanian 2009) (Figure 1.3). Ivanov and co-workers demonstrated that especially 
the commonly abundant phylum of Bacteroidetes is essential to restore the immunological 
tolerance in germfree mice (Ivanov, Frutos et al. 2008). Another proposed mechanism involves 
bacterial DNA that is known to be able to trigger some TLRs, which leads to redirecting of the 
differentiation of T cell populations that supports a decreased susceptibility to infection (Lee, 
Lyons et al. 2011). Intriguingly, conventionally raised mice that were deliberately colonized 
by a defined mix of Clostridium strains in their early life were more resistant to colitis, which 
involved in particular the clusters IV and XIVa of Clostridium that stimulated the development 
of Tregs in the colon mucosa (Atarashi, Tanoue et al. 2011). In addition, Faecalibacterium 
prausnitzii has been proposed to promote anti-inflammatory responses that can protect against 
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2, 4, 6-trinitrobenzene sulfonic acid (TNBS) induced colitis in a mouse colitis model (Sokol, 
Pigneur et al. 2008). These experiments using simplified microbial interaction models in 
ex-germfree and conventional animal models, have provided elegant examples of the role of 
the intestinal microbiota in the shaping of the host immune system by instructing T helper cell 
differentiation, by bringing about shifts in the balance between regulatory and inflammatory 
immune responses (Lee and Mazmanian 2010). These findings also have illustrated that an 
intact epithelial barrier and a balanced innate and adaptive immune system are prerequisites 
for the maintenance of intestinal homeostasis. Gross deviations from homeostasis elicit 
detrimental effects in the host’s physiology, and altered or aberrant microbial composition 
(also called dysbiosis) may include the decreased abundance of anti-inflammatory microbes 
and/or the increased abundance of potentially pathogenic symbionts, or pathobionts (Chow 
and Mazmanian 2010) that can trigger inflammatory responses.  Such microbiota aberrations 
can lead to inadequate immune functioning and inflammatory responses by an imbalance 
between regulatory and pro-inflammatory T cells (Th1 and Th17) (Figure 1.3), which may 
especially occur in genetically susceptible hosts (Lee and Mazmanian 2010; Zhu, Yao et al. 
2011). In these situations, the gut microbiota becomes harmful to its host and ultimately in an 
interplay with the host genotype and environmental triggers (Packey and Sartor 2009) may lead 
to a variety of diseases, including inflammatory bowel disease (a collective term for Crohn’s 
disease and ulcerative colitis), autoimmunity, rheumatic diseases, cardiovascular diseases and 
atherosclerosis, allergy, autism, as well as cancer (Sekirov, Russell et al. 2010). The favorable 
response of inflammatory bowel disease patients to antibiotic treatment (Round and Mazmanian 
2009) supports the fundamental role of microbiota in the pathology of the disease. Analogously, 
animal models for colitis depend on the presence of an intestinal microbiota and animals that are 
living under germfree conditions do not develop disease symptoms (Burczynski, Peterson et al. 
Figure 1.3. A schematic model of microbiota-mediated immune response. (A) Adequate gut immune defense 
is achieved in the presence of balanced microbial community and an associated regulated immune response. 
(B) Inadequate gut immune defense as a result of dysbiosis during which the number of pathobionts increases, loss 
of intestinal barrier and the consequent loss of well-balanced immune response, which would lead to inflammation.
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2006). Inflammatory responses in the gut of humans as well as animal models for inflammatory 
bowel disease have been shown to be strongly associated with increased abundance levels 
of certain bacterial groups including Escherichia coli (Zhu, Yao et al. 2011), Clostridium, 
Enterococcus, and Helicobacter (Chow, Tang et al. 2011), and  decreased abundance of microbes 
like Faecalibacterium prausnitzii (Sokol, Pigneur et al. 2008). In addition, Crohn’s disease was 
found to be associated with reduced diversity of gut microbiota (Manichanh, Rigottier-Gois et 
al. 2006; Qin, Li et al. 2010; Lepage, Haesler et al. 2011) including a decrease in the mucolytic 
bacteria, Akkermansia (Png, Linden et al. 2010), and Firmicutes, in particular the Clostridium 
leptum group (Manichanh, Rigottier-Gois et al. 2006). These findings support a pivotal role of 
microbial dysbiosis in inflammatory diseases (Garrett, Lord et al. 2007; Swidsinski, Doerffel et 
al. 2011), particularly in combination with host genetic and environmental alterations. 
The Role of Gut Microbiota in Host Metabolism, Energy Harvest, and Metabolic 
Diseases
The gut microbiota is able to perform chemical transformations of diet and host derived 
compounds that are of significant importance to the host metabolism (Nicholson, Holmes et al. 
2005). The microbiota were proposed to be a “metabolically active organ” inside the human 
body (O’Hara and Shanahan 2006). This microbial community has a profound effect on the 
intestinal metabolic functions and drives metabolic adaptations in the host tissues both locally 
(in the intestine), but also systemically (Figure 1.4) (Bäckhed, Ley et al. 2005). 
Figure 1.4. A schematic model illustrating the impact of gut microbiota on host metabolism. (A) Colonization 
by gut microbiota leads to the production of SCFAs that bind to GPR41 and 43 receptors to control energy balance, 
partly via the induction of the gut-derived hormone PYY, and anti-inflammatory responses. Microbial signals 
inhibit the expression of Angptl4 , thereby promoting the peripheral Lpl-fat storage. (B) High levels of LPS 
(endotoxemia) observed in obese and diabetic patients are transported from the intestine to the blood leading to 
impaired gut integrity and activation of macrophages which in turn causes low-grade inflammation. Adapted from 
(Delzenne, Neyrinck et al. 2011; Tilg and Kaser 2011).
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The microbiota stimulates glucose uptake in the small intestine, leading to substantial elevation 
of serum glucose and insulin levels, which in its turn stimulates hepatic lipogenesis (Towle 
2001; Bäckhed, Ding et al. 2004; Delzenne and Cani 2010). Moreover, the gut microbiota in the 
large intestine contributes to the degradation of complex carbohydrates from the diet, making 
these components accessible for the host as an energy source (Varki 1993; Ley, Bäckhed et al. 
2005). This fermentation process results in the production of SCFAs and the gases CO2 and H2 
(Flint, Bayer et al. 2008). The most predominant SCFAs are acetate (taken up by peripheral 
tissues (Cummings, Pomare et al. 1987) or used by adipocytes for lipogenesis (Bergman 1990), 
propionate (transported to the liver), and butyrate (metabolized by intestinal epithelium into 
ketone bodies or oxidized to CO2), but may also include fermentation end-products with higher 
energy contents like lactate or succinate. SCFAs represent the main energy source of the large 
intestine epithelium (Cummings and Macfarlane 1991) and their presence in the large intestine 
lumen leads to a lowering of the local pH, which may cause changes in the microbial composition 
that may include expansion of the Bificobacterium spp. and Lactobacillus spp. that are supposed 
to contribute to the host’s health (Kleerebezem and Vaughan 2009). Several studies highlighted 
the role of SCFAs in human health. Butyrate has been the focus of many studies aiming to 
unravel its suggested role in cancer prevention (Cummings, Pomare et al. 1987; Hamer, Jonkers 
et al. 2008) and overall impact on the human physiology. Butyrate plays a vital role in epithelial 
cell proliferation and differentiation whereas it inhibits the growth of colorectal cancer cells 
(Blottiere, Buecher et al. 2003). SCFAs signal via the G-protein coupled receptors 41 and 
43 (Gpr41,43). Gpr43 plays an important role in immune modulation (Maslowski, Vieira et 
al. 2009) and has a pivotal role in the regulation of energy balance (Bjursell, Admyre et al. 
2011). Gpr41 is expressed in enteroendocrine cells and influences the production of specific gut 
peptides such as peptide YY (PYY), ghrelin, and glucagon-like peptide-1 (GLP-1), which have 
been proposed to modulate insulin secretion, lipid and glucose metabolism, and food intake 
(Cani, Hoste et al. 2007) (Figure 1.4A). 
Using germfree animal models, the microbiota has been shown to stimulate fat storage processes 
in the animals through the modulation of its key regulator, angiopoietin like protein-4 (Angptl4, 
also known as Fiaf), which signals that there is a change in the host energy supply, shifting 
from lipid rich to polysaccharide rich diet (Bäckhed, Ding et al. 2004). Suppression of Fiaf 
elicits a subsequent increase in the activity of lipoprotein lipase enzyme (Lpl) that catalyzes 
adipogenesis and lipogenesis (Bäckhed, Ding et al. 2004; Cani and Delzenne 2009) (Figure 
1.4). Bäckhed and co-workers found that the increase in microbiota-induced body fat storage 
coincides with an increase in the adipocyte-derived hormone leptin (Pelleymounter, Cullen et 
al. 1995; Bäckhed, Ding et al. 2004), which in addition to its role in reducing food intake and 
increasing energy expenditure (Pelleymounter, Cullen et al. 1995), also has an impact on the 
immune response (La Cava and Matarese 2004) preventing excessive inflammatory responses to 
microbial infection (Guo, Roberts et al. 2011). These findings exemplify the close interrelation 
between host metabolism and immune response.
Microbial colonization and its role in host energy homeostasis in conventionalized germfree 
mice has been linked to increased fat storage and weight gain (Bäckhed, Ding et al. 2004), which 
underpinned earlier observations of increased caloric intake in germfree animals compared to 
their conventionally raised counterparts (Wostmann, Larkin et al. 1983). With the increasing 
prevalence of obesity especially among Western populations and its link to associated diseases 
like hypertension,  cardiovascular disease, type 2 diabetes, and cancer (Haslam and James 2005) 
this finding has stimulated many research approaches to unravel the underlying mechanisms 
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and microbial interactions. Several recent studies have aimed to illustrate the link between gut 
microbiota and obesity and have, to a certain extent, generated conflicting results. Initial studies 
by Ley and co-workers, using a leptin deficient ob/ob mouse model for obesity, associated 
obesity to a shift in  the ratio of Firmicutes over Bacteroidetes (Ley, Bäckhed et al. 2005). 
In contrast, Turnbaugh and colleagues showed that gut microbiota transplantation from obese 
donor (ob/ob genotype) to lean acceptor (wild-type) mice resulted in increased fat deposition 
and weight gain in the transplanted mice, indicating that the microbiota played a causal role 
in the obesity phenotype in this model (Turnbaugh, Ley et al. 2006). Later studies from the 
same group confirmed that the differences observed in obese and lean mouse microbiotas were 
conserved in obese people and could be influenced by caloric restriction (Ley, Turnbaugh et al. 
2006). However, other studies could not directly confirm these initial findings and suggests that 
obesity may be associated with more subtle changes in the microbiota composition (Duncan, 
Lobley et al. 2008; Zhang, DiBaise et al. 2009; Schwiertz, Taras et al. 2010). In addition, some 
studies have related the changes observed in the microbial composition of obese patients to 
high fat, high energy diet (Cani, Amar et al. 2007). Moreover, Cani and co-workers correlated 
the increase in the lipid content in high energy diets to low-grade inflammation, which was 
found to be associated with obesity and was proposed to be triggered by elevated plasma levels 
of bacterial lipopolysaccharides (LPS) that was designated “metabolic endotoxemia” (Gregor 
and Hotamisligil 2011) (Figure 1.4B). High energy diets have been proposed to cause an 
impairment of the epithelial barrier and a subsequent increased diffusion of bacterial LPS and 
their increased transport via chylomicrons into the submucosal tissues and blood. This rupture 
of the gut epithelial barrier may lead to an activation of macrophages and a type of low-grade 
inflammation, that is typical for obesity (Delzenne 2011). These findings again illustrate the 
strong correlations between metabolic and immune processes.
In conclusion, the gut microbiota intimately interacts with the host and plays a key-role in shaping 
the host’s physiology, with an impact on health and disease.  The post-conventionalization 
period during which germfree animals are exposed to the colonizing microbiota is assumed 
to resemble the post natal period during which neonate mucosal surfaces become gradually 
colonized after emerging from the sterile environment of the mother’s uterus. This neonatal 
stage represents the most critical period during which the host is influenced by the microbiota 
(Macpherson and Uhr 2004; Palmer, Bik et al. 2007; Tlaskalova-Hogenova, Stepankova et 
al. 2011). Analysis of microbiota in newborns illustrates the relatively unstable colonization 
during early stages of life, characterized by low diversity, facultative anaerobes. This early 
community is followed by a dynamic and unstable succession of low diversity microbial 
composition (Palmer, Bik et al. 2007; Adlerberth and Wold 2009) until the establishment 
of a relatively stable, complex and host-specific microbial community towards adulthood. 
Together with the great post-natal development of the metabolic profile and immune system 
which marks the first years of life (Round and Mazmanian 2009), these findings suggest that 
any deviation from the normal development of microbiota during this early stage of life may 
affect the host physiological homeostasis and result in predisposing individuals to disease in 
later stages of life. Our knowledge of host-gut microbe interactions is accelerated by rapidly 
expanding genomics based molecular techniques such as transcriptomics, metabonomics, and 
metagenomics, especially in combination with the use of in vivo host models such as germfree 
animals. The research described in this thesis aims to define the temporal and region-specific 
dynamics of establishing the microbial community which colonizes germfree mice during their 
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conventionalization. In addition, the investigation of microbial development is paralleled by 
deciphering the molecular host responses over time, which may provide important insights in 
the microbial impact on host metabolism and immune system, and gene regulatory programs 
involved in establishing a homeostatic state that accommodates the microbiota. 
THESIS OUTLINE AND AIMS
The work presented in this thesis was embedded in a larger Top Institute of Food and Nutrition 
(TIFN) funded project, “Nutritional and microbial modulation of intestinal epithelial integrity”. 
Within this framework, this project aimed at understanding the molecular dynamics of the mouse 
intestinal mucosa responses to the gut microbial community and its role in maintenance of 
mucosal homeostasis. To study this, C57/BL6 J male, germfree mice were used as a reductionist 
model. The germfree mice were colonized with bacterial suspension obtained from freshly 
collected fecal material of conventionally raised mice, and the molecular responses in the 
intestine of these conventionalized mice were followed at different time-points over a period of 
30 days. The analyses that were included addressed both the dynamics of mucosal transcriptome 
responses, and the parallel metabonome changes occurring in these mucosal tissues and plasma, 
with the simultaneous determination of the colonizing microbiota (Figure 1.5). The specific 
objectives that are addressed in each chapter are listed below.
Chapter 2 aimed to decipher the genetic regulation of the dynamics of host immune response to 
the colonizing microbiota throughout the GI tract. Time-resolved transcriptome and (immune)-
histochemical analyses were evaluated in three different intestinal regions, jejunum, ileum, and 
colon, after microbial conventionalization of germfree mice during 30 days. The combined 
analyses revealed a sequential development of the innate and adaptive immune arms in the mucosa 
of the mice, and enabled the identification of a core gene network that controls the dynamic, 
region-specific establishment of intestinal immune homeostasis during conventionalization. 
The results of this study highlighted the high responsiveness of the proximal small intestine to 
the presence of the microbiota, which was the focus of Chapter 3. In this chapter, histological, 
transcriptome, and 1H NMR metabonome analyses, as well as microbial profiling were 
employed to provide insight in the detailed molecular dynamics by which the presence of the 
microbiota coopts the metabolic function of the jejunal tissue. In addition, mining of the jejunal 
transcriptomes allowed the reconstruction of a core gene regulatory network that is proposed to 
orchestrate the jejunal metabolic changes in response to the colonizing microbiota, and which 
displays strong correlation to insulin-coordinated responses in tissue, supporting a prominent 
diet and microbiota sensing role of the jejunal mucosa. In Chapter 4 we monitored the succession 
of microbial groups during conventionalization by determining the time-resolved composition 
of colon microbial communities in detail, in parallel with the colon mucosa transcriptomes, and 
the colon and urine metabonomes. The latter data were determined by 1H NMR spectroscopic 
profiling of the complete mucosal tissue and urine.  Computational modeling was applied 
to correlate the obtained multi-variate data from germfree and conventionalized mice. This 
study enabled an overall description of transient and more permanent alterations in the colon-
microbiome-metabonome interaction. Chapter 5 focused on a transient mucosal state that was 
characterized by a transient loss of immune homeostasis, which was identified within the time 
frame studied in Chapter 2. This transient state appeared to reflect the boundaries of tolerance 
of the mucosal immune system towards the luminal microbiota. Colon tissue transcriptomes, gut 
microbiota composition, and specific plasma metabolites were employed to enable multi-variate 
analysis of this transition state during conventionalization. Microbiota profiling illustrated the 
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dominance of specific microbial groups that have previously been identified as “pathobionts” 
which appeared to play a role in the subsequent activation of the adaptive immune response. 
Finally, Chapter 6 summarizes and discusses the contribution of this work to the current 
knowledge of the host-microbe interrelations with an emphasis on future directions.                
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Figure 1.5. Outline of the conventionalization experiments performed on C57/BL 6 J germfree mice in this study. 
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Table 1.2.  Composition of the semi-synthetic chow diet. (*) Nurish 1500 (DuPont Protein Technologies),               
(#) Analyses were performed by Eurofins scientific. 
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CHAPTER 2
ABSTRACT
During microbial conventionalization of germfree mice, molecular responses of the intestinal 
mucosa initiate and maintain a balanced immune response. However, the genetic regulation 
of appropriate responses to microbiota is obscure. To better understand the genetic regulation 
of the dynamics of this balanced response toward the colonizing microbiota, transcriptomic 
profiles were determined at different time-points and in three different intestinal regions 
after microbial conventionalization of germfree mice. Combined analyses of germfree and 
conventionalized mice revealed that the major molecular responses could be detected initiating 
at day 4 post-conventionalization, with a strong induction of innate immune functions including 
the production of antimicrobial peptide molecules followed by stimulation of adaptive immune 
response at later stages of conventionalization.  A central regulatory network that controls the 
dynamic, region-dependant mucosal responses to the colonizing microbiota could be identified. 
Some of the genes within this regulatory network have known roles in mucosal inflammatory 
diseases in mouse and human. Our data suggest that the identified central regulatory network 
could serve as a genetic signature for control of intestinal homeostasis in healthy mice and may 
help to decipher the genetic basis of pathway dysregulation in human intestinal inflammatory 
diseases.
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INTRODUCTION
Mammals are germfree in utero and become colonized by microbes during and after birth fol-
lowing a dynamic process that results in taxonomically diverse bacterial populations that estab-
lish a symbiotic relationship with the host (Falk, Hooper et al. 1998). After colonization is com-
pleted, the intestine of conventionally raised mice is in continuous contact with a vast diversity 
of microbes, collectively termed as gut microbiota. Notwithstanding the exposure to trillions 
of microbiota, the intestinal mucosa maintains a state of homeostasis which involves tightly 
controlled immune responses. To achieve this, epithelial cells and immune cells of the lamina 
propria mount innate and adaptive immune responses that sustain tolerance to microbiota but 
at the same time will detect and kill infiltrating pathogens (Sansonetti and Di Santo 2007). 
Maintenance of mucosal immune homeostasis is essential for intestinal health. For example, in 
human, disproportionate immune responses that cause loss of homeostasis may lead to inflam-
matory bowel diseases (Baumgart and Carding 2007; Abraham and Cho 2009). Gut microbiota 
is proposed to play a crucial role in the establishment and maintenance of adaptive immunity 
and homeostasis (Lee and Mazmanian 2010), in which the complexity of the microbial commu-
nity elicits an equally complex immunological response in the host. This host response is estab-
lished by microbial cross-talk with the mucosal immune system through a variety of highly in-
tegrated signaling pathways and gene regulatory networks. Notwithstanding our knowledge on 
signaling pathways that play roles in the mucosal immune system (West, Koblansky et al. 2006; 
Hayden and Ghosh 2008; Chen, Shaw et al. 2009; Zhu, Yao et al. 2011), our understanding of 
the genetic regulation of homeostasis is still very incomplete. In healthy animals, maintenance 
of homeostasis is a dynamic process where changes in the gut microbiota composition will lead 
to appropriate, tolerant responses in the mucosa. Comparative studies of germfree mice and 
their conventionalized counterparts that have been inoculated with microbial communities from 
conventionally raised donors, established a prominent role of the microbiota in guiding immune 
cell development, maturation, and function (Macpherson and Harris 2004). 
 In a hallmark study by Gaboriau-Routhiau and colleagues (Gaboriau-Routhiau, Rakotobe et 
al. 2009), it was reported that nearly 50% of the genes differentially expressed in the intestine 
of gnotobiotic mice during microbial conventionalization regulated T cell development and re-
sponses to gut microbiota. Especially a particular member of the microbial community, the seg-
mented filamentous bacteria, was capable of eliciting an immune response in the mucosa that 
resembled the response to conventionalization. The study of (Gaboriau-Routhiau, Rakotobe et 
al. 2009) aimed to unravel the mechanisms by which segmented filamentous bacteria induced 
mucosal adaptive immune responses, with the main focus on the terminal ileum. In the current 
study we present the time-resolved, genome-wide immune-related gene expression programs 
that are elicited in the mucosa of jejunum, ileum, and colon in germfree mice upon their con-
ventionalization, and the validation of these programs by immunohistochemistry. Our findings 
show that conventionalization of germfree mice induced multigenic defense- and  immune- 
related transcriptional responses that reflect the sequential activation of innate and adaptive 
immune responses, most pronounced processes associated with T cell development and matura-
tion. The intestinal transcriptomes enabled the reconstruction of a core gene regulatory network 
that is proposed to govern the dynamic intestinal response to the microbiota and thereby play 
a key-role in maintenance of mucosal homeostasis. The human counterparts of some of the 
genes in this regulatory network have been associated with human mucosal inflammation and 
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diseases. This finding suggests that the expression pattern of these network-genes could serve 
as a genetic signature for the control of mucosal-homeostasis in healthy mice, which may aid 
the unraveling of the genetic basis of pathway dysregulation in human intestinal inflammatory 
diseases.
RESULTS
Changes in the Intestinal Physiology and Morphometry during Conventionalization
This study was aimed at identifying the time-resolved intestinal mucosal changes in germfree 
and conventionalized mice as measured in three independent experiments where intestinal 
tissues as well as luminal content were sampled after short and longer term conventionalization 
periods (for an experimental set-up, see: Chapter 1- Figure 1.5).  As a typical hallmark of 
conventionalization, the cecal weight was 80% reduced upon conventionalization when 
compared to germfree mice (Figure 2.1A); this difference was measured from day 4 post-
conventionalization onward. Intestinal morphometric analysis revealed clear, time-dependent 
alterations in mucosal tissue morphology upon conventionalization. An initial significant 
increase (p < 0.01) in the intestinal crypt depth was observed in the small intestine and the 
colon of conventionalized mice 4 days post-conventionalization, which was not yet visible on 
days 1 and 2. In the small intestine, crypt depth increased continuously during the first 16 days 
to decline at 30 days of conventionalization; at day 30, small intestinal crypt depth remained 
higher as compared to the germfree mice. In contrast, the colon crypt depth reached a maximum 
level from day 8 to day 16 but at day 30, had returned to crypt depths that were also measured 
in the germfree mice (Figure 2.1B). Concomitant to the lengthening of the crypts, the lamina 
propria in both the jejunum and ileum expanded by a global increase in connective tissue cells 
combined with the infiltration of lymphocytes and other mononuclear cells (Figure S2.1A). 
Conventionalized mice at days 4, 8, and 16 had significantly (p <0.05) higher number of Ki-67-
positive cells compared to germfree (Figure 2.1C). Ki-67 positive cells predominantly localized 
in the crypts, but were also seen in the intervillus region and in the lamina propria of the small 
intestine at day 30. Relative enumeration of Ki-67-positive and –negative cells in colonic crypt 
epithelia revealed a maximal percentage of positive cells on days 4 and 8, followed by a decline 
at day 16 post-conventionalization (Figure S2.1B). Notably, the percentage of proliferating 
cells had declined further at day 30 but remained significantly (p <0.05) higher than in the 
germfree (not shown). 
To obtain global information on induction of innate immunity at day 4 post-conventionalization, 
the day at which the largest transcriptome shift was initiated; High Iron Diamine-Alcian Blue 
(HID-AB) staining of mouse intestinal sections was performed. The HID-AB stain detects the 
mucin load of goblet cells and discriminates between sialylated and sulfated mucins. The results 
showed that in jejunum and colon (but not ileum), less mucin-filled goblet cells were observed 
at day 4; in the colon, day 4 was also characterized by a transient domination of sialylated 
over sulfated mucin-containing goblet cells (Figure 2.1D). Taken together, these results clearly 
illustrate the region-specific transient and permanent changes in the intestinal morphology and 
cell proliferation as a consequence of microbial colonization. These changes did become most 
pronounced from day 4 post-conventionalization onward.
Establishment of the Gut Microbiota during Conventionalization
In order to get insight in the dynamics of the establishment of the microbiota in the gastrointestinal 
(GI) tract of conventionalized mice, samples from jejunum, ileum, and colon were collected 
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at days 1, 2, 4, 8, and 16 post-conventionalization and were compared for 16S RNA gene 
diversity among each other and with the inoculum. Quantitative (qPCR) detection of 16S 
rRNA gene copies in colon samples indicated that a full-sized microbial community was very 
rapidly established, i.e., already on day 1 post-conventionalization the microbial community 
contained approximately 11.6±0.5 16S rRNA copies/g colon content (expressed as log10). This 
community size-estimate did not significantly change during the experiment, indicating that 
the microbial community reached its climax size in a single day. Molecular fingerprinting of 
the composition of the colonizing microbiota was performed using MITChip analysis, a 16S 
rRNA-based phylogenetic array specifically designed to classify murine microbiota (Geurts, 
Lazarevic et al. 2011).  These analyses revealed that the colon microbial diversity remained 
relatively low during days 1 and 2 and significantly increased (p=0.001) at later time-points of 
conventionalization, reaching a stable diversity level on days 8 and 16. This diversity resembled 
that of the original inoculum (Figure 2.2A). Pearson correlation based similarity analysis of 
MITChip profiles of the colon samples indicated that the similarity of the colon microbiota 
relative to the inoculum increased from approximately 60 % to 80 % during the course of 
conventionalization (Figure 2.2B), indicating that the climax community was indeed comparable 
to that of conventional mice. This level of similarity is comparable to what is commonly found 
when the microbiota of individual conventionalized mice was compared (not shown). MITChip 
analysis also allows more detailed evaluation of the dynamics of colonization by specific 
phylogenetic groups, revealing that day 1 was characterized by a higher relative abundance of 
Gram-negative Bacteroidetes while later stages of conventionalization (days 8 and 16) showed 
an expansion of the relative abundance of the Gram-positive Firmicutes (Figure 2.2C). The 
expansion of the Firmicutes phylum was particularly large for the members of Clostridium 
clusters IV and XIVa, while the initial abundance of the bacilli (days 1 and 2) declined upon 
prolonged conventionalization (Figure S2.2A). Finally, multi-variate analysis (RDA) of colon 
and small intestine derived microbiota profiles (jejunum and ileum) clearly established that 
each intestinal location did harbor different microbial consortia; especially the diversity of the 
small intestine community appeared to be significantly lower than that encountered in the colon 
(Figures S2.2B,C). These data indicate that microbial colonization of the intestine proceeds via 
the rapid appearance of early colonizers, followed by the establishment of a stable community 
that resembles the microbiota of the conventional donor animals. This outcome clearly indicates 
efficient colonization of the GI tract in the conventionalized mice. 
Mucosal Transcriptomes Reveal Temporal and Region-Specific Immune Responses
In order to investigate the pathways underlying the mucosal changes observed, tissue gene 
expression patterns of jejunum, ileum, and colon at all time-points post-conventionalization 
were compared to day 0 (germfree state). Taking into account the time series experimental 
design used, the Short Time series Expression Miner (STEM) software program was used to 
identify genes with similar, time-dependent gene expression patterns over the 30-days timespan 
of conventionalization. Clustering of genes was determined separately for each location of the GI 
tract. STEM significantly fitted the small intestine and colon data to different expression profiles 
models (Figure S2.3). In these profiles, immune-related gene ontology (GO) categories were 
strongly enriched (p <0.001; nearly 40% of the genes regulated in response to conventionalization 
were annotated with immune-related GO terms). Interestingly, the expression patterns of 
immune related genes were different in the small intestine and colon (Figure S2.3). STEM 
output was confirmed by GO-enriched bayesian clustering which demonstrated that the most 
strongly upregulated GO categories included immune system processes and cell differentiation, 
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Figure 2.2 Establishment of 
the gut microbiota during 
conventionalization. (A) Diversity 
of the total colon microbiota 
at different time-points post-
conventionalization, expressed as 
Simpson index of the hybridization 
profiles analyzed by the MITChip. 
(B) Pearson correlation similarity 
index of the MITChip profiles from 
colon samples at different time-
points post-conventionalization, 
including the comparison to the 
inoculum. Significant differences 
between time-points are indicated 
by distinctive characters above 
the measurement groups. 
(C) Dynamics of the relative 
contribution of different microbial 
groups (level 0, which is similar 
to phylum level phylogeny) to the 
overall microbiota in the colon 
of mice at different time-points 
post-conventionalization, and in 
comparison to the inoculum. d=day.
Figure 2.1. Effect of 
microbial colonization on 
the intestinal physiology 
and morphology. (A) Total 
cecal weight determined 
as a measure of bacterial 
colonization, and the insert 
shows a photograph of cecum 
at day 0 (left) and day 4 (right), 
respectively.   (***= p <0.001 
compared to germfree). (B) 
Mean crypt depth measured 
from villi and crypts from the 
jejunum, ileum, and colon in 
germfree, conventionalized 
mice at six time-points 
post- conventionalization. 
Results are presented as 
means ± SD. Significant 
differences between time-
points are indicated by 
distinctive characters above 
measurement groups. (C) IHC 
detection of Ki-67 positive 
cells using Mib-1 antibody in 
ileal tissues in germfree (a), 
days 4 (b), and 30 (c) post-
conventionalization.(D) Representative HID-stained colon sections, showing the dynamics of mucin subtypes 
distribution in germfree (a), days 4 (b), and 16 (c) post-conventionalization. Sialylated mucins stain blue, while 
sulfated mucins stain brown/black.
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especially of immune cells (Figure S2.4). Among the upregulated categories was one gene 
set annotated with GO category “immune response” which was induced on 72% of the arrays 
used. Collectively, these results showed that the majority of the differentially expressed genes 
during conventionalization participate in the immune response, in a time- and region-dependent 
manner. 
Induction of Local Antimicrobial Defense and Surface Receptors at Day 4 Post- 
Conventionalization
STEM time-series analysis identified gene clusters assigned to GO-terms associated with 
innate immunity as a major response category. GO enrichment analysis (supplemental 
information) highlighted the induction of expression of surface receptors involved in microbial 
recognition at day 4 post-conventionalization throughout the GI tract. These receptors included 
Figure 2.3. Dynamics of induction of innate immune molecules during conventionalization.  (A) Gene 
expression levels of RegIIIγ, RegIIIβ, Retnlβ, and Pla2g2a, in jejunal, ileal, and colonic tissues, and Mmp7 in 
jejunal and ileal tissues from germfree and conventionalized mice at indicated days post-conventionalization. 
Individual values determined in the animals and their medians are shown. Significant differences between time-
points are indicated by distinctive characters above the measurement groups (p <0.05). (B) Representative IHC 
of lysozyme-P in ileum tissues from germfree (a), days 1 (b), 2 (c), 4 (d), 8, and 16 (f) post-conventionalization. 
(C) Representative IHC of RegIIIγ in ileum tissues from germfree (a), days 4 (b), and 30 (c) post-conventionalization. 
Arrows indicate positively stained cells.
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the lipopolysaccharides (LPS) receptor (Cd14), the intracellular signaling adaptor protein 
(Myd88) and the toll-like receptors Tlr1, 2, 8, 9, and 12 but not Tlr4 or 5 (Figures S2.5A,B). In 
parallel, the expression levels of several antimicrobial peptides, including lysozyme P (LyzP), 
regenerating islet derived protein (Reg) IIIβ and -γ, resistin like beta (Retnlβ) and phospholipase 
A2 (Pla2g2a) had clearly increased (Figure 2.3A). The fold-changes related to these innate 
immune responses increased gradually during days 1 and 2 followed by a strong increase at day 
4 post-conventionalization in both the small intestine and colon. Notably, prolonged exposure 
to microbiota (30 days) retained increased expression levels of RegIIIβ and -γ in the small 
intestine, but returned to the germfree-level in the colon. In contrast, the expression levels of 
Retnlβ and Pla2g2a returned to germfree-levels in the small intestine, but remained high in the 
colon. These results suggest that mucosal innate immunity is based on different molecules in the 
small intestine versus the colon. Indeed, immunohistochemical (IHC) analysis verified the LyzP 
loading of secretory granules in the Paneth cells in the small intestine of day 4 (Figure 2.3B), 
which is in agreement with the coinciding increase of expression of matrix metalloprotease 
7 (Mmp7) (Figure 2.3A) that regulates the activity of defensins in intestinal mucosa (Wilson, 
Ouellette et al. 1999). IHC analysis also confirmed the peak production of RegIIIγ at day 4 
(Figure 2.3C). The gene expression and IHC data show that transient induction of innate immune 
factors is region-dependent and was most pronounced after 4 days of conventionalization.  
Antigen Presentation and Pro-inflammatory Cytokine Production at Day 4 Activates 
Local B and T Cells during Later Days of Conventionalization
To further assess the induction of innate and adaptive immune responses during 
conventionalization, the expression patterns of cytokines were used as markers for the release of 
pro-inflammatory signals and attraction of immune cells. Tumor necrosis factor alpha (Tnf-α), 
and interferon gamma (Ifn-γ), a strong activator of microbicidal function in macrophages 
and adaptive immunity (Schroder, Hertzog et al. 2004), were significantly higher expressed 
throughout the intestine upon conventionalization (Figure 2.4A). In the small intestine, their 
expression increased from day 4 onward, and peaked at day 16 post-conventionalization, while 
in the colon, peak induction occurred at day 4 followed by a decline of expression at later time-
points and a gradual return to the levels seen in germfree mice (Figure 2.4A). To investigate 
whether elevated expression of pro-inflammatory cytokines coincided with the expected 
induction of surface expression of MHC class I and II complexes, the dynamics of expression 
of the associated genes were investigated. Members of the MHC class I complex and their 
activators were induced from day 4 onward throughout the GI tract, while the induction of 
members of the MHC class II complex and their transactivator (Ciita) appeared to occur at later 
time-points, mainly peaking at days 8 and 16 post-conventionalization (Figures 2.4A,B).
Adaptive Immune System Development
As anticipated, the increased expression of pro-inflammatory cytokines and MHC class I and 
II molecules during the later stages of conventionalization elicited the induction of expression 
of genes required for T cell function and development on day 8 (colon) and day 16 (small 
intestine) post-conventionalization. The most prominent among these genes were those coding 
the T cell accessory molecules that participate in antigen response, inflammatory chemokine 
ligands (Cxcl9, 10, Ccl2, 3, and 5) and chemokine receptors (Cxcr3, Ccr2, and 5) (Figure 
S2.6). Increased expression of these genes coincided with the increased villus width and lamina 
propria cellularity in the small intestine that were observed in hematoxylin and eosin-stained 
tissue sections (Figure S2.1A).
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Ingenuity Pathways Analysis (IPA) (www.ingenuity.com) and GO-enriched bayesian clustering 
were employed to further detail the biological functions and signaling pathways involved in 
the time- and region-dependent events related to immune (T) cell activation and development. 
According to IPA, (positive) regulation of lymphocyte activation, T cell selection and positive 
thymic T cell selection were among the most significantly enriched (p <0.001) GO categories 
throughout the intestine (Figure S2.7A). Using Genomica (described in supplemental 
information), detailed inspection of the gene set annotated with GO category “T cell activation” 
(Figures S2.7B,C) allowed to further exploring the tissue distribution of T cells. This gene set 
was upregulated from day 4 onward in ileum and from day 8 to 30 throughout the intestine 
(Figure S2.7C) and included the surface markers of T cell infiltration (DeJarnette, Sommers et 
al. 1998); Cd3ε, Cd4, and Cd8.
IHC was used to verify that the suggested gradual increase of T cells expressing the mentioned 
surface markers, with the largest numbers in the small intestine, did indeed occur. Microscopic 
inspection of sections hybridized with the appropriate antibodies showed increased numbers of 
cells positive for the T-cell maturation markers Cd3ε and Cd8 from day 8 onward and highlighted 
the prominent localization of Cd8 positive cells along the epithelial lining of the small intestine 
(Figure 2.5). Compared to Cd8+ and Cd3ε cells, cells positive for the Cd4+ marker were observed 
at lower numbers in the lamina propria of the small intestine at day 16 post-conventionalization 
(Figure 2.5) suggesting a lower Cd4+ T cell influx . Notably, prolonged conventionalization (day 
30) revealed that the increase in T cell numbers (especially Cd8+) had continued in the small 
intestine but had already reached a more steady level in the colon between days 8 and 16. Gene 
expression data demonstrated that the influx of Cd4+Cd8+ T cells was associated with increased 
expression levels of perforins (Prf1) and granzymes (Gzm) (data not shown), molecules that 
are typically produced by activated T cells. Altogether, the increased numbers of cells positive 
for typical markers of T cell activation and maturation indicate activation and development of 
the adaptive arm of the immune system. Development of adaptive immunity appeared to have 
reached a climax level on day 8 in the colon and day 16 post-conventionalization in the small 
intestine and appeared to follow the strong activation of innate immune response that was 
apparent at day 4.
Negative Regulation of the Activated Immune Response 
So far, pro-inflammatory signals have been shown to activate innate and adaptive immunity in 
response to the microbiota. No signs of disease were noticed in the mice during conventionalization 
and no microscopic signs of damage to the intestine or the associated infiltration of immune 
cells were identified. The tolerant immune responses therefore were assumed to have been 
induced by the microbiota, implying negative regulation of the immune response. To investigate 
this, the expression profiles of immune-suppressive cytokines were analyzed. As expected, the 
induction of immune responses coincided with elevation of expression of tolerance-associated 
molecules, starting on day 8 post-conventionalization and continuing during later time-points 
with a climax level on day 8 in the colon and day 16 post-conventionalization in the small 
intestine. These molecules included the forehead box P3 (Foxp3), the marker for Tregs cells (Hori, 
Nomura et al. 2003), Interleukin-10 (Il10), which enforces immune tolerance (Fujio, Okamura 
et al. 2010), and Tbx21 (T-bet), a transcription factor that drives Th1 cell maturation (Miller and 
Weinmann 2010) (Figure 2.6). In addition, the increased expression of cytotoxic T-lymphocyte-
associated protein 4(Ctla4) and Fas ligand (Fasl), in particular at day 8 in the colon and day 
16 post-conventionalization in the small intestine, suggested that apoptotic pathways were 
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Figure 2.4. Expression of TNF-α, Ifn-γ and MHC class I and II complexes. (A)  Jejunum, ileum, and colon gene 
expression levels of TNF- α and Ifn-γ, and MHC class I and II complex activators were analyzed in germfree and 
conventionalized mice at indicated days post-conventionalization. Values are depicted as box and whisker diagrams 
(top-to-bottom, maximum value, upper quartile, median, lower quartile, and minimal value, respectively). Any 
data not included between the whiskers is plotted as an outlier with a dot. Significant differences between time-
points are indicated by distinctive characters above the measurement groups (p <0.05). (B)  Heat map generated 
from the significantly expressed MHC class I and II genes (p <0.05) between the germfree and conventionalized 
mice at the indicated time-points. 
A
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induced in the tissues harboring proliferating immune cells as a regulatory mechanism to avoid 
accumulation of cytotoxic T cells (Figure 2.6). Collectively, the gene expression profiles and 
IHC studies appear to correlate with the region-specific induction of pro- and anti-inflammatory 
signals that together drive a balanced, tolerant type of adaptive immune response that is required 
to ensure appropriate responses to the microbiota.
Figure 2.5. Regional variation of increasing T cell numbers and maturation. Representative IHC of Cd8a (A), 
Cd4 (B), and Cd3ε (C) in ileal tissues from germfree (a), days 16 (b), and 30 (c) post-conventionalization. Dot 
plots represent the expression levels of Cd8a, Cd4, and Cd3ε in jejunal, ileal, and colonic tissues in germfree and 
conventionalized mice at the indicated days post-conventionalization. Individual values and medians are shown. 
Significant differences between time-points are indicated by distinctive characters above the measurement groups 
(p <0.05). All panels are shown at the same magnification; arrows indicate positively stained cells (brown color).
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A Universal, Core Regulatory Network Orchestrates the Immune Responses towards  
the Microbiota 
From the STEM and GO-enriched bayesian clustering results, we hypothesized that there might 
be a common gene regulatory network that governs the re-establishment of mucosal homeostasis 
upon conventionalization throughout the GI tract. The genes that are part of such a network were 
further assumed to show differential expression during all time-points of conventionalization. 
Therefore, STEM time series analysis output sets were mined for genes that display the same 
expression profiles in jejunum, ileum, and colon, and these genes were used to construct a 
protein-protein interaction network in IPA. The resulting network illustrated the strong impact 
of conventionalization on both innate and adaptive immune gene expression (Figure 2.7), 
encompassing several central regulatory nodes that control the induction of innate and adaptive 
immune responses. The IPA-derived network combined the major gene categories that were 
identified by STEM and were strongly induced from day 4 post-conventionalization onward, 
including nodes belonging to bacterial recognition (Cd14), pro-inflammatory cytokines (Tnf-α, 
Ifn-γ), chemokines (Ccl5, Ccr5, Cxcl9, Cxcr3, Ccl8), and MHC Class I (Psmb8, 9, Tap1,2, 
H2-Q).  The network also included nodes representing MHC Class II molecules (Ciita, H2-
Ab1, H2-DMa, H2-DMb1), T cell differentiation and maturation (Lck, Lat, Zap70), cell surface 
markers (Cd3ε, Cd4, Cd8), and B cell differentiation (Ptprc). These nodes showed an increased 
expression at later time-points, i.e. day 8 in the colon and day 16 in the small intestine (Figure 
2.7B). Notably that repression of the genes in this network only occurred during the early days; 
at 8, 16, and 30 days post conventionalization, all genes in this network were induced (Figure 
2.7B).
Figure 2.6. Increased expression of tolerance associated functions at later time-points of conventionalization.
Jejunum, ileum, and colon gene expression levels of regulatory cytokines were analyzed in germfree and 
conventionalized mice at the indicated days post-conventionalization. Values are depicted as box and whisker 
diagram (top-to-bottom; maximum value, upper quartile, median, lower quartile, and minimal value, respectively). 
Any data not included between the whiskers is plotted as an outlier with a dot. Significant differences between 
time-points are indicated by distinctive characters above the measurement groups (p <0.05).
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In parallel, a protein-protein interaction map was generated from the cluster-driven time series 
analysis of GO categories using bayesian statistics (Figure S2.8). This network combined genes 
that belong to T cell differentiation and maturation (e.g. the kinases Lck and Zap70), innate 
immune effectors (C2, C3), chemokines (Cxcl2, Il10, Tnf-α), MHC (H2-Q) and cell surface 
markers (Cd3ε, Cd4, Cd8). These two latter analyses showed that T cell selection, - induction 
and - differentiation pathways were among the most important induced mucosal pathways 
during mouse conventionalization. Notably, the two core regulatory networks, constructed 
using very different approaches and statistical methods, contained identical major regulatory 
nodes, supporting the prominent roles of these nodes during immune system development. 
IPA found 13 associated genes in the core network with known roles in inflammatory bowel 
disease (indicated with arrows in Figure 2.7A). These findings support the biological relevance 
of the central nodes within this regulatory network in maintenance of homeostasis. We propose 
that these genes are key regulators of appropriate immune interactions with the gut microbiota 
Figure 2.7. Core regulatory network that governs the dynamic establishment of intestinal homeostasis 
during conventionalization. (A) The ingenuity protein-protein interaction network derived by plotting STEM 
output genes that occur in the profiles involved in immune response in the jejunum (J), ileum (I), and colon (C). 
Transcriptional data was projected onto the interaction map. Arrows refer to associated genes with known role in 
inflammatory bowel disease. (B) Heat map of the genes that constitute the core regulatory network. The heat map 
in panel B is placed on the next page (38).
38
CHAPTER 2
and that the expression profiles of these genes may be used 
to construct a molecular signature of mucosal control of 
homeostasis. 
DISCUSSION
It has been widely recognized that the interplay between gut 
microbiota and the host is crucial for proper development of 
the (adaptive) immune system (Lee and Mazmanian, 2010) 
and that dysregulation of this interaction contributes to the 
development of inflammatory bowel disease symptoms 
(Abraham and Cho 2009). There is a clear requirement 
for the balanced genetic regulation of appropriate, tolerant 
responses to the microbiota (Bouma and Strober 2003; 
Geuking, Cahenzli et al. 2011). This is also supported by the 
finding that mutated forms of genes involved in regulation 
of basal immunological processes such as microbial uptake 
are strongly associated with inflammatory bowel disease 
phenotypes (Deretic and Levine 2009). 
The present study implemented profiling the genome-wide 
expression of genes involved in local (jejunum, ileum, 
and colon) mucosal immune system development in a 
time-resolved (6 time-points) manner, in germfree mice 
upon conventionalization. Our study corroborated several 
important findings from the study by Gaboriau-Routhiau 
and colleagues (Gaboriau-Routhiau, Rakotobe et al. 2009). 
In both studies, it was found that the largest category 
of genes that is regulating the response to microbial 
colonisation is the immune response, and that T cells (not 
B cells) play key roles in the mucosal response to microbial 
colonization of germfree mice. Transcriptomic analysis 
including gene ontology (GO) enrichment and pathway and 
(gene regulatory) network analysis, showed that there was 
a time- and region-dependent enrichment of genes involved 
in balanced innate and adaptive immune responses. These 
tolerant responses ensured that a novel state of homeostasis 
was reached within 30 days of conventionalization. 
Strikingly, both transcriptomic and immunohistochemical 
analyses for cytokines, chemokines, T cell surface markers 
and immune cell transcription factors and histological 
stainings of innate immune parameters showed that a novel 
homeostasis had been reached in the colon within 8 to 16 
days, whereas establishment of homeostasis in the small 
intestine required 16 to 30 days of conventionalization.
Remarkably, the shift in the microbiota composition (day 
4) coincided with the shift in host responses. Microbial 
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profiling of the colon microbiota during conventionalization indicated that initially colonizing 
microbial communities are characterized by low diversity and higher abundance of Bacteroidetes 
(days 1 and 2), while the stable community established on day 8 is more diverse and dominated 
by Firmicutes (particularly the Clostridium clusters IV and XIVa).
Day 4 post-conventionalization consistently stood out in the transcriptome analyses and was 
characterized by drastic changes in gene transcription. For instance, gene expression could 
switch from induction to repression and vice versa; and some genes were no longer expressed 
while others were expressed for the first time. At this time-point, the activation of cascades of 
genes involved in innate immunity activation and initiation of adaptive immune responses was 
most pronounced.
No changes in the expression level of Il-17 were noticed throughout the GI tract during the 
process of conventionalization (not shown) suggesting that the colonization of the C57BL/6 J 
mice with their normal fecal microbiota did not induce Th17 differentiation, which corroborates 
the results of Ivanov et al. who  reported that colonization of C57BL/6 mice purchased from 
the Jackson laboratories (J) was not sufficient to induce Th17 differentiation in their lamina 
propria due to the absence of segmented filamentous bacteria (Ivanov, Atarashi et al. 2009).  As 
recently reported (Geuking, Cahenzli et al. 2011), our data support the notion that inflammatory 
tissue conditions were avoided by Tregs, inferred from increased expression of Foxp3, and 
Il10 markers for tolerance-promoting Tregs that were induced especially from day 8 onward. 
Interestingly, these two and other cytokine markers showed a tendency towards increasing 
expression in jejunum and ileum throughout the experiment. However in the colon, expression 
of the same tolerance markers clearly peaked at day 8 and subsequently declined at days 16 and 
30 post-conventionalization but remained higher than the levels observed in the germfree and 
early days of conventionalization. Notably, the climax expression level of Tregs at day 8 post-
conventionalization in the colon coincides with the colonization of Clostridium groups which 
were previously reported to stimulate the expression of colonic regulatory T cells (Atarashi, 
Tanoue et al. 2011).
Similar differential expression in small intestine versus colon was also observed for six 
inflammatory chemokine ligands and the corresponding three receptors. We propose that the 
expression of these chemokines contributes to T cell chemotaxis. IHC showed that at day 8, 
Cd8+ T cells were predominantly localized near the mucosal epithelia, which likely resulted 
from epithelial chemokine secretion and expression of MHC class I molecules. This timing of 
Cd8+ T cell accumulation in response to accumulation of Th1 chemokines in “danger zones” is 
in line with the results reported by Valbuena et al. during bacterial infection of mice (Valbuena, 
Bradford et al. 2003). Moreover, the faster accumulation of Cd8+ T in the lamina propria of the 
colon at day 8 but at day 16 in the small intestine illustrates an important location difference that 
is relevant in the context of establishing homeostasis.
Epithelia contain, in addition to the common enterocytes that are mainly involved in metabolic 
functions, specialized Paneth cells that secrete high amounts of a broad range of antimicrobial 
pepides, and goblet cells that secrete mucins. One of the broad spectrum antimicrobials secreted 
by Paneth cells, RegIIIγ, was induced in this study in agreement with Gaboriau-Routhiau et al. 
(Gaboriau-Routhiau, Rakotobe et al. 2009), together with the related RegIIIβ. The expression 
of these two peptides appeared to peak at day 4 post-conventionalization, in particular in the 
ileum as supported by IHC analysis. This could reflect a pronounced induction of acute innate 
immune responses at day 4 post-conventionalization, corroborated by peak expression levels 
of the genes encoding the innate immune molecules Retnlβ and Pla2g2a, and the coinciding 
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lyzP load of secretory granules in Paneth cells. Although innate immunity was clearly induced 
in every location of the GI tract, its dynamics over time was distinct per location. For example, 
RegIIIβ and RegIIIγ expression peaked at day 4 post-conventionalization in both small intestine 
and colon, and high level expression was retained in the small intestine but declined to germfree 
levels in the colon at later time-points. Conversely, expression of Retnlβ and Pla2g2a peaked 
also at day 4 but returned to germfree levels in the small intestine whereas expression remained 
high in colon. These data suggest that RegIIIβ and RegIIIγ are important to keep microbes 
at bay in the small intestine whereas this antimicrobial function is predominantly exerted by 
Retnlβ and Pla2g2a in the colon. This is in agreement with the presence of Reg3 peptide-
producing Paneth cells in the small intestine and their absence in the colon. In contrast, Pla2g2a 
and Retnlβ are exclusively secreted by goblet cells (Fijneman, Peham et al. 2008; Krimi, 
Kotelevets et al. 2008). These results show that, in healthy germfree mice and during bacterial 
colonization, innate immune responses are the first line of defence against microbiota, and that 
this response displays location (small intestine versus colon) differences in terms of molecules 
and expression levels. Other responses of epithelia to increasing bacterial colonization were 
the increased proliferation of crypt epithelial cells and villus connective tissue cells, measured 
as Ki-67 expression starting at day4 post-conventionalization and the transient lengthening of 
the crypts, measured as crypt depth also starting at day 4. Our data corroborate results obtained 
by Cherbuy and co-workers demonstrating the role of microbial colonization in maturation of 
epithelial cells in gnotobiotic animals (Cherbuy, Honvo-Houeto et al. 2010).
The change in biochemistry of colon mucins at day 4 post-conventionalization, characterized 
by a reduction in the amounts of sulfated, thus stronger antimicrobial mucins, compared to 
sialylated, less antimicrobial mucins (Deplancke and Gaskins 2001; Linden SK 2008), could 
have led to a more intense contact between microbiota and epithelia. This could indeed be shown 
using the bacterial FISH EUB338 probe (Figure S2.9). It seems that the biochemical changes of 
the mucin barrier at day 4 post-conventionalization may have allowed a more intense contact 
between the microbiota and the mucosa, which then primed innate immune responses that were 
followed by adaptive immune responses four days later.
This study provides a solid catalogue of genes, pathways, and histology of intestinal adaptations 
of germfree mice to microbial colonization, thereby providing an important resource that 
complements various other studies of mouse intestinal colonization by microbiota. Taken 
together, the data presented here show that within 30 days following their conventionalization, 
the germfree mice established a novel state of immune homeostasis in the intestine that 
accommodates the microbiota. Notably, this novel state of homeostasis was reached earlier in 
the colon (days 8 and 16) as compared to the jejunum and ileum (days 16 and 30). 
The extensive transcriptomic datasets for jejunum, ileum, and colon enabled us to reconstruct a 
central gene regulation network that governed the major transcriptome changes throughout the 
intestine during the 30-day conventionalization. This network included several genes of which 
the human orthologues are inflammatory bowel disease-associated genes that have also been 
discovered in genome-wide association studies (GWAS). We propose that this network could be 
exploited as a genetic signature to further investigate genes and pathways that are dysregulated 
in inflammatory bowel disease patients. 
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EXPERIMENTAL PROCEDURES
Animals, Experimental Design, and Sampling
All procedures were carried out according to the European guidelines for the care and use of 
laboratory animals and with permission 78–122 of the French Veterinary Services. Germfree 
and conventionalized mice (male, C57 BL/6 J) were maintained in sterile conditions, on a 
commercial laboratory chow diet (diet composition is described in Chapter 1, Table 1.2). 
Three independent biological experiments were performed using mice of different age. 
After 2 weeks of acclimatization and diet adaptation, a first set of germfree mice (n=3) were 
randomly assigned to sacrifice by oral anesthesia using isoflurane. The remaining germfree 
mice were conventionalized by oral gavage with 0.5ml of mixed fecal suspension obtained 
from 0.2g of freshly obtained fecal material of conventionally raised mice (C57 BL/6 J) diluted 
100-folds in Brain Heart infusion (BHI) broth. In the first 2 experiments; conventionalized 
mice were sacrificed at days 1, 2, 4, 8 and 16 post-conventionalization (n=3 per group per 
experiment). In the third experiment; conventionalized mice were sacrificed at days 4 and 30 
post-conventionalization (n=4-5 per group). Small intestine; (jejunum, and ileum), and colon 
from each mouse were removed. The 2 segments of the small intestine and the entire colon 
were then divided into 2 cm segments that were immediately: stored in RNAlater® at room 
temperature for 1 hour prior to subsequent storage at -80°C for RNA isolation, fixed overnight 
(O/N) in 4% (wt/vol) paraformaldehyde (PFA) or snap frozen and stored at -80°C for IHC 
procedures. Luminal content from intestinal segments was removed by gentle squeezing, snap 
frozen, and stored at -80°C for microbiota analysis.
Histology and Immunohistochemistry
The 2 cm intestinal segments fixed in 4% (wt/vol) PFA and paraffin-embedded. 4 μm-thick 
cross sections were stained with haematoxylin (Vector Laboratories, Burlingame, CA) and 
eosin (Sigma-Aldrich, Zwijndrecht, the Netherlands). To detect morphometric differences, 
12-15-well oriented villi and crypts were chosen per intestinal segment and measured. Mucin 
histochemistry was performed using HID-AB as described (Bogomoletz, Williams et al. 1987). 
For Lysozyme-P detection, sections were incubated with anti-Lysozyme P (1:50 in PBS, 
DakoCytomation, Denmark). For Cd3ε and Ki-67 detection, sections were incubated with anti-
Cd3ε (DAKO, Heverlee, Belgium) or anti-Ki-67 (NovoCastra Laboratories, Newcastle upon 
Tyne, UK), respectively. Expression of RegIIIγ was detected using a custom-made antibody 
(detailed descriptions are presented in the supplemental material). For Cd4-8 detection, cryostat 
sections were incubated with anti-Cd4 and anti-Cd8 (DakoCytomation). Primary antibodies 
were detected using VECTASTAIN ABC Elite kit (Vector Laboratories), including biotinylated 
Donkey anti-rat serum (Sigma-Aldrich) using the manufacturer’s instructions. For all stainings, 
nuclei were counterstained with haematoxylin (Vector Laboratories). Stained tissues were 
examined using a Nikon Microphot FXA microscope (for detailed descriptions see supplemental 
material). All data were presented as means ± SD for the number of animals indicated above. 
Comparisons of data were performed at each time-point using one-way analysis of variance 
(ANOVA) followed by Tukey’s Studentized range test (SPSS program, Chicago, IL). For all 
parameters p < 0.05 was considered the level of significance.
Microbial Profiling of Intestinal Luminal Contents
Luminal contents from jejunum, ileum, colon, as well as inoculum were analyzed by Mouse 
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Intestinal Tract Chip (MITChip), a diagnostic 16S rRNA arrays that consists of 3,580 unique 
probes especially designed to profile murine gut microbiota (Rajilic-Stojanovic, Heilig et al. 
2009; Geurts, Lazarevic et al. 2011).
Quantification of total bacteria was performed using qPCR detection of 16 S rRNA-gene copies 
while Fluorescent in situ hybridization (FISH) was used to detect bacteria from tissue samples 
(for detailed descriptions see supplemental material).
Transcriptome Analysis
High quality total RNA was obtained from a 2 cm segment of jejunum, ileum, and colon 
by extraction with TRIzol reagent, followed by DNAse treatment and column purification. 
Samples were hybridized on Affymetrix GeneChip Mouse Gene 1.1 ST arrays. Quality control 
and statistical analysis were performed using Bioconductor packages integrated in an on-line 
pipeline (Lin, Kools et al. 2011). Probesets were redefined according to (Irizarry, Bolstad et 
al. 2003; Heber and Sick 2006). Expression estimates of probesets were computed by robust 
multiarray (RMA) analysis (Dai, Wang et al. 2005). ComBat (Johnson, Li et al. 2007), an 
empirical Bayes method, was used to correct for the systematic error introduced during labeling. 
Differentially expressed probe sets were subsequently identified using linear models, applying 
moderated t-statistics that implement intensity-dependent Bayes regularization of standard 
errors (Storey and Tibshirani 2003; Sartor, Tomlinson et al. 2006). Data were corrected for 
multiple testing using a false discovery rate (FDR) method (Storey and Tibshirani 2003). Only 
genes with a fold-change of at least 1.2 (up/down) and FDR < 0.05 % were considered to be 
significantly regulated. 
Several complementary methods were used for the biological interpretation for the transcriptome 
data; gene clustering using Multi-experiment Viewer (MeV) software  (Saeed, Hagabati 
et al. 2006), overrepresentation analysis of Gene Ontology (GO) terms using temporal and 
location comparative analysis using STEM (Ernst and Bar-Joseph 2006), Bayesian clustering 
using Genomica, and construction of biological interaction networks using IPA (for detailed 
descriptions see supplemental material).
Accession Numbers
The mouse microarray dataset is deposited in the Gene Expression Omnibus (GEO) with 
accession number GSE32513.
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Animals, Experimental Design, and Sampling
Germfree and conventionalized mice (male, C57 BL/6 J) were purchased from the Centre de 
Recherché, Institute National de la Recherche Agronomique (Jouy-en-Josas, France). All mice 
were maintained in sterile conditions. Mice had ad libitum access to sterilized water and were 
maintained on a commercial laboratory chow diet (UAR 1016C Laboratory Chow, UAR, SAFE, 
Route de Saint-Bris, F-89290 Augy, France) that was sterilized by gamma irradiation (45KGy). 
The first and second experiments of the three performed independent biological experiments 
included 36 mice obtained in 2 biologically independent batches of 18 mice each, aged 8 and 
10 weeks, respectively. The third experiment included 15 mice, aged 10 weeks old (Chapter 1, 
Figure 1.5). 
Immunohistochemistry
For immunohistochemistry, 4 μm-thick cross sections were deparaffinized and treated with 3% 
hydrogen peroxide in methanol (20 min, room temperature). Antigen retrieval was performed 
by microwave treatment (citrate buffer, 10 mM, pH 6.0). For Lysozyme-P detection, sections 
were blocked for 1 h in 1% Blocking reagent (Roche, Almere, The Netherlands) and incubated 
O/N at 4˚C with anti-Lysozyme P (1:50 in PBS, DakoCytomation, Denmark). For Cd3ε and 
Ki-67 detection, sections were blocked with 10 mM Tris, 5 mM EDTA, 0.15 M NaCl, 0.25% 
gelatine, 0.05% Tween-20 (TENG-T), 10% normal mouse serum (NMS) or TENG-T, 10% 
normal goat serum (NGS), respectively. Sections were incubated O/N at 4˚C with anti-Cd3ε 
(DAKO, Heverlee, Belgium) or anti-Ki-67 (NovoCastra Laboratories, Newcastle upon Tyne, 
UK) at dilutions of 1:400 and 1:200, respectively, in PBS containing 1% BSA and 0.1% Triton 
X-100. Expression of RegIIIγ was detected using a custom-made antibody (1:25,000 in PBS 
containing 1% BSA and 0.1% Triton X-100). RegIII-γ antibodies (custom made by Eurogentec, 
Seraing, Belgium), were generated in rabbits against synthetically produced peptides, using the 
peptide sequences GEDSLKNIPSARISC (RegIIIβ) and EVAKKDAPSSRSSC (RegIIIγ). The 
chosen peptide sequences correspond to unique sequences within the REGIII protein and allow 
differentiation between the RegIII-β and -γ proteins. Serum from immunized rabbits was affinity 
purified using the same peptides. The signal of the secondary HRP-conjugated antibody (Goat-
anti-Rabbit HRP, 1:100000, Jackson ImmunoResearch, Suffolk, UK) was detected by using 
the ECL Plus chemiluminescent detection kit (GE Healthcare, Den Bosch, the Netherlands). 
Primary antibodies were detected using VECTASTAIN ABC Elite kit (Vector Laboratories, 
Burlingame, CA), including biotinylated goat anti-rabbit serum (Sigma-Aldrich, Zwijndrecht, 
the Netherlands) using the manufacturer’s instructions. 
Cd4-8 staining: 6 μm-thick cryostat sections were fixed in hydrogen peroxide and acetone and 
blocked for 1 h in 1% Blocking reagent (Roche) and incubated O/N at 4˚C with anti-Cd4 and 
anti-Cd8 (DakoCytomation) diluted 1:5 in PBS containing 1% BSA and 0.1% Triton X-100. 
Primary antibodies were detected using VECTASTAIN ABC Elite kit (Vector Laboratories), 
including biotinylated Donkey anti-rat serum (Sigma-Aldrich) using the manufacturer’s 
instructions. Nuclei were counterstained with Haematoxylin (Vector Laboratories).
Fluorescent In Situ Hybridization (FISH)
Paraffin slides were deparaffinized, rehydrated and were subjected to lysozyme treatment for 60 
min (20 mg/ml Tris-HCL, pH. 8.2; Sigma-Aldrich, Zwijndrecht, the Netherlands), washed in 
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demineralized water, and dipped briefly in 96 % ethanol.  Once dry, a probe mixture containing 
20 μl FITC-labeled oligonucleotide general probe EUB338 (Eurogentec-the Netherlands) (100 
ng/μl) (, 20 μl Milli-Q (Millipore), and 160 μl hybridization buffer (52 g NaCl, 20 ml Tris-
HCL, pH 7.2, 10 ml 10% SDS in 1 liter demineralized water, filtered through 0.2 μm filter) 
was applied to the slides. Subsequently, slides were incubated at 50˚C O/N in a dark moist 
chamber in an incubator (Marius), and the next day, slides were washed in washing buffer 
(hybridization buffer without SDS) for 30 min at 50˚C, and, after briefly rinsing in ultrapure 
water, slides were air dried rapidly. Slides were DAPI stained (Sigma), washed in 1x PBS, and 
rinsed shortly in ultrapure water. After rapid drying, slides were mounted with VECTASHIELD 
(Vector Laboratories) and evaluated under the fluorescent microscope (Leica DM5500; Leica 
Microsystems).  
Microbiota Analysis 
Microbial DNA was isolated from intestinal lumen samples (jejunum, ileum, colon, and 
inoculum) using the Fast DNA Spin kit (Qbiogene, Inc, Carlsbad, CA, USA), applying 0.05 to 
0.1 g of luminal content and eluting the DNA yield in in 50 μl DES.
Quantification of total bacteria was performed in each sample using qPCR detection of 16 S rRNA-
gene copies using universal primers, Bact-1369-For (5´-CGGTGAATACGTTCYCGG-3´) and 
Prok-1492-Rev (5´-GGWTACCTTGTTACGACTT-3´)(Suzuki, Taylor et al. 2000). QPCR was 
executed on an IQ5 Cycler apparatus (Bio-Rad, Veenendaal, The Netherlands). Reactions were 
performed in triplicate in a single run. Samples were analyzed in a 25 µl reaction mixture 
consisting of 12.5 µl Bio-Rad master mix SYBR Green (50 mM KCl, 20 mM Tris-HCl, pH 
8.4, 0.2 mM of each dNTP, 0.625 U iTaq DNA polymerase, 3 mM MgCl2, 10 nM fluorescein), 
0.1 µM of each primer and 5 µl of template DNA diluted 10 times (jejunum) and 100 times 
(ileum and colon). Standard curves of 16 S rRNA PCR product from Lactobacillus casei as a 
standard pure culture were generated using serial 10-fold dilution of the purified PCR product 
corresponding to 108 to 100 16 S rRNA copies. Amplification employed the following set-up: 
95°C for 10 min, followed by 35 cycles of denaturation at 95°C for 15 sec, annealing temperature 
for 20 sec, extension at 72°C for 30 sec and a final extension step at 72°C for 5 min. A melting 
curve was determined at the end of each run to verify the specificity of the PCR amplicons. Data 
analysis was performed using the Bio-Rad software.
The Mouse Intestinal Tract Chip (MITChip) design was carried out in analogy as described 
for the Human Intestinal Tract Chip (HITChip) (Rajilic-Stojanovic, Heilig et al. 2009). Briefly, 
over 9,000 mouse intestine derived full-length 16 S rRNA sequences obtained from the public 
databases were reduced to 1,885 Operational taxonomic units (OTUs) or phylotypes, sharing 
<98% sequence similarity, and represent the so-called level 3 groups. These level-3 groups 
were grouped into 94 genus-like (level-2) clusters, sharing > 90%, which in turn were clustered 
into 27 order-like groups (level-1), and 10 phylum-like groups (level-0). Sequences from the 
variable V1 and V6 regions from each OTU were extracted and reverse-complemented, before 
being divided into six tiling probes that were printed on an Agilent oligonucleotide array (Agilent 
Technologies, Palo Alto, CA). In order to profile jejunum, ileum, and colon microbiota, 20 ng 
of DNA extract was used to amplify the 16S rRNA genes with the primers T7prom-Bact-27-
for (5’-TGAATTGTAATACGACTCACTATAGGGGTTTGATCCTGGCTCAG-3’) and Uni-
1492-rev (5’-CGGCTACCTTGTTACGAC-3’). The PCR program used was: pre-denaturation 
of 2 min at 94°C followed by 35 cycles of 94°C during 30 sec (denaturation), 52°C during 
40 sec (annealing), 72°C during 90 sec (elongation) and a final extension at 72°C for 7 min. 
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PCR products were purified (High Pure PCR Cleanup Micro Kit, Roche Diagnostics GmbH, 
Mannheim, Germany) and the DNA concentration was measured using a NanoDropÒ ND-
1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). The 16S rRNA 
genes carrying the T7-promoter were transcribed using the Riboprobe System (Promega, La 
Jolla, USA). The amplicon (500 ng) together with rATP, rGTP, rCTP and a 1:1 mix of rUTP 
and aminoallyl-rUTP (Ambion, Austin, TX, USA) were incubated at room temperature for 2h; 
afterwards possible DNA present was digested with the Qiagen RNAse-free DNAse kit (Qiagen, 
Hilden, Germany). Purification of RNA was done using the RNeasy Mini-Elute Kit (Qiagen) 
and concentration was quantified using NanoDrop. Subsequently, an in vitro transcription and 
labeling with Cy3 and Cy5 dyes was performed as previously described (Rajilic-Stojanovic, 
Heilig et al. 2009). The Cy3/Cy5-labeled target mixes were fragmented using 10× fragmentation 
reagent (Ambion) and fragmented material was hybridized on the arrays at 62.5˚C for 16 h in a 
rotation oven (Agilent Technologies). Slides were washed at room temperature in 2× SSC with 
0.3% SDS (10 min) followed by 0.1× SSC + 0.3% SDS at 38°C (10 min) and 0.06× SSPE (5 
min). The slides were washed and dried before scanning. Signal intensity data were obtained 
from the microarray images using Agilent Feature Extraction software, version 9.1 (http://
www.agilent.com). Microarray data normalization and further analysis were performed using 
a set of R-based scripts (http://r-project.org) in combination with a custom-designed relational 
database, which operates under the MySQL database management system (http://www.mysql.
com), as previously described (Rajilic-Stojanovic, Heilig et al. 2009).
Microbial diversity, similarity of the microbiota profiles, and gene copy numbers, were analyzed 
by a one-way analysis of variance (ANOVA) in SPSS Statistics 17.0 (SPSS Inc., Chicago, IL), 
with the group distinction as a fixed factor and time-points as the dependent variable, followed 
by Tukey’s post hoc test. Diversity of microbial profiles obtained by MITChip analysis was 
expressed as Simpson’s reciprocal index of diversity (1/D)(Simpson 1949). Diversity was 
calculated with the equation D= 1/ΣPi2, where Pi is the proportion of ith taxon. This is the 
proportion of each probe signal compared to the total signal for each sample. A higher Simpson’s 
index value indicates a higher degree of diversity.
Multi-variate analysis was carried out in SPSS Statistics 17.0 (SPSS Inc., Chicago, IL). 
A p value < 0.05 was considered to be statistically significant. In order to relate the change 
of the microbiota to environmental variables (experiment, days, anatomical locations), 
representational difference analysis (RDA) was used, as implemented in the CANOCO 4.5 
software package (Biometris, Wageningen, the Netherlands), on average signal intensities for 
94 bacterial groups (levels 2). All environmental variables were transformed as log (1+X). The 
environmental variables tested were the anatomical regions jejunum, ileum, and colon. The 
Monte Carlo Permutation Procedure (MCPP) as implemented in the Canoco package was used 
to assess statistical significance of the variation in large datasets. A Monte-Carlo permutation 
test based on 499 random permutations was used to test the significance, and p-values < 0.05 
were considered significant. 
Transcriptome Analysis
RNA quantity and quality was assessed on the total RNA obtained from jejunum, ileum, and 
colon spectrophotometrically (ND-1000, NanoDrop Technologies, Wilmington, USA) and with 
6000 Nano chips (Bioanalyzer 2100; Agilent), respectively. RNA was judged as being suitable 
for array hybridization only if samples showed intact bands corresponding to the 18S and 28S 
ribosomal RNA subunits, displayed no chromosomal peaks or RNA degradation products, and 
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had an RIN (RNA integrity number) above 8.0. 
The Ambion WT Expression kit (Life Technologies, P/N 4411974) in conjunction with the 
Affymetrix GeneChip WT Terminal Labeling kit (Affymetrix, Santa Clara, CA; P/N 900671) 
was used for the preparation of labeled cDNA from 100ng of total RNA without rRNA 
reduction. Because of the large number of samples (i.e. 154), RNA labeling was performed in 
three rounds using a complete block design. Labeled samples were hybridized on Affymetrix 
GeneChip Mouse Gene 1.1 ST arrays, provided in plate format. Hybridization, washing, and 
scanning of the array plates was performed on an Affymetrix GeneTitan Instrument, according 
to the manufacturer’s recommendations. Detailed protocols can be found in the Affymetrix 
WT Terminal Labeling and Hybridization User Manual (P/N 702808 revision 4), and are also 
available upon request.
Quality control of the datasets obtained from the scanned Affymetrix arrays was performed 
using Bioconductor (Gentleman RC 2004) packages integrated in an on-line pipeline (Lin, 
Kools et al. 2011). Various advanced quality metrics, diagnostic plots, pseudo-images, and 
classification methods were applied to ascertain only excellent quality arrays were used in the 
subsequent analyses (Heber and Sick 2006). An extensive description of the applied criteria is 
available upon request. Ten of the 154 arrays did not pass the quality control, and were therefore 
not included in the subsequent analyses.
The more than 825.000 probes on the Mouse Gene 1.1 ST array were redefined according to 
Dai et al. (Dai, Wang et al. 2005) utilizing current genome information. In this study, probes 
were reorganized based on the Entrez Gene database, build 37, version 1 (remapped CDF v13). 
Normalized expression estimates were obtained from the raw intensity values using the robust 
multiarray analysis (RMA) preprocessing algorithm available in the Bioconductor library 
AffyPLM using default settings (Bolstad, Collin et al. 2004). Next, an empirical Bayes method, 
called ComBat (Johnson, Li et al. 2007), was used to correct for the systematic error (batch 
effect) introduced during labeling. 
Differentially expressed probe sets were identified using linear models, applying moderated 
t-statistics that implemented empirical Bayes regularization of standard errors (Storey and 
Tibshirani 2003). The moderated t-test statistic has the same interpretation as an ordinary 
t-test statistic, except that the standard errors have been moderated across genes, i.e. shrunk 
to a common value, using a Bayesian model. To adjust for both the degree of independence 
of variances relative to the degree of identity and the relationship between variance and signal 
intensity, the moderated t-statistic was extended by a Bayesian hierarchical model to define a 
intensity-based moderated T-statistic (IBMT) (Sartor, Tomlinson et al. 2006). IBMT improves 
the efficiency of the empirical Bayes moderated t-statistics and thereby achieves greater power 
while correctly estimating the true proportion of false positives. P-values were corrected for 
multiple testing using a false discovery rate (FDR) method proposed by Storey et al. (Storey 
and Tibshirani 2003). Only probe sets with a fold-change (FC) of at least 1.2 (up/down) 
and FDR < 0.05 were considered to be significantly regulated.
Biological Interpretation of Expression Datasets
Several complementary methods were applied to relate changes in gene expression to functional 
changes. Hierarchical clustering of modulated genes in the mucosa that were unique for each 
time-point (or several time-points) were generated by MeV (Multi-experiment Viewer) (Saeed, 
Hagabati et al. 2006). Temporal and spatial comparative analysis were carried out using 
STEM (Short Time-series Expression Miner), which differentiates between real and random 
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gene expression patterns from short (up to 8 time-points) time-series microarray experiments 
(Ashburner, Ball et al. 2000). The statistical significance of the profiles generated by STEM was 
calculated via a permutation test (n=1000) corrected using a false discovery rate (FDR <0.001) 
(Ernst and Bar-Joseph 2006). 
Biological interaction networks among regulated genes activated in response to 
conventionalization were identified using Ingenuity Pathways Analysis (IPA) (Ingenuity 
Systems). IPA utilizes a large expert-curated repository of molecular interactions, regulatory 
events, gene-to-phenotype associations, and chemical knowledge, mainly obtained from peer-
reviewed scientific publications, that provides the building blocks for network construction. 
IPA annotations follow the GO annotation principle, but are based on a knowledge base 
of  > 1,000,000 protein–protein interactions. The IPA output signaling pathways with statistical 
assessment of the significance of their representation being based on Fisher’s Exact Test. Our 
IPA analyses included comparison of differentially regulated genes in the jejunum, ileum, and 
colon in days 1, 2, 4, 8, 16, and 30 in each case relative to expression observed in the control 
group (germfree=day 0). The input was all differentially regulated genes (p value ≤ 0.001, 
FC ≥ 1.2 and intensity ≥ 20) of jejunum, ileum, and colon after 1, 2, 4, 8, 16, and 30 days post-
conventionalization. 
To improve bayesian clustering, it is necessary to remove those genes that hardly change across 
time and location from the analysis. Cluster 3.0 (de Hoon, Imoto et al. 2004) was used to filter 
for uninformative gene expression data. As input, log2 gene expression fold-change data were 
used and genes that had FC higher than 1.2 in at least 8 microarrays, and that showed at least 
1 fold-change difference between the highest and the lowest values were selected. The 4506 
genes that passed these filtering criteria were used as input for clustering.
Identification of clusters containing genes that participate in the immune response was performed 
by using as gene sets collections of Mus musculus genes that make up Gene Ontology categories 
(http://www.geneontology.org). These categories contained 2475 mouse-specific annotations. 
To identify the arrays in which each gene set (GO category) was significantly induced or 
repressed, the induced (or repressed) genes in each array were defined to be those genes whose 
change in expression was greater than twofold. For each gene set and each array, the fraction of 
genes was calculated from that gene set that was induced (or repressed) in that array and used 
the hypergeometric distribution to calculate a P value for this fraction (compared with the null 
hypothesis of choosing the same number genes at random). FDR correction of 5% was used 
to correct for multiple tests. To determine statistical significance of array–gene set pairs, the 
number of array–gene set pairs in which the gene set was significantly induced (or repressed) 
in the array was evaluated. 
To identify gene set clusters, (bottom-up) hierarchical clustering of the gene sets in the matrix 
of all significant array–gene set pairs was carried out. This resulted in a tree in which each leaf 
node, corresponding to some gene set G, is associated with a vector (indexed by arrays) that is 
zero everywhere except for entries that correspond to arrays in which set G was significantly 
induced (or repressed). In the latter case, the entry contains the fraction (or negative fraction) 
of genes from set G that are induced (or repressed) in an array. Each internal node is associated 
with a vector representing the average of the entire gene set vectors at its descendant leaves. 
Each interior node was annotated with the Pearson correlation between the vectors associated 
with its two children in the hierarchy. A cluster was defined as each interior node whose 
Pearson correlation differed by more than 0.05 from the Pearson correlation of its parent node 
in the hierarchy. Such interior nodes represent points in the tree with a large gap between the 
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similarities in expression of the node’s children and the similarity in expression of the node and 
its sibling. To evaluate the consistency of a gene with expression of a gene set, given a gene 
set G and a gene g, we tested whether the expression of g was consistent with the significant 
changes in the expression of G (for statistics, see below). 
In order to find clusters of genes that together participate in a GO category and that could be 
involved in changing gene expression at later time-points of the mouse conventionalization 
experiment, we wanted to derive modules from clusters of gene sets. Modules were defined 
as sets of co-regulated genes that share a common function and/or that respond together to 
changes in the environment. For each cluster of gene sets, G was defined to be the union of the 
gene sets in the cluster. Each gene in G was then tested for consistency (as described above). 
The resulting module consists of genes whose expression is significantly consistent with the 
expression of the gene set (after FDR correction for multiple hypotheses using a 5% FDR). 
All analyses and heat map visualizations used for bayesian clustering were performed using 
Genomica. This software tool identifies arrays in which gene sets are significantly expressed, the 
GO annotations enriched in these arrays, and generates heat maps of gene clusters. Genomica 
is freely available for academic use at http://genomica.weizmann.ac.il/.
SUPPLEMENTAL RESULTS
Gene Sets that Mediate Localization-Specific Regulation of Intestinal Immune Cell 
Development 
Comparing changes in GO-based gene clusters across intestinal regions and time-points 
could help to find distinct gene regulatory networks expected to derive the changes seen in 
immune-related GO sets. To this end, we first normalized gene expression using the expression 
data of mice at day 0 (germfree state) and prefiltered all microarray data to remove genes 
that did hardly change across time-points and locations. Clustering of the prefiltered gene 
expression data resulted in 282 clusters of genes that show significant co-regulated changes. 
In order to find the genes that are most basal to the co-regulated changes in the clusters, a 
module map (Segal, Friedman et al. 2004) was created; 48 modules were found. Some of the 
modules contained genes that were co-regulated in a specific intestinal region or showed a 
separation in expression at early versus later time-points. Interestingly, one module included 
genes that were near-always down-regulated in colon and were differentially regulated at earlier 
versus later time-points in ileum and jejunum (Figure S2.10A). The differential expression 
was predicted to be dependent upon expression of the mitogen-activated protein kinase kinase 
kinase 9 (Map3k9) that regulates cell fate, and the extracellular protease inhibitor Expi (now 
named Psmc6 or proteasome (prosome, macropain) 26S subunit, ATPase, 6). Expi (Psmc6) is 
part of the immuno-proteasome, the protein degradation complex which main function is the 
processing of class I MHC peptides. Regulatory network analysis showed that in this module, 
expression of several other regulators (including two RIO kinases, melanoregulin Mreg and the 
DEAH box polypeptide 35 Dhx35 that are all involved in cell differentiation) was dependent on 
the transcription factor hepatocyte nuclear factor 4 alpha (Hnf4a) (Figure S2.10B).
The prefiltered list of genes was then used to perform GO-enriched bayesian clustering and to 
identify significantly modulated GO categories (for more details see supplemented experimental 
procedures). 164 GO categories were significantly modulated in at least one microarray (Figure 
S2.4). The most strongly upregulated GO categories included immune system processes and 
cell differentiation, especially of immune cells (Figure S2.4). These categories contained sets of 
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genes including chemokines, transcription factors, cell surface markers, kinases, and structural 
proteins such as enzymes. Several immunity-related GO gene sets that were of particular interest 
to our research questions were then explored as shown in the main text.                  
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SUPPLEMENTAL FIGURES
Figure S2.1. Transient and continuous changes in the intestinal morphology 
during conventionalization. (A) Representative photomicrographs of Haematoxylin 
and Eosin-stained cross sections of ileal tissues in germfree (a), days 4 (b), and 30 
(c) post conventionalization,  showing the increase in the thickness of lamina propria 
during conventionalization (as depicted by black lines). (B) IHC determination of Ki-
67 using Mib-1 antibody in colon tissues in germfree (a), days 1 (b), 2 (c), 4 (d), 8 (e), 
and 16 (f) post-conventionalization. The arrow indicates the positively stained cells 
(dark brown). The square bracket shows the state of the transient crypt lengthening 
at day 8 post-conventionalization in the crypt region. All images are of the same 
magnification. 
A B
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Figure S2.2. Temporal and local dynamics of the colonizing microbiota. (A) Relative contribution of the 
detected level 1 phylogenetic groups (Class- like) with Firmicutes (Bacilli, Clostridium clusters, and Mollicutes) 
with MITChip in colon samples over time. (B) RDA triplot representing the effect of intestinal locations on 
microbiota, projecting the averaged hybridization signals of 94 genus-like groups on the two canonical axes that 
had the highest explanatory potential (accounting for 39.3% of the total variance in the species). The intestinal 
locations are the environmental variables [(ileum (), jejunum (♦), colon (•)], represented as centroids. Percentage 
values at the axes indicate contribution of the principal components to the explanation of the total variance of the 
species in the dataset. MCPP indicated that source of the sample (colon versus small intestine) had a significant 
effect of the intestinal microbiota composition (MCPP=0.001). (C) Diversity of the jejunum, ileum, and colon 
microbiota at days 8 and 16 post-conventionalization, expressed as Simpson index of the hybridization profiles 
analyzed by the MITChip. 
A
B C
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Figure S2.4
Figure S2.3. Comparison of the temporal expression profiles of genes 
associated with immune response. Screenshots of detailed model profile 
windows for the data of STEM. The profiles shown were those which 
had the majority of genes assigned for the GO “immune response”. 
STEM filtered the input data (gene expression data for all genes) to find 
those genes that show significant differential expression across all time-
points. All profiles were significant. Along the top of each window are the 
temporal expression patterns and the statistical analysis for the enrichment 
p-value based on the permutation test. The colored boxes at the bottom-
left of each window correspond to the model expression profile available 
in STEM. The data is drawn from the response of colonic (A), jejunal and 
ileal (B) tissue to conventionalization.  
Figure S2.4. Induction of immune system process during 
conventionalization. Graphical overview of GO enrichment categories 
(listed at the right of the graph) across all arrays (listed at the bottom part 
of the graph). A black square indicates that the indicated GO category 
was not significantly (p <0.05) enriched; a color indicates that the GO 
category was enriched; a red square indicates that the respective pathway 
or process was induced; blue indicates that the pathway or process was 
repressed.
A
B
Figure S2.3
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Figure S2.5. Modulation of bacterial recognition receptors and signaling pathways during conventionalization.
(A) Jejunum, ileum, and colon gene expression levels of Myd88 and Cd14 were analyzed in germfree and 
conventionalized mice at indicated days post-conventionalization. Values are depicted as box-and whisker diagrams 
(top to bottom; maximum value, upper quartile, median, lower quartile, and minimal value, respectively). Any 
data not included between the whiskers is plotted as an outlier with a dot. Significant differences between time-
points are indicated by distinctive characters above the measurement groups (p <0.05). (B) Heat map of Toll-like 
receptors (Tlr) and their regulators representing the changes in their expression level at days 1, 2, 4, 8, 16, and 30 
post-conventionalization in comparison to the germfree state. 
A B
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Figure S2.6. Microbial colonization results in region-specific regulation of chemokines. Jejunum, ileum,  and 
colon gene expression levels of inflammatory chemokines and their receptors were analyzed in germfree and 
conventionalized mice at indicated days post-conventionalization. Values are depicted as box and whisker diagrams 
(top-to-bottom, maximum value, upper quartile, median, lower quartile, and minimal value, respectively). Any 
data not included between the whiskers is plotted as an outlier with a dot. Significant differences between time-
points are indicated by distinctive characters above the measurement groups (p <0.05).
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Figure S2.7. Enriched biological functions and pathways modulated during mouse conventionalization. 
(A) Cellular pathways significantly modulated in the jejunum and ileum during conventionalization was calculated 
via a one-tailed Fisher’s Exact test in IPA and represented as -log (p value); -log values exceeding 1.30 were 
significant (p <0.05). (B) Cytoscape graph showing the interrelationships between GO categories. Representation 
of the GO subcategories belonging to the major enriched GO category "Immune response" that was identified 
using Genomica software. Here, the nodes indicate GO subcategories, and the edges between nodes indicate that 
nodes are interrelated (the GO system is hierarchical). The network shows that the major GO categories within the 
"Immune response" category correspond to the biological processes "T cell selection", "regulation of lymphocyte 
activation" and "activation of the immune response". (C) Gene list for the enriched GO category "T cell activation” 
that was identified using Genomica software. The genes are listed at the top of the graph, and the arrays on which 
the respective genes were significantly induced (squares in red) are indicated to the right of the graph. Black 
squares indicate that a gene was not significantly expressed on the respective array. 
C
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Figure S2.8. Protein-protein interaction networks representing the enriched GO categories "immune 
response" and "T cell activation". (A) Cytoscape protein-protein interaction (PPI) map of the GO category 
"Immune response" that was significantly enriched across all arrays, calculated using Genomica. Here, nodes indicate 
proteins and edges between nodes indicate a functional relationship between the nodes, e.g. protein-protein binding 
or phosphorylation. Note the similarity between the genes included in this network and the genes included in the 
network shown in Figure 2.7, although both networks were calculated by two very different methods. (B) Cytoscape 
PPI network for the significantly induced genes belonging to the GO category "T cell activation". Gene induction 
significance was calculated using Genomica software. (C) Statistics for the GO category "immune response".  Bar 
height corresponds to the number  of genes annotated with the respective GO term; the % corresponds to the 
number of genes from the dataset belonging to a GO term relative to the total number of genes in the human genome 
that were annotated with that GO term. The asterisks represent Fisher's exact statistics; * corresponds to p <0.05, 
and ** corresponds to p <0.001.
C
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Figure S2.9. Transient intense microbiota-host 
epithelium contact during conventionalization.
Fluorescent in situ hybridization (FISH) in mouse 
colonic sections with the bacterial universal 
probe EUB338. The colon exhibits microbiota 
in close proximity to the epithelia and goblet 
cells (as depicted by white arrows) at day 4 (a) 
which was remarkably reduced at day 8 post- 
conventionalization (b).
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Figure S2.10. Differential expression of genes belonging to a Genomica module, predicted to be driven by 
the genes Map3k9 and Expi. (A) The graph lists genes (at the right) that are induced (indicated by red squares) or 
repressed (blue squares) on the arrays that are listed at the top of the graph. The yellow interrupted lines separate 
groups of arrays that show significantly (p <0.05) distinct expression patterns. The Map3k9 gene encoding a 
mitogen-activated protein kinase (3) member 9 was predicted to determine the complete induction (rightmost) 
or induction or repression (leftmost and central group) of the set of genes listed at the right of the graph. The 
Expi gene, encoding a extracellular proteinase inhibitor, was predicted to determine the induction-repression 
pattern (leftmost) or the near-complete repression (middle) of the same set of genes. Note that the central group 
corresponds to microarrays that measured gene expression in the colon, whereas the left- and rightmost groups 
correspond to arrays from the small intestine. This graph shows a set of genes that were repressed in the colon and 
much more often induced in the small intestine, thereby exemplifying location- and time-specific gene expression 
patterns. (B) The corresponding PPI network belonging to the genes listed in (A). This PPI network shows that the 
transcription factor Hnf4a was in the center of a small gene regulatory network that also included two Rio kinases 
(Riok1, 2) that are involved in ribosome biogenesis and cell cycle progression.
B
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ABSTRACT
Proper interactions between the intestinal mucosa, gut microbiota, and nutrient flow are relevant 
to establish homeostasis of overall host physiology, immune status, and metabolism. Since the 
proximal part of the small intestine is the first region where these interactions take place, it is 
important to understand the molecular dynamics of metabolic responses in the mucosa of this 
region.
Combined transcriptome, histological, 1H NMR metabonomics, and microbiota analyses in 
ex-germfree mice highlighted the acute response of jejunal mucosa to the microbiota after 
only 1 day of conventionalization. These acute responses led to major altered gene expression 
and metabolic profiles after 4 days of conventionalization upon which a novel, permanent 
homeostatic state was established. These secondary responses included a drastic transcriptome 
shift in genes that control the rate of key metabolic pathways, including fatty acid oxidation, 
glycolysis, gluconeogenesis, amino acid, and nucleotide metabolism. The transcriptional 
changes in metabolic pathways could be confirmed at the mucosal tissue metabolite level. 
Detailed transcriptomic analysis throughout the 30-day period of conventionalization identified 
a central regulatory network that appears to be involved in dynamic control of the reorientation 
of the metabolic response to the colonizing microbiota in the jejunal mucosa. The majority of 
the genes in the identified network participate in human metabolic disorders, including insulin 
sensitivity and type 2 diabetes mellitus. These results illustrate the molecular dynamics of 
microbiota sensing by the mouse jejunal mucosa, and support a prominent role of the jejunum 
in systemic metabolic control, including glucose homeostasis.
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Dynamics of Microbial Signaling Response of Jejunum
INTRODUCTION 
The gut microbiota is recognized as a key determinant in the regulation of host metabolism 
including energy harvest from the diet and fat storage (Bäckhed and Crawford 2010). A large 
proportion of the microbiota metabolism is beneficial to the host and contributes to its nutritional 
demand by supplying essential nutrients. The microbiota can also convert and neutralize 
potentially harmful metabolites from the dietary flow and enhance energy harvest from the diet 
(Bäckhed, Ley et al. 2005). For example, the gut microbiota modulates the absorption of dietary 
lipids (Bäckhed, Ley et al. 2005), affects glucose absorption (Bäckhed, Ding et al. 2004), and 
metabolizes indigestible polysaccharides to absorbable nutrients including monosaccharides 
and short chain fatty acids (SCFAs) (Hooper, Midtvedt et al. 2002). It is now firmly established 
that the gut microbiota has a major impact on the host phenotype in humans and mice (Bäckhed, 
Ding et al. 2004; Dumas, Barton et al. 2006; Turnbaugh, Ley et al. 2006). In a pioneering 
study by Bäckhed and colleagues, it was shown that conventionalization of adult germfree 
C57 BL/6 J mice with a normal mouse microbiota leads to a nearly 60% increase in body fat 
content and insulin resistance within 14 days, despite a reduced food intake (Bäckhed, Ding 
et al. 2004). This study showed that suppression of Fasting-induced adipocyte factor (Fiaf, or 
Angptl4) is essential for the induction of de novo hepatic lipogenesis, which is triggered by the 
induction of elevated absorption of monosaccharides such as glucose from the gut lumen and 
is a prominent factor in obesity (Bäckhed, Ding et al. 2004). Subsequent studies in ex-germfree 
mice revealed the important roles of SCFA- and endocrine hormone-binding G–protein coupled 
receptors, Gpr41 and 43, in microbial modulation of host energy balance (Tilg and Kaser 2011). 
Notwithstanding the recognition of the crucial importance of host-microbiota interaction in 
controlling metabolic changes in the intestinal mucosa, these insights are mainly derived from 
studies focused on the ileal or colonic intestinal tissues in studies comparing germfree, and 
conventional, or conventionalized ex-germfree mice. However, the impact of the microbiota 
on metabolism in more proximal parts of the small intestine (such as the jejunum), has so 
far remained largely unexplored. The relatively diminutive microbial community residing in 
this intestinal region may have been the rationale behind the lack of interest in this region in 
terms of host-microbe communication. The luminal microbiota encompasses 103-107 bacterial 
cells per gram in the human jejunum (O’Hara and Shanahan 2006), and comprises a relatively 
simple community that is dominated by aerotolerant microbial species like the streptococci 
and other members of the bacilli (Hayashi, Takahashi et al. 2005). The role of the jejunum as 
an intestinal region that controls systemic metabolic responses is illustrated by the observation 
that gastric bypass surgery, which allows nutrients to bypass the duodenum and proximal small 
bowel (Rubino, Moo et al. 2009), leads to improvement or resolution of type 2 diabetes in both 
obese and non-obese individuals. Gastric bypass surgery ensures the persistence of normal 
concentrations of plasma glucose and insulin in 80–100% of the cases (Rubino 2006).  Although 
the mechanisms underlying the increased insulin sensitivity following gastric bypass surgery 
remain obscure, changes in lipid metabolism (Williams, Hagedorn et al. 2007), intestinal 
gluconeogenesis (Troy, Soty et al. 2008), as well as altered secretion of gut hormones (Korner, 
Bessler et al. 2005), have been suggested to be involved. 
Recently, we described the molecular dynamics of host immune response development in ex-
germfree mice upon conventionalization in different regions of the GI tract, over a time-span of 
30 days (Chapter 2). This study illustrated the prominent responsiveness of the jejunal mucosa 
to the colonizing microbiota. Therefore, the current study focuses on this intestinal region, 
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and employs tissue-transcriptome, tissue-metabonome (1H NMR), and microbiota profiling, in 
combination with histological analysis, to improve our understanding of the molecular dynamics 
involved in microbiota-mediated control of jejunal metabolism. Our findings demonstrate that 
the mouse jejunum has a unique sensory role in monitoring the luminal microbiota-diet interplay. 
The results showed that one day of microbial colonization of germfree mice induced an acute 
and transient response in the jejunal mucosa that was followed by a secondary response starting 
on day 4 post-conventionalization. After four days, gene metabolic profiles and metabolic fluxes 
suggested that the original homeostasis representing the germfree state had been replaced by a 
novel state of homeostasis that appeared to be established and sustained throughout the 30-day 
period of conventionalization. Detailed mining of the jejunal transcriptomes during the 30-days 
of conventionalization allowed the reconstruction of a core gene-regulatory network that is 
proposed to govern the jejunal metabolic changes in response to the colonizing microbiota. Of 
the genes encompassed in the network, 26 % is reported to play a role in glucose homeostasis 
and insulin control, indicating that this network with its core regulatory nodes could be used 
to further improve our understanding on the genetic regulation involved in type 2 diabetes 
development. 
RESULTS  
Conventionalization Elicits Early and Late-Adjustments in Jejunal Tissue Morphology
This study comprised three independent experiments aimed to identify the dynamics of jejunal 
mucosal changes in germfree and conventionalized mice. The jejunal mucosal response to 
conventionalization characteristically proceeded through two distinct phases: an early (acute) 
response at day 1 post-conventionalization that is associated with transient alterations in secretory 
cell-lineages and repression of nuclear receptors involved in the regulation of gut hormones 
and fatty acid metabolism, and a second response at four days post-conventionalization that is 
characterized by persistent changes in pathways involved in energy and anabolic metabolism. 
At one day post-conventionalization, the colonizing microbiota had induced acute changes in 
the secretory cell-lineages within the jejunal tissues (Figure 3.1). The most distinguishable 
morphological change in the secretory cells on day 1 post-conventionalization (and to a 
lesser extent day 2 post-conventionalization) was the increase (approximately 40%, p <0.05 
as compared to the germfree state) in the number of swollen, mucin-filled goblet cells 
in the villus epithelia that were detected by Alcian blue (AB-PAS) staining. Extending the 
conventionalization period to four days led to an overall decrease of goblet cells that stained 
only weakly and appeared to be smaller with a more columnar morphology as compared to days 
1 and 2 post-conventionalization. This change in morphology was transient since the number of 
large, mucin-filled goblet cells recovered to a level that slightly exceeded that of germfree mice 
from day 16 post-conventionalization onward (Figure 3.1). 
Response to Danger Signals Dominates the Acute Transcriptional Response in Jejunal 
Tissue
Ingenuity Pathways Analysis (IPA) (www.ingenuity.com) was employed to further elucidate the 
cellular functions and signaling pathways involved in the acute responses of the jejunal mucosa. 
The first day post-conventionalization was most prominently associated with the induction of 
tissue damage response pathways, e.g., the P2Y pyrogenic receptor and HMGB1 signaling 
pathways, as well as the repression of pathways involved in regulation of cell cycle control, 
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e.g., Notch and P53 signaling pathways (Figure 3.2A).  
To further investigate the genes and pathways underlying this acute jejunal response, the day 
1 post-conventionalization transcriptomes were compared to those of the control animals 
(germfree). Short term conventionalization led to an immediate repression of genes encoding 
enteroendocrine hormones, including cholecystokinin (Cck), pancreatic and duodenal 
homeobox 1 (Pdx1), gastric inhibitory peptide (Gip), and ghrelin (Ghrl) (Figure 3.2B). These 
changes coincided with the reduced expression of several Notch pathway genes, including the 
Notch gene homologue 1 (Notch1), the hairy and enhancer of split 1 (Hes1), and neurogenin 3 
(Neurog3), but not the atonal homolog 1 (Atoh1), (Figure S3.1A). 
Short term conventionalization also elicited a strong repression of specific metabolic function-
encoding genesets, such as  genes involved in complex I of the oxidative phosphorylation 
pathway (Figure S3.1B) and the fumarate hydratase gene (Fh1) involved in the citrate cycle 
(TCA), which converts fumarate to malate and is known as a tumor suppression gene. Taken 
together, the transcriptional changes that characterized the acute phase of conventionalization 
(day 1 post-conventionalization) in jejunal tissues suggest an early response to danger signals 
which could be endogenous or derived from the microbiota, its metabolites, and its interaction 
with nutrient flow or both. These danger signals activated tissue damage response pathways and 
that co-mediated repression of the cell cycle and parts of basal metabolism.
Microbial Colonization Resulted in a Gradual Reorientation of Jejunal Metabolic 
Homeostasis
Gene expression time series analysis using the STEM software (Ernst and Bar-Joseph 2006) 
was performed in order to monitor changes in gene ontology (GO) categories during 30-days 
of conventionalization. STEM clustering of gene expression indicated that GO terms related 
to metabolism were strongly enriched over the timespan of the experiment (p <0.001). The 
majority of the metabolic genes that were differentially expressed in time, particularly those 
that belonged to the GO categories lipolysis, oxido-reductase activity and transport, displayed 
a gradual down-regulation during the 30 days of conventionalization. The repression of genes 
associated with metabolism (that was apparent at day 1 post-conventionalization) became more 
pronounced during extended periods of conventionalization, and was mainly characterized by 
gradual repression of fatty acid oxidation and transport (Figure S3.2). This is illustrated by the 
continuous repression (up to day 30 post-conventionalization) of the major regulator of fatty acid 
oxidation, Ppar-α (peroxisome proliferator activated receptor alpha) and its downstream target 
genes, including the fatty acid transporter Cd36 and Angptl4. Concurrent with the repression 
of Ppar-α, other genes involved in fatty acid oxidation were also downregulated, including 
Hmgcs2 (Hydroxy-3-methylglutaryl-coenzyme A synthase 2) that facilitates the synthesis of 
ketone bodies (Vila-Brau, Luisa De Sousa-Coelho et al. 2011). Conversely, the expression of 
HmgCoA reductase that encodes the rate-limiting step of steroid synthesis (Dempsey 1974) was 
induced. These data suggest that the lipolysis, an important source of cellular energy, is repressed 
during conventionalization, together with fatty acid oxidation and transport. Consequently, 
the jejunal metabolism appears to shift towards an alternative energy source. This proposed 
reorientation is supported by the remarkable downregulation of the Ppar-α downstream target 
gene, Pdk4 (pyruvate dehydrogenase), suggesting the conversion of pyruvate into acetyl-CoA in the 
jejunal mucosa (figure S3.3), which in turn would affect glucose metabolism.
To further refine our understanding of the postulated metabolic reorientation, expression changes 
of metabolic genes were projected onto metabolic maps (Figure S3.3). These projections 
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showed that the suppression of fatty acid oxidation parallels an induction of glycolytic, 
lipogenic, amino acid, and nucleotide metabolism pathways. This induction was apparent at 
day 4 and persisted up to day 30 post-conventionalization. The continuous downregulation 
of the gene encoding Pck1 (phosphoenolpyruvate carboxykinase 1), suggested repression of 
gluconeogenesis, while the cellular demand for glucose appeared to be induced by elevated 
expression of the transporter Slc2a1 (also known as Glut1). The imported glucose appeared 
to be converted through both the oxidative arm of the pentose phosphate pathway (PPP), as 
illustrated by elevated expression of G6pd (Glucose-6-phosphate dehydrogenase), and the non-
oxidative arm of the PPP that generates the ribose that serves as a substrate for nucleic acid 
synthesis. The significant induction of nucleotide synthesis and metabolism was exemplified 
by the induction of thymidylate synthase (Tyms), ribonucleotide reductase (Rrm1, 2), Pola, 
e, and h (DNA polymerase a, e, and h), and Dnmt (DNA methyltransferase) (Figure S3.3). 
In addition, the metabolic mapping of transcriptome changes also highlighted the impact of 
conventionalization on lipogenesis by the induction of Acly (ATP citrate lyase), Acaca (acetyl-
CoA carboxylase alpha), and, Fasn (fatty acid synthase) (Figure S3.3).
In addition to the above-detailed fatty acid oxidation, carbohydrate and nucleotide metabolic 
adaptations, the jejunal metabolism also underwent dynamic changes in expression of genes 
involved in amino-acid metabolism, including the glutamine, glutamate, and glutathione 
associated pathways. This was apparent from the induction of Asns (asparagine synthetase), 
and the repression of the Gclc and Gclm (glutamate consuming γ-glutamylcysteine), Glul 
(glutamine synthetase), and the Glud1 (mitochondrial glutamate dehydrogenase) genes. 
Moreover, the mitochondrial Bcat1 (branched-chain amino acid transaminase), Tat (tyrosine 
transaminase), and Shmt2 (serine-glycine hydroxymethyl transferase) were induced, while 
several additional steps in tryptophan, tyrosine, phenylalanine, and branched chain amino acid 
(BCAA) metabolism were repressed (Figure S3.3). These transcriptome changes support the 
dynamic modulation of jejunal metabolism during conventionalization. Bacterial colonization 
of the jejunum induced changes in a variety of metabolic pathways and suggested a reorientation 
of both energy generating and biosynthetic pathways, presumably to maintain overall mucosal 
energy homeostasis.
A Possible Association of Jejunal Responses with a Shift in the Colonizing Microbiota
The jejunum is colonized by a relatively low-diversity and relatively small-sized bacterial 
community compared to the ileum and colon (O’Hara and Shanahan 2006). Molecular analysis 
by qPCR detection of the 16 S rRNA gene copies in jejunum samples indicated that a mouse 
microbial community of the density that is expected in the jejunum was already established on 
day 1; this community contained approximately 4.9±0.3 16 S rRNA copies/ml jejunal content 
(expressed as log10). This microbial count did not significantly change during the duration of 
conventionalization. To investigate which bacterial taxa were specifically associated with the 
acute and subsequent secondary responses observed, the jejunal microbiota composition at days 
1 and 4 post-conventionalization, respectively, was analyzed at the various levels of phylogenetic 
based on the MITChip profiles. At level 0 (phylum-like), day 1 post-conventionalization jejunal 
microbiota consisted mainly of Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria 
(Figure 3.3A). Interestingly, at level 1, which equates to bacterial class, members of the 
Firmicutes such as Clostridium clusters XIVa (9.4±1.6 %), XVI (12.9±3.1 %), XVII (6.8±1.3 
%), XVIII (17.2±5.6 %) as well as Bacilli (5.2±2.5%) dominated the jejunal microbiota at 
day 1 post-conventionalization (Figure 3.3B). Moreover, level-2 (genus-like) analysis, the 
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Figure 3.2. Acute jejunal transcriptome 
response to the colonizing microbiota. 
(A) Cellular pathways significantly 
modulated in the jejunum at day 1 post-
conventionalization, calculated via a 
one-tailed Fisher’s Exact test in IPA and 
represented as -log (p value); -log values 
exceeding 1.30 were significant (p <0.05). 
(B) Heat map of the expression values 
for genes encoding enteroendocrine 
hormones, genes involved in Notch 
signaling pathway, and histone variants. 
The data represent the changes in gene 
expression levels at days 1-30 post-
conventionalization in comparison to 
germfree. Notably, the lower expression 
levels of histone signaling pathway genes 
was transient and only measured at day 
1 post-conventionalization in contrast to 
the persistent downregulation of genes 
encoding enteroendocrine hormones. 
Figure 3.1. Early and late morphological changes in 
jejunal mucosa in response to conventionalization. 
(A) Representative AB-PAS stain photomicrographs from the 
jejunum showing the dynamics of mucin subtypes distribution 
in germfree (a) and conventionalized mice at days 1 (b), 4(c), 
and 16(d). (B) The individual goblet cells scores in the jejunum. 
Significant differences between time-points are indicated 
by distinctive characters above the measurement clusters (p 
<0.05). (Score germfree: 9.6 ± 0.7) , (score day 1: 19.7± 3.6), 
(score day 4: 7.1 ± 1.1), and (score day 16: 14.7 ± 3.2).
A
A
B
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deepest level of phylogenetic assignment that can be reliably deduced from MITChip datasets, 
indicated that the phylotypes belonging to the Clostridium clusters were related to Coprobacillus 
cateniformis, Clostridium leptum, while the members of the bacilli were mostly assigned to 
Lactobacillus plantarum and relatives (Figure S3.4). This microbiota composition at day 1 
post-conventionalization appeared to be specific for the jejunum, since the ileal microbiota 
comprised the prominent presence of gamma-proteobacteria, mainly members of Clostridium 
cluster XIVa and the colon microbiota were dominated by Bacteroidetes (data not shown). 
These two groups  appeared to be much less abundant in the jejunal communities.
Microbial composition of samples collected at day 4 post-conventionalization was significantly 
different from the composition of the day 1 post-conventionalization samples with a clear shift in 
microbiota already apparent at the crude phylogenetic level-0. While Firmicutes accounted for 
the largest proportion of the jejunal microbiota at day 1 post-conventionalization, the abundance 
of members of the Bacteroidetes increased significantly (p=0.01) to account for 39.08±7.48% 
of the total population (Figure 3.3A). Remarkably, the subgroups within this phylum increased 
simultaneously indicating that the impact was not related to specific subgroups. This contrasted 
to the Firmicutes, in which only a few genera decreased, especially the members of the 
Clostridium cluster XVI (Figure 3.3). In conclusion, microbiota analysis of these  samples 
showed that the jejunum is colonized by low amounts of bacteria with relatively low diversity 
and a community structure that is distinct from that in the ileum and colon (Chapter 2), which 
was apparent throughout the conventionalization course (data not shown). 
Jejunal Tissue Metabolic Profiling during Conventionalization Confirms its Metabolic 
Reorientation 
Metabolic phenotyping by 1H NMR of jejunal tissues obtained from germfree and the time-
resolved post-conventionalization animals was conducted to delineate the effects of the 
colonizing microbiota on jejunum metabolism throughout the conventionalization process. 
These analyses provided insight into the dynamic alteration of amino acid and energy 
metabolism. Orthogonal partial least-square discriminant analysis (OPLS-DA) models were 
constructed focusing on the differences between germfree and conventionalized mice over 
time. The analysis showed that the presence of the gut microbiota was reflected by relatively 
increased levels of ascorbate, ethanolamine, aspartate, fumarate, glutamate, glutamine, inosine, 
dihydroxyacetone† (†=tentative assignment), and hypoxanthine also increased over time and 
the levels of tauro-conjugated bile acids and glycerol were found to decrease.  A number of 
metabolites such as guanosine and glycine were transiently altered during conventionalization 
(Figure 3.4). The altered metabolic profile of the majority of assigned tissue metabolites seem 
to correlate well with the differential regulation of the corresponding genes (Figure S3.3 and 
Table S3.1).
In order to investigate whether there are any statistical correlation between 1H NMR metabolic 
spectra and transcriptome data obtained from jejunal tissues, computed correlations were 
modeled by using O2PLS regression (Trygg and Wold 2003). The relationships between the 1H 
NMR spectra and the transcriptome data were visualized in the form of correlation heat maps, 
which revealed a negative correlation between the 1H NMR identified metabolite glutathione 
and a set of 128 genes that are mainly involved in amino acid and purine and pyrimidine 
metabolism, that were expressed at elevated levels starting at day 4 post-conventionalization 
onward (Figure S3.5). Taken together, the identified changes in metabolic profiles at the jejunal 
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tissue level confirm the remarkable transcriptome shift in genes particularly those involved in 
energy, amino acid, and nucleotide metabolism.
A Core Regulatory Network Orchestrates the Microbiota Driven Metabolic Reorientation 
of the Jejunal Mucosa
Proper regulation of animal physiology relies for an important part on gene regulatory networks 
(Davidson 2010). To evaluate whether a central regulatory network could specify the metabolic 
reorientation observed, STEM time series analyses were mined for metabolic-related GO 
assignments in the jejunal mucosa. The genes recovered were used to construct a protein-
protein interaction network in IPA. The resulting network (Figure 3.5) contains genes involved 
in the regulation of various cellular pathways, including xenobiotic metabolism, fatty acid 
metabolism, glutathione and arachidonic acid metabolism, amino acid metabolism, ammonia 
detoxification, glycolysis and gluconeogenesis (Figure S3.6). The network encompassed 76 
nodes that had at least 110 connections, the largest number for any node was 20. These central 
regulatory nodes belonged to the nuclear receptor subfamily, including Ppar-α and Ppar-γ, 
Nr1i3 (nuclear receptor subfamily 1-group I-member 3), Nr0b1 (nuclear receptor subfamily 
0-group B-member 2), as well as Insr (insulin receptor), and Thrβ (thyroid hormone receptor 
beta) (Figures 3.5 and 3.6). These central regulators and their known downstream target genes 
were included together in the regulatory network (Figure 3.5). Presence of regulators and 
downstream genes in the identified GO: metabolism corroborates the observed reorientation 
of the metabolism associated transcriptional profiles and the corresponding tissue-metabolites. 
Interestingly, IPA analysis of the association of the constituents of the regulatory network with 
functionality and disease exemplified the involvement of 20 genes of the 76 core regulatory 
genes in metabolic disorders including type 2 diabetes and insulin resistance (indicated by red 
arrows in Figure 3.5). This suggests that the core regulatory genes that play roles in the systemic 
metabolic control of glucose homeostasis in response to microbial colonization of the intestine 
could also be used to investigate metabolic dysregulation. 
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Figure 3.4. Correlation coefficient heat 
map that shows that relative increase or 
decrease of concentrations of respective 
metabolites during conventionalisation 
compared to the germfree state. A series 
of pair-wise OPLS-DA models were 
constructed from which the correlation 
coefficients of the significantly altered 
metabolites in jejunum tissues during 
days 1-16 post-conventionalization were 
extracted.  Red color represents an increased 
level and green color represents a decreased 
level. (†) indicates tentative assignment. 
Figure 3.3. Establishment of the colonizing jejunal microbiota
(A) Bar plot depicting the relative abundance of bacterial phyla at 
days 1 and 4 post-conventionalization. (B) Heat map showing the 
relative contribution of specific bacterial classes (level 1 group) 
in the jejunal lumen at days 1 and 4 post-conventionalization. 
Asterisks indicate significant differences between both days 
(p <0.05) assessed by t test executed in SPSS Statistics 17.0 
(SPSS Inc., Chicago, IL).
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Figure 3.5. A core regulatory network governs the dynamics of jejunal metabolic adaptation during 
conventionalization. (A) The Ingenuity protein-protein interaction (PPI) network generated by mining STEM 
time series analyses for metabolic-related GO assignments in the jejunal mucosa. Red arrows refer to genes known 
to be associated to human insulin resistance and type 2 diabetes based on IPA disease annotation. (B) Heat map 
diagram of the genes involved in the regulatory network, representing the changes in their jejunum expression 
level during days 1-30 post-conventionalization in comparison to germfree state. 
A
B
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DISCUSSION
The gut microbiota has been recognized to play a prominent role in the modulation of 
intestinal and systemic energy and lipid metabolism in healthy hosts. In addition, improper 
host-microbiota interactions have been suggested to underlie the development of metabolic 
disorders (Bäckhed, Ding et al. 2004; Claus, Ellero et al. 2011). The proximal intestine, and in 
particular the jejunum can be considered as the initial site of intestinal interaction between the 
host mucosa, the microbiota and ingested food. Therefore, it may be anticipated that especially 
this part of the intestinal tract will respond strongly to the presence of microbiota, despite 
the fact that the microbial densities in this intestinal region are relatively low (O’Hara and 
Figure 3.6. Nuclear receptors which regulate gut hormones and fatty acid metabolism constitute the major 
nodes in the identified regulatory network. Jejunal gene expression levels of nuclear receptors and their target 
genes were analyzed in germfree and conventionalized mice at indicated days of conventionalization. Values are 
depicted as dot plots. Significant differences between time-points are indicated by distinctive characters above the 
measurement groups (p< 0.05).
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Shanahan 2006).  
In a recent study, it was reported that metabolic changes in liver tissues in response to intestinal 
conventionalization involved two distinct temporal phases, which were characterized by a shift 
from glycolysis (observed at 5 days post-conventionalization) to triglyceride biosynthesis (at 
20 days post-conventionalization) (Claus, Ellero et al. 2011). The present study focuses on 
time-resolved analysis of metabolic responses in the jejunal mucosa and confirms a two-phase 
response to conventionalization. The jejunal response to conventionalization was characterized 
by an acute and transient phase, which was followed by a secondary stable phase, as evidenced 
by both transcriptomic and metabonomic analyses of the jejunal tissue (Figure 3.7). This rapid 
and dynamic metabolic response to conventionalization was not observed in the ileum or colon 
(data not shown) lending further support to the unique role of the proximal intestine in sensing 
and monitoring the luminal microbiota-diet interplay. During the acute response (day 1 post-
conventionalization), “danger signals” appeared to have played important biological roles, 
judged by the induction of IPA danger signal pathways such as HMGB1, and P2Y pyrogenic 
receptor signaling cascades (Kono and Rock 2008; Kouzaki, Iijima et al. 2011). The bacterial 
groups that dominated at day 1 post-conventionalization (e.g. Bacilli ), produce TCA cycle 
intermediates which have been reported to act as “alarm or danger signals” (Poelstra, Heynen 
et al. 1992; Rubic, Lametschwandtner et al. 2008) and are associated with the induction of 
rescue pathways and hypoxia associated metabolic responses in host cells (Oppenheim and 
Yang 2005), suggesting that these bacterial groups participated in the induction of danger 
signals in this study. The strikingly increased number of mucin-filled goblet cells observed 
in the jejunum during the acute response (day 1 and to a lesser extent on day 2) could reflect 
a physiological defence mechanism in response to accumulating “danger signals” during the 
early days of conventionalization.
Transcriptome analysis including GO enrichment and pathway and gene regulatory network 
analysis showed that the secondary phase of  response to conventionalization (days 4-30) was 
characterized by molecular changes illustrative of the metabolic reorientation of jejunal tissue. 
Notably, the repression of the nuclear receptors involved in the regulation of this secondary 
metabolic response had been already initiated during the first day of conventionalization. 
The secondary phase of jejunal responses was consolidated during extended periods of 
conventionalization (up to day 30), illustrating the establishment of a novel metabolic 
homeostasis that accommodates the microbiota in this region of the intestinal tract. This novel 
homeostasis included the repression of genes belonging to fatty acid oxidation, lipid absorption 
(Pnliprp2, Clps, and Apoa4), lipid transport (Cd36), but also included 14 important regulators, 
among which Ppar-α, Ppar-γ, and Angptl4. Repression of lipid metabolism pathways appeared 
to favour glucose utilization in the jejunal tissues, which is supported by the increased expression 
of (among others) G6pd, and Slc2a1, and repression of Pck1, G6Pc (glucose-6-phosphatase), 
and Pdk4. The transcriptome changes appear to describe a shift in the jejunal metabolism from 
an oxidative energy supply to an anabolic metabolism that may be required to meet the energy 
demand of the mucosal tissue and its epithelial cells that goes through drastic morphological 
changes and increase in the turnover rate during later stages of conventionalization (Chapter 
2). Proliferating cells require nucleotide supplies that are synthesized from precursors derived 
from glycolytic and TCA cycle intermediates (Tong, Zhao et al. 2009). Indeed, the induced 
phosphoglycerate dehydrogenase (Phgdh), phosphoserine aminotransferase 1 (Psat1), and 
Shmt2, may have participated in glycine biosynthesis, which was confirmed on the metabolite 
level (Figure 3.4). Moreover, the induction of Ripa (ribose-5-phosphate isomerase) and 
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Pgd (6-phosphogluconate dehydrogenase) may have led to increased ribose-5-phosphate 
biosynthesis. Both glycine and ribose-5-phosphate are important precursors of nucleotide 
biosynthesisintermediate 3-phosphoglycerte to glycine, and ribose-5-phosphate biosynthesis 
(Snell and Weber 1986; DeBerardinis, Sayed et al. 2008). These adaptations resemble the 
so-called “Warburg effect” that is described to occur in the highly proliferating cancer cells, 
which produce energy via an increase in glycolysis followed by lactic acid production in the 
cytosol. This energy-limited anabolism observed in cancer cells is clearly different from the 
comparatively low rate of glycolysis coupled to mitochondrial oxidative phosphorylation that 
is exhibited by normal cells (Kim and Dang 2006). 
Metabolic tissue profiling by 1H NMR confirmed the induction of anabolic metabolism, 
illustrated by the accumulation of glutamine, glutamate, and aspartate, which is in agreement 
with their previously reported elevated levels in the ileum and colon upon colonization of 
germfree mice (Claus, Tsang et al. 2008). Glutamine has been shown to be extensively utilized 
by the highly proliferating cells of the intestine and is an important substrate for the anabolic 
metabolism (Wu 1998) to sustain the increased epithelial turnover and the development of 
the immune system during conventionalization (Chapter 2). Notwithstanding the decreased 
expression levels of Glud1 gene encoding the enzyme that is involved in glutamine production 
during the metabolic reorientation phase, consistent elevation of glutamine level in jejunal tissue 
was detected by 1H NMR at day 4 post-conventionalization onward. These results suggest that 
upon conventionalization the proliferating intestinal cells require the import of glutamine to 
meet their highly anabolic demands. This finding is in agreement with the notion that glutamine 
is mainly taken up by jejunal mucosa from the blood circulation (Windmuel and Spaeth 1974). 
In addition, the remarkable decreased expression of Glud1 (Fold change ranges from -2.8 at day 
4 and -2.5 at day 30 post-conventionalization) implies a repressed replenishment of TCA cycle 
intermediates using glutamate as a substrate in conventionalized mice (Brosnan 2000). 
At day 4 post-conventionalization, genes encoding glutathione reductase (Gsr), and peroxidases 
were up-regulated, presumably because of their involvement in the protection of intestinal 
tissues against oxidative stress and tissue damage (Dahm and Jones 1994). Two associated 
genes encoding subunits of γ-glutamyl cysteine ligase (Gclc and Gclm) were downregulated. 
γ-glutamyl cysteine ligase is the rate-limiting enzyme in the de novo synthesis of glutathione 
(Krzywanski, Dickinson et al. 2003). Downregulation of Gclc and Gclm correlates with the 
observed accumulation of glutamate. Remarkably, conventionalization led to strong repression 
of two glutathione transferases (GST-α and μ)  which are involved in phase II metabolism 
of xenobiotics (Waxman 1990) and in the biosynthesis of arachidonic acid metabolites like 
prostaglandins and leukotrienes (Vessey and Zakim 1981). Suppression of prostaglandin 
and leukotriene synthesis by reduced GST expression may have contributed to avoidance of 
excessive inflammatory reactions from day 4 post-conventionalization onward (Chapter 2). We 
propose that the protection of tissue injury from oxidative stress contributes to maintenance of 
tissue integrity towards a novel state of homeostasis that accommodates the microbiota and its 
metabolites.
Using gene ontology (GO) enrichment and IPA-driven biological annotations of genes, pathways, 
and processes, we obtained an integrative view of the jejunal transcriptomes and metabolites 
that were modulated upon colonization of germfree mice. Data integration allowed the 
reconstruction of a gene regulatory protein-protein interaction network that included repression 
of genes involved in hormonal regulation and key metabolic genes that play important roles 
in (among others) fatty acid oxidation and gluconeogenesis. Of note, the identified regulatory 
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network comprised genes of which the human 
orthologues are dysregulated in metabolic 
disorders, including insulin resistance and 
type 2 diabetes. In addition, on the basis of 
genome-wide association studies (GWAS), 
at least 26 % of the regulatory genes were 
associated with metabolic diseases. One 
extrapolation that could harness the linkage 
between the jejunum and its microbiota 
with basic systemic metabolic processes 
and diseases, may come from the study of 
possible mechanisms by which gastric bypass 
rapidly improves insulin sensitivity (Troy, 
Soty et al. 2008). It has been reported that 
the enhanced intestinal gluconeogenesis that 
is observed post-surgery stimulates portal 
sensing of glucose and rapidly modifies 
the insulin sensitivity of hepatic glucose 
production (Troy, Soty et al. 2008). The 
prominent effect of the colonizing microbiota 
on the host genes that are essential for proper 
glucose metabolism that was observed in 
this study, suggests that the microbiota is a 
key determinant of proper jejunal glucose 
metabolism. Apparently exclusion of the 
jejunum together with its microbiota from 
the nutrient flow can promote recovery of 
insulin sensitivity (Pories, Swanson et al. 
1995; Troy, Soty et al. 2008). It is tempting 
to speculate that specific microbiota changes 
that are caused by the exclusion of the 
nutrient-flow contribute to jejunal responses 
that may underlie the major health promoting 
effect of a gastric bypass. Taken together, the 
present study supports a critical sensory role 
Figure 3.7. Dynamics of the metabolic response 
in jejunal mucosa during conventionalization. A 
schematic model of the time-resolved jejunal mucosal 
changes of fat, energy, and amino acids and nucleotide 
metabolism during conventionalization. Color coded 
boxes represent changes in metabolic processes at early 
(1-2) and late (4-30) days of conventionalization. Red 
color represents up-regulated processes, green color 
represents down-regulated processes, over control 
(germfree=day 0). The intensity of the green color 
depicted in the figure is proportional to the relative 
decrease in gene expression. 
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of the jejunum in the perception of the local nutrient-microbiota interplay, which is a major 
determinant of systemic glucose homeostasis. 
EXPERIMENTAL PROCEDURES
Animals, Experimental Design, and Sampling
All procedures were carried out as previously described (Chapter 2). In brief, germfree 
and conventionalized mice (male, C57 BL/6 J) were maintained in sterile conditions, on a 
commercial laboratory chow diet. Three independent biological experiments were performed 
using mice of different age after 2 weeks of acclimatization and diet adaptation. The first and 
second experiments of the three performed independent biological experiments included 36 
mice obtained in 2 biologically independent batches of 18 mice each, aged 8 and 10 weeks, 
respectively. The third experiment included 14 mice, aged 10 weeks old. The jejunum from 
each mouse was removed and divided into 2 cm segments that were immediately: stored in 
RNAlater® at room temperature for 1 h prior to subsequent storage at -80°C for RNA isolation, 
fixed overnight (O/N) in 4% (wt/vol) paraformaldehyde (PFA) followed by paraffin embedding 
for histological analysis, or snap frozen and stored at -80°C for metabolic analysis. Luminal 
content from jejunal segments was removed by gentle squeezing, snap frozen, and stored at 
-80°C for microbiota analysis.
Histological Staining
Cross sections (4 μm-thick) of the intestinal tissue segments were stained with Alcian Blue 
(AB) followed by the periodic acid-Schiff’s reaction (periodic acid-Schiff (PAS) stain); to 
stain neutral and acid mucins as previously described (Spicer 1965). Since the villus length 
in the different jejunal tissue samples was not identical, it was important to define a common 
denominator to determine the number of positively stained goblet cells. Therefore the number 
of goblet cells was expressed relative to the villus surface area. All data are presented as means 
± SD for the number of animals indicated. Comparative analyses of the histochemical and 
cell-enumeration data were performed at each time-point using one-way analysis of variance 
(ANOVA) followed by Tukey’s Studentized range test (SPSS program, Chicago, IL), and for 
all variables p < 0.05 was considered significant.
Transcriptome Analysis
High quality total RNA was isolated from a 2 cm segment jejunum by extraction with TRIzol 
reagent, followed by DNAse treatment and column purification. Samples were hybridized on 
Affymetrix GeneChip Mouse Gene 1.1 ST arrays. Quality control, statistical analysis, and 
complementary methods for the biological interpretation for the transcriptome data, were 
performed as previously described (detailed descriptions are provided in the supplemental 
material of Chapter 2).
Microbial Profiling of Jejunal Luminal Contents
Luminal contents of the jejunum were analyzed by Mouse Intestinal Tract Chip (MITCHip), a 
diagnostic 16S rRNA array that consists of 3,580 unique probes especially designed to profile 
mouse intestine microbiota (Geurts, Lazarevic et al. 2011) in analogy to the human intestinal 
tract (HIT)Chip (Rajilic-Stojanovic, Heilig et al. 2009). In short, 20 ng of jejunal DNA extract 
was used to amplify the 16S rRNA genes with the primers T7prom-Bact-27-for  and Uni-1492-
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rev (Chapter 2). Subsequently, an in vitro transcription and labeling with Cy3 and Cy5 dyes 
was performed. Fragmentation of Cy3/Cy5-labeled target mixes was followed by hybridization 
on the arrays at 62.5˚C for 16 h in a rotation oven (Agilent Technologies, Amstelveen, The 
Netherlands). The slides were washed and dried before scanning. Signal intensity data were 
obtained from the microarray images using Agilent Feature Extraction software, version 9.1 
(http://www.agilent.com). Microarray data normalization and further analysis were performed 
using a set of R-based scripts (http://r-project.org) in combination with a custom-designed 
relational database, which operates under the MySQL database management system (http://
www.mysql.com).
Of note, microbial analysis should be interpreted with particular caution due to the technical 
challenges encountered in handling the small sized and low density samples obtained from the 
jejunum. 
Tissue Metabolite Profiling
Tissue samples were homogenized and extracted in acetonitrile/water (1:1), as previously 
described (Waters, Holmes et al. 2002). The supernatant containing the aqueous phase was 
collected, freeze-dried and dissolved in 600 µl of D2O. Samples were centrifuged for 10 min 
at 15,000 g, and 500 µl of the supernatant and 50 µl of water were transferred into 5mm (outer 
diameter) NMR tubes for analysis by 1H-NMR spectroscopy.  All spectra were acquired on an 
Avance II 600MHz NMR spectrometer (Bruker Biospin, Rheinstetten, Germany) equipped with 
a Bruker 5mm TXI triple resonance probe operating at 600.13 MHz, and using a BACS auto-
sampler. Spectral acquisition of the aqueous phase was performed using the first increment of 
a standard nuclear Overhauser enhancement scpectroscopy (NOESY) 1-dimensional 1H NMR 
experiment ((noesypr1D)(RD-90°-t1-90°-tm-90°-acquisition), where RD is a relaxation delay, t1 
is a short delay of 2 μs and tm is a mixing time of 100 ms.  Water suppression was applied during 
the RD and a 90° pulse set at 10 μs. For each spectrum, a total of 256 scans (16 dummy scans) 
were collected into 64k data points over a spectral width of 20 ppm. 
Data were analyzed by applying an exponential window function with a line broadening of 0.3 
Hz prior to Fourier transformation to all 1D NMR spectra. The resultant spectra were phased, 
baseline corrected and calibrated to lactate (δ 1.33) manually using Topspin (2.0a, Bruker BioSpin 
2006).  The spectra were subsequently imported into MatLab (R20010aSV, The MathsWorks 
inc.) where the region containing the water resonance (δ 4.6-5.2) was removed.  The data were 
then normalized to the probabilistic quotient (Dieterle, Ross et al. 2006) to minimize the effects 
of inter-sample variation due to phenomena such as disparate sample volume, although every 
effort was made to keep this constant during sample preparation. 
Metabonomic data were visualized by Principal Component Analysis (PCA). OPLS-DA models 
(Trygg and Wold 2003) were then fitted between successive time-points in order to highlight 
discriminant metabolites. PCA, O-PLS, O-PLS-DA and Statistical total correlation spectroscopy 
(STOCSY) were performed in Matlab (using an in-house routine) (Cloarec, Dumas et al. 2005). 
Permutation testing of the Y matrix for PLS-based models was conducted using an in-house 
algorithm (Cloarec, Dumas et al. 2005) to determine whether the Q2Y (predictive ability) of 
the model was significantly different from the Q2Y calculated from 100 random permutations 
of Y.  Variables with a correlation coefficient |r| > 0.4 were reported in Figure 3.4 to ascertain 
an overview of temporal metabolic changes. Assignments were made using additional two-
dimensional NMR experiments and reference to databases of spectra of authentic compounds.
An O2PLS model was conducted to integrate metabonomic and transcriptomic datasets as 
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described by Li et al (Li, Wang et al. 2008) using an in-house algorithm (Cloarec, Dumas et al. 
2005). The O2PLS model was calculated for pairwise datasets (metabolome and transcriptome) 
and displayed .O2PLS models were fitted on tables built from 2 merged datasets reflecting the 
2 phases of conventionalization: (1) d0, d1 and d2 (n=18) and (2) d4, d8 and d16 (n=14). The 
first model on d0, d1 and d2 was not significant and is not discussed in the chapter. The second 
model computed with 1 predictive component, 1 orthogonal component and a 7-fold cross-
validation procedure had a good predictive ability, as reflected by the following parameters: 
R2Y=0.36 and Q2Y=0.15. The significant variables were then selected based on their correlation 
with the scores of the model (p < 0.01).
Accession Numbers
The mouse microarray dataset was deposited in the Gene Expression Omnibus (GEO) with 
accession number GSE32513.
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Figure S3.1. Pathway maps analysis of Ingenuity’s canonical Notch signaling pathway (A) and mitochondrial 
dysfunction pathway (B) including the genes that were differentially expressed in the jejunal tissue at day 1 post-
conventionalization. The grey color depicts a decrease in gene expression. 
SUPPLEMENTAL FIGURES 
A
B
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Figure S3.2. Gene Ontology enrichment analyses of jejunum during the time course of 30 days experiment. The 
table shows the GO enrichment results for the set of genes shown in the graph right to the table. The graph shows 
the expression patterns for all the genes assigned to the profile. The table shows a count of the number of genes 
assigned, and the STEM profile’s p-value.
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Figure S3.3. Schematic map indicating the changes in the expression of genes encoding metabolic enzymes at 
days 1-30 post-conventionalization versus germfree mice. Each gene box is divided into six sub-boxes with color 
codes representing the changes observed for each of the six time-points. Red color represents upregulated genes 
and green color represents downregulated genes (relative to germfree mice). 
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Figure S3.4. Bacterial genera (level 2 data, genus-like) that were significantly different when comparing microbiota 
profiles of jejunal lumen samples obtained on days 1 and 4 post-conventionalization (p <0.05). 
Figure S3.5. Genes negatively 
correlated with glutathione 
metabolite at the second phase 
of conventionalization. Heat 
map of the genes which were 
significantly anti-correlated 
with glutathione metabolite 
detected by 1H NMR in jejunal 
tissue samples. The heat map 
represent the changes in gene 
expression levels at days 1-16 
post-conventionalization. 
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Figure S3.6. Ingenuity canonical pathways (A) and cellular functions (B) that were significantly modulated in the 
jejunum during conventionalization. Significance was calculated via a one-tailed Fisher’s Exact test in IPA and is 
represented as -log (p value); -log values exceeding 1.30 were significant (p <0.05).
B
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Table S3.1. Correlation between the identified jejunal tissue metabolites and the corresponding genes involved 
in the metabolic reactions of which the metabolites are end- or by-products. The heat map of the expression 
values for the genes represents the changes in gene expression levels at days 1-16 post-conventionalization in 
comparison to germfree as depicted by MADMAX analysis. Red color depicts upregulation and green color 
depicts downregulation
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ABSTRACT
The interplay between dietary nutrients, gut microbiota, and mammalian host tissues of the 
gastrointestinal tract is recognized as highly relevant for host health. In this study, we employed 
a combination of transcriptomic, metabonomic, and microbial profiling tools to analyze the 
dynamic responses of germfree C57/BL6 J mouse colonic mucosa to conventionalization by 
normal mouse microbiota at different time-points during 16 days. The colonizing microbiota 
showed a shift from low (days 1 and 2) towards a high diversity (days 8 and 16). The dynamic 
changes in the microbial community were rapidly reflected by the urine metabolic profiles 
(day 1) and at later stages (day 4 onward) by the colon mucosa transcriptomes, and metabolic 
profiles. A major part of the dynamic transcriptome alterations in the colon mucosa included 
gene expression that control key metabolic pathways, including glycolysis, glycan biosynthesis 
and degradation, and amino acid and nucleotide metabolism. Altered gene expression 
correlated with altered levels of specific tissue metabolites that all participated in the metabolic 
pathways listed above.  Correlations of host transcriptomes, metabolite patterns, and microbiota 
composition were modeled and revealed correlations between Bacilli and Proteobacteria and 
differential expression of host genes involved in energy and carbohydrate, glycerophospholipid, 
and anabolic metabolism. Differential gene expression did strongly correlate with scyllo-, and 
myo-inositol, glutamine, glycine, and alanine levels in colonic tissues during the time span of 
conventionalization. The results of the time-resolved multi-variate analyses that were applied 
here may help to expand our knowledge of host-microbe molecular interactions during the 
microbial establishment.
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INTRODUCTION
The mammalian gastrointestinal (GI) tract is home to an estimated 100 trillion microbial cells, 
representing the largest microbial community associated with the mammalian body (Savage 
1977; Lee and Mazmanian 2010). This complex ecosystem provides a vast reservoir of 
metabolic capabilities that complement the metabolism of the host (Bäckhed, Ding et al. 2004; 
Nicholson, Holmes et al. 2005; Turnbaugh, Hamady et al. 2009) and plays a crucial role in 
several developmental and nutritional processes in the intestine (Kau, Ahern et al. 2011). The 
colon is the most prominent site of microbial colonization, with bacterial densities reaching 
up to 1012 per gram of content (O’Hara and Shanahan 2006).  Nevertheless, the effects of the 
intestinal microbiota can be observed in diverse regions of the host. “Top-down” systems biology 
using metabolic profiling of  conventional mice revealed large, systemic effects of the microbial 
community on absorption, storage, and metabolism of dietary compounds in the blood, urine, 
liver, and feces (Martin, Wang et al. 2007; Claus, Tsang et al. 2008). These, and other studies, 
have demonstrated that host metabolism is responsive to intestinal-microbial metabolism which 
provides complementary pathways for dietary ingredients and drugs (Nicholson, Holmes et al. 
2005). 
There has been a clear influence of changes in the human diet on gut microbiota, to the extent 
that there appears to have been a coevolution between the diet, human population, and the 
composition of the human microbiota (Walter and Ley 2011). The microbiota is composed 
of well-established, resident bacteria that form long-term associations with the host, as well 
as transient bacteria that do not colonize the GI tract permanently. This large and dynamic 
community undergoes dramatic changes after initial colonization of the sterile-born host 
(Hooper 2004; Palmer, Bik et al. 2007). During colonization, all microbes compete with other 
residing microbes and are under attack  by the host’s defense systems (Ley, Peterson et al. 
2006). Stable establishment of microbial groups requires cooperation in food networks, where 
metabolites from one organism can act as a substrate for another (cross-feeding) (Duncan, 
Holtrop et al. 2004; Fischbach 2011).
In the intestinal microbial ecosystem, the most prominent microbial activity is the fermentation 
of dietary or host-derived components, in particular, the conversion of non-digestible 
carbohydrates and host glycans into short chain fatty acids  (SCFAs) (Bäckhed, Ding et al. 
2004). SCFAs activate a G-protein coupled receptor 43 (Gpr43), which has been reported to play 
an important role in immune modulation (Maslowski, Vieira et al. 2009) and plays a key-role 
in the regulation of energy balance (Bjursell, Admyre et al. 2011). In addition to fermentation 
of dietary or host glycans, the microbiota synthesizes essential vitamins such as vitamin k 
and certain B vitamins; these vitamins have to be supplemented in higher amounts in diets for 
germfree animals (Hooper, Midtvedt et al. 2002). The extensive chemical and macromolecular 
cross-talk between the microbiota and the host has a marked impact on the host mucosa and 
its local and systemic metabolic profile (Bäckhed, Ley et al. 2005) to such extent that the co-
evolution of the host-microbe interaction has enabled mammals to harvest nutrients from novel 
sources (Bäckhed, Ley et al. 2005; Walter and Ley 2011). In return, the gut microbiota are 
provided with a ‘’protected’’, nutrient-rich niche that enables bacterial multiplication (Hooper, 
Midtvedt et al. 2002), and that has been proposed to provide high-affinity adhesion sites for 
specific microorganisms to accommodate their persistence in the intestine (Bäckhed, Ley et 
al. 2005). Such adaptive accommodation of specific microbes by the host stimulates their 
colonization thereby contributing to the colonization resistance against incoming pathogenic 
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bacteria (Hultgren, Abraham et al. 1993, Salyers and Pajeau 1989). 
There is increasing evidence for an association between interference in the symbiotic microbiota-
host relations via changes in proper microbial colonization (dysbiosis) and development of 
human disease (Neish 2009). Dysbiosis of the microbial community has been associated with 
a variety of diseases including inflammatory bowel disease and colon cancer (Azcárate-Peril 
Andrea M. 2011) along with systemic diseases (Huycke and Gaskins 2004) such as obesity 
(Bäckhed, Ding et al. 2004; Bäckhed, Manchester et al. 2007). In view of the increasing 
awareness of disease-associated shifts in intestinal microbiota communities, it is important to 
improve our understanding of the molecular basis and dynamics of the ‘normal’ interrelations 
governing intestinal homeostasis. To this end, we aimed to monitor the succession of microbial 
colonization and the dynamic molecular alterations in the host-microbe metabolic relationship. 
Following conventionalization, the time-resolved composition of colonic microbial communities 
was determined in parallel with colon mucosa transcriptomes and 1H NMR spectroscopic 
profiling of the colonic tissue and urine. Statistical modeling showed correlations between 
microbial diversity and host transcriptomics and metabonomics and allowed us to reconstruct a 
comprehensive overview of the transient and more permanent alterations in the symbiotic host-
microbe relationship. 
RESULTS
Dynamic Establishment of Microbial Communities
The colonic microbiota composition of conventionalized mice was assessed for five time-points 
post-conventionalization using the mouse intestinal tract (MIT)Chip phylogenetic platform 
that allows profiling of murine gut microbiota. Previously, we described a composition shift 
in the microbiota during the conventionalization period (Chapter 2). The colonic microbiota 
of conventionalized mice proceeded through two major stages discriminated by low diversity 
of the microbiota during early stages (days 1-2) and increasing microbial diversity at later 
stages (days 8 and 16) of conventionalization, ultimately reaching levels similar to those 
observed in conventional animals. MITChip analysis confirmed that this early-to-late shift 
is characterized by early, rapid colonizers (days 1-2) belonging predominantly to the phyla 
Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria, while at later stages (days 4, 
8, and 16 post-conventionalization) specific subgroups of the Firmicutes, particularly the 
members of Clostridium clusters IV and XIVa increased in abundance, (Figure 4.1).  Days 
1 and 2 post-conventionalization were characterized by relatively high abundance of genera 
like Enterococcus (Enterococcus urinaeequi et rel), Bacteroides fragilis et rel., Prevotella, and 
Lactobacillus salivarius (Table S4.1).  Days 8 and 16 post-conventionalization were typically 
characterized by an increased abundance of genera such as Dorea, Butyrivibrio crossotus et rel, 
and unclassified TM7 (Table S4.1). Taken together, MITChip analysis identified the  microbial 
communities that had established in the colon of mice over time during conventionalization. 
Moreover, the detailed analysis identified the dynamic abundance of the microbial groups that 
comprised the climax community. This community appeared to be established from day 8 post-
conventionalization onward, and strongly resembled the inoculum (conventional) microbiota in 
terms of composition and abundance. The established microbial community was characterized 
by a general increase of anaerobes and distinct colonization patterns of the major groups 
Bacteroidetes and Clostridium clusters IV and XIVa.
In addition to determination of the phylogenetic composition of the microbiota, gene-specific 
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qPCR was employed to quantify the relative abundance of the 16 S rRNA gene and specific 
functional genes within the intestinal microbiota ecosystem. For the latter,  well-studied marker 
key-genes that belong to the pathways of sulfate reduction (dissimilatory sulfite reductase (dsr) 
gene); (Ben-Dov, Brenner et al. 2007)) and methanogenesis (methyl coenzyme-M reductase 
(mcrA) gene); (Steinberg and Regan 2008)) were used. Dsr and McrA were targeted to monitor 
the succession of hydrogen-utilizing species (sulfate reducers and methanogens), which ensure 
efficient H2 removal to maintain fermentation balance in the colon (Gibson, Macfarlane et al. 
1993). Butyrate producers were detected by butyrate production and butyryl-CoA-transferase 
(Louis and Flint 2007). The overall microbial community size as estimated by 16S rRNA gene 
copy number per gram of colonic content was stable at a level of approximately 11.63±0.59 
(expressed as log10) during conventionalization experiment (Chapter 2). In agreement with this 
apparent stable 16 S rRNA gene abundance, the relative abundance of the mcrA gene appeared 
to be stable and stayed at low levels (4.82±0.82 at day 1, 5.2±0.26 at day2, 5.15±0.76 at day 
4, 3.82±1.18 at day 8, and 4.93±0.64 at day16) (expressed as log10), over the entire duration 
of the conventionalization, suggesting that the methanogen population was among the early 
colonizers and had already reached its final population site early in the experiment. In contrast, 
the dsr gene appeared to be approximately 100-fold more abundant in the ecosystem during 
later stages of the conventionalization (Figure 4.2A), increasing from approximately 2.54±0.2 
(expressed as log10 ) during days 1-2 to 4.4±0.86 (expressed as log10 ) at days 4, 8 and 16 
post-conventionalization. Additionally, the butyryl-CoA gene abundance in the ecosystem 
increased more than 100 folds from approximately 9.3±0.42 at days 1-2 to 11.87±0.78 
(expressed as log10) on days 8 and 16 post-conventionalization, while the microbial ecosystem 
on day 4 post-conventionalization appeared to contain an intermediate abundance of this gene 
(10.5±0.96 (expressed as log10)). These results are in accordance with phylogenetic analysis 
of the community where the relative populations of typical sulfate reducing organisms such as 
Bilophila and Desulfovibrio and butyrate producing organisms like Roseburia intestinalis et rel, 
Subdoligranulum, Faecalibacterium prausnitzii et rel, and Butyrivibrio (Table S4.1) appeared 
to increase during later stages of conventionalization (days 4, 8, and 16 for the sulfate reducers 
and days 8 and 16 for butyrate producers).
Dynamics of Microbial Fermentation End-Products The phylogenetic analysis predicted 
a change in global fermentative capacities of the microbiota, with a shift towards increased 
production of butyrate at later time-points. To assess the fermentative capacities of the successive 
microbial communities, concentrations of the short-chain fatty acids (SCFAs) acetate, propionate, 
butyrate, as well as lactate and succinate were determined in cecal contents. Especially lactate 
and succinate, together with relatively high amounts of acetate and propionate dominated the 
microbial fermentation-profile measured during the early stages of conventionalization (days 
1-2 and to lesser extend day 4), whereas butyrate concentrations were below the detection 
limit (0.11 μmole/mg). The concentrations of fermentation metabolites drastically shifted at 
later stages of conventionalization (days 8 and 16 post-conventionalization) when lactate and 
succinate levels were decreased below the detection limit and acetate and propionate were 
significantly increased (Figure 4.2B). Moreover, butyrate was also clearly detected at these 
later stages, which correlates very well with the increased abundance of butyrate producers (as 
shown above).
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Figure 4.2. Dynamics of specific functional gene abundance in the microbiota. (A)Quantification of butyrate 
producers and sulfate reducers expressed as mean ± SD log10 number of ButyrylCoA(•) and  dsr (♦)  genes /g 
content respectively. Statistical analysis was performed using a one-way ANOVA test executed in SPSS Statistics 
17.0 (SPSS Inc., Chicago, IL). Significant differences between time-points are indicated by distinct characters 
above the measurement groups (p <0.05). (B) HPLC analysis of the large intestinal content for SCFAs including 
acetate, butyrate, propionate, lactate, and succinate.
Figure 4.1. Dynamics of the colonizing 
microbiota in the colon. (A) Hierarchical 
clustering analysis of MITChip fingerprints 
generated from the inoculum and colonic samples 
collected from days 1-16 post-conventionalization. 
The highest phylogenetic assignments of probe 
specificity are provided at the right side of the 
gel-view dendogram. (B) Dynamics of the 
relative contribution of different level 1 (class-
like) microbial groups to the total microbiota in 
the colon of mice at different time-points post-
conventionalization.
A
A
B
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Colon Mucosa Transcriptome Profiling Focusing on Metabolic Functions
Previously we established a time- and location-dependent modulation of gene expression 
profiles during conventionalization, in which the colon mucosa transcriptomes supported the 
establishment of a novel state of homeostasis within 16 days of conventionalization (Chapter 
2). One set of genes that showed time-dependent differential expression in the colon was 
significantly enriched (p <0.001) for the gene ontology (GO) category “metabolic processes”. 
The genes belonging to this GO category were further analyzed by ingenuity pathway analysis 
(IPA), which illustrated their involvement in a variety of carbohydrate, lipid, glycolysis/
gluconeogenesis, amino acid, and nucleotide metabolism associated pathways (Figure 4.3). 
To predict possible metabolic consequences of the changing metabolic gene expression profiles 
during conventionalization, gene expression changes were projected onto KEGG metabolic 
maps (Figure 4.4). These projections showed a significant modulation of glycolytic, amino 
acid, and nucleotide metabolic pathways on days 4, 8, and 16, in comparison to day 0 (germfree 
mice) and earlier days (1 and 2)  post-conventionalization. The significant induction of 
nucleotide synthesis and metabolism pathways were illustrated by the induction of thymidylate 
synthase (Tyms) and ribonucleotide reductase (Rrm1 and 2), which is an essential enzyme for 
the production of deoxyribonucleotides (Parker, Begley et al. 1995). The colonic metabolism 
also underwent dynamic changes in expression of genes involved in amino-acid metabolism, 
including the glutamine and glutamate associated pathways. This was apparent from the 
induction of Asns  (asparagine synthetase), and the repression of the Glul (glutamine synthetase), 
Glud1 (mitochondrial glutamate dehydrogenase), and Abat (4-aminobutyrate aminotransferase 
or GABA transaminase), which converts 4-aminobutyrate into oxaloglutarate and glutamate. 
The strong downregulation of the genes encoding Sord (sorbitol dehydrogenase), Sis (sucrase 
isomaltase), and Gbe1 (glucan [1,4-alpha-], branching enzyme 1), suggests that carbohydrate 
metabolism is repressed. Moreover, also inositol and choline metabolism appeared to be repressed, 
which was inferred from decreased expression of Chpt1 (choline phosphotransferase 1) and 
Chkb (choline kinase beta). Fut2 (fucosyltransferase 2) and B3galt5 (UDP-Gal:betaGlcNAc 
Figure 4.3.  Significantly altered signaling pathways 
in response to microbial colonization. Cellular 
pathways significantly modulated in the colon during 
16 days of conventionalization as calculated via 
a one-tailed Fisher’s Exact test in IPA and represented 
as -log (p value); -log values exceeding 1.30 were 
significant (p <0.05). 
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beta 1,3-galactosyltransferase, polypeptide 5) involved in glycosphingolipid biosynthesis were 
upregulated from day 1 post-conventionalization onward. These transcriptome changes illustrate 
the dynamic changes in the expression of metabolic pathway genes in the colon mucosa upon 
conventionalization, which encompass a broad area of intracellular (amino acid, glycolysis, and 
nucleotide metabolism) as well as membrane (sphingolipid) and extracellular matrix (glycan 
biosynthesis) metabolic pathways.
The Dynamics of Local and Systemic Metabolic Profiles 
Metabolic phenotyping using 1H NMR, was performed on colonic tissue and urine samples 
from germfree and conventionalized mice to investigate the impact of the colonizing gut 
microbiota on host colonic metabolism during conventionalization. Tissue metabolic profiling 
was performed to measure changing concentrations of metabolites as a result of changes in the 
mucosal amino acid and energy  metabolism, while urine metabolic profiling was employed as 
a proxy for the systemic metabolic changes. The time-resolved metabolite datasets were used 
to build orthogonal partial least-square discriminant analysis (OPLS-DA) models, focusing on 
the differences between germfree and conventionalized animals over time. The analysis showed 
that the presence of microbiota was not significantly reflected by the colonic mucosa metabolic 
profiles during the first two days of conventionalization (days 1-2). However, during the later 
time-points (days 8 and 16) of conventionalization, the microbial colonization was detectable 
in the mucosal metabolite profiles through significantly increasing levels of alanine, fumarate, 
glycine, uracil, and methylmalonate† (†=tentative assignment), and decreasing levels of 
glycerol, glucose, and formate. Some, but not all, changes in these metabolic profiles appeared 
to be initiated at day 4 post-conventionalization (Figure 4.5A). In addition, concentrations of 
several mucosal metabolites appeared to transiently respond to conventionalization, including 
modulated levels of acetate, aspartate, glutamine, scyllo-inositol, tyrosine, and choline, taurine, 
and phosphorylcholine (Figure 4.5A). Contrary to the tissue metabolite data, urine metabolite 
profiles appeared to reflect the consequences of microbial colonization during the early time-
points (days 1-2), where the excretion of  metabolites such as creatine and formate were increased 
on day 1 and days 1-2 post-conventionalization, respectively. Whereas concentrations of the 
urine metabolites 2-hydroxy-3-methylvalerate, trimethylamine, TMAO, β-aminoisobutyrate 
and β-hydroxybutyrate†, appeared to fluctuate (Figure 4.5 B), the metabolites tryptophan and 
phenylacetylglycine were consistently detected at a higher level during conventionalization 
as compared to germfree animals. The identified changes in the local and systemic metabolic 
profiles appeared to coincide with the transcriptome shifts and the succession of the microbial 
communities that established during the conventionalization period. Statistical modeling  (using 
O2PLS methods) was employed to detect significant correlations between microbial groups and 
the mucosal transcriptomes, the mucosal and urine metabolic profiles. 
Microbiota, Metabolite, Transcriptome Correlation Mining
O2-PLS regression-models (Trygg and Wold 2003) between 1H NMR urine spectra and level-2 
(genera-like) MITChip absolute abundance scores were performed to search for statistically and 
biologically meaningful correlations between microbial taxa in the colon, colon transcriptomes, 
and concentrations of specific metabolites. The MITChip probe intensities that were best 
predicted by the variation in the 1H NMR data were assigned to level-2 groups within the 
phylum Bacteroidetes. The closest relative isolates of the identified genera included, Prevotella 
ruminicola et rel., Alistipes, Rikenella, and unclassified Porphyromonadaceae. O2-PLS 
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modeling found multiple correlations between these microbial groups and the urine metabolites, 
fumaric acid, 2-oxo-glutaric acid, and malic acid† (Figure S4.1). 
A similar modeling strategy was also employed to search for correlations between colonic tissue 
1H NMR metabolomes and transcriptomes. The positive and negative correlations that could be 
identified were visualized by correlation heat maps (Figure S4.2). During conventionalization, 
the metabolites glutamate, alanine, and glycine were significantly correlated with a set of 
induced genes that play role in multiple metabolic pathways, including nucleotide metabolism, 
and O- and N-glycan biosynthesis and degradation. In contrast, the tissue concentrations of 
scyllo- and myo-inositol were positively correlated with a set of repressed genes that also played 
roles in multiple metabolic pathways, including phosphoglycerolipid metabolism, sialylated 
glycan biosynthesis and degradation, and glycine and serine metabolism. 
Correlation analysis of changes in colonic tissue metabolites, host metabolic gene expression, 
and microbiota taxonomical assignments illustrated that level-1 (MITChip level-1, class-
like) microbial groups correlated to subsets of genes within the mucosal transcriptome 
data. More specifically, a positive correlation between Bacilli with a subset of the genes of 
which expression was positively correlated with scyllo- and myo-inositol concentrations was 
identified. Analogously, a positive correlation between alpha- and epsilon-proteobacteria and a 
subset of the genes of which the expression correlated with tissue concentrations of glutamate, 
alanine, and glycine (Figure S4.3). The O2-PLS correlation analysis found strong correlations 
between changes in the microbial colonizers of the colon, subsets of genes from the tissue 
transcriptomes and concentrations of specific tissue metabolites. These statistical correlations 
can be assumed to be of biological relevance since the differentially expressed genes and the 
correlating metabolites belong to coherent metabolic pathways.
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Figure 4.5. Heat map summarizing the colonic metabolic variation during conventionalization. A series of 
pair-wise OPLS-DA models were constructed for (A) colon tissue, and (B) urine metabolite profiles with significant 
modulation during the days(d) 1-16 post-conventionalization period, compared to germfree.  Red color represents 
an increased level and green color represents a decreased level. (†) refers to tentative assignment.
DISCUSSION
Several studies have shown that interactions between colonic microbes and germfree mice, 
lead to basal changes in host metabolism (Bäckhed, Ding et al. 2004; Nicholson, Holmes 
et al. 2005; Turnbaugh, Hamady et al. 2009). However these changes have hardly been 
investigated at a multi-variate and time-resolved molecular level. Here a time-resolved multi 
variate approach was employed to investigate the interactions between colonizing microbes 
and colonic transcriptome and metabonome, as well as systemic changes in metabonome based 
on urine metabolites. Our study employed a reductionist experimental design, using germfree 
mice that were conventionalized and taking samples at specific time-points over a period of 16 
days. Detailed analysis of the composition of the colonizing microbiota demonstrated that the 
establishment of microbiota in the mouse colon is characterized by two major phases. The early, 
transient phase (days 1 and 2) showed low microbial diversity with typical formate, lactate, 
and succinate production, while the later phase that appeared to be more stable showed more 
diverse microbial communities that resembled the inoculum. The latter state is characterized 
by expansion of the sulfate reducers such as Desulfovibio spp. and the strict anaerobic species 
belonging to the major Clostridia clusters such as Clostridium cluster IV and XIVa that 
contain butyrate producers. This bacterial expansion was confirmed by the qPCR detection of 
the genes associated with these bacterial groups (dsr and butyryl CoA, respectively). At day 
4 post-conventionalization, transient colonization by some Proteobacteria was found. These 
microbiota colonization succession showed statistically significant and biologically relevant 
correlations with alterations in the gene-expression patterns and metabolite profiles from 
the colonic-tissue . These colonic mucosa correlations were especially significant from day 
4 post-conventionalization and onward. In contrast, statistical correlations between systemic 
A
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metabolite concentrations that were measured in urine samples could be detected at earlier 
time-points during conventionalization (i.e., days 1-2), suggesting a rapid and transient systemic 
metabonome-change by altered metabolite absorption from the gut. This implies that already 1 
day after microbial colonization of the intestine, the presence of the microbiota led to changed 
systemic metabolites profiles that are most likely due to altered luminal metabolite profiles and 
their absorption by the intestine. Remarkably, such absorption changes did not appear to induce 
changes in gene expression profiles in the colon mucosa, and may therefore derive from more 
proximal regions of the intestine (Chapter 3). 
Clear correlation was found between the abundance of Prevotella ruminicola et rel. with the 
urine concentrations of the metabolites, fumaric acid and 2-oxo-glutaric acid. This correlation 
may have reflected a temporarily decreased utilization of tricarboxylic acid (TCA) cycle 
intermediates by the host. Alternatively, these metabolites could have been derived from the 
bacterial metabolism, which would be in agreement with the capacity of the correlated bacterial 
groups to produce oxaloglutarate by reductive carboxylation of succinate (Henderson 1980). 
Succinate was detected at high levels in the cecal lumen from 1 to 4 days post-conventionalization. 
The early stages of conventionalization of the colon were also characterized by accumulation 
of lactate, which can be formed by intestinal lactic acid bacteria or by a variety of other 
microorganisms in the gut ecosystem (Barcenilla, Pryde et al. 2000). It is of relevance that the 
results have shown that the initial microbial ecosystem that establishes during the first days of 
conventionalization (days 1-2) appears to be relatively ineffective in the extraction of energy 
from dietary materials, which is exemplified by the accumulation of “high-energy fermentation 
metabolites” such as lactate and succinate. At later days, the subsequent establishment of typical 
secondary fermenters in the microbial ecosystem such as the members of the Clostridium 
clusters IV, XIVa, and sulfate reducers led to depletion of lactate and succinate in the colonic 
lumen. The increasing concentrations of typical secondary metabolites such as propionate, 
butyrate, and acetate in the colon lumen, known to be produced by the Clostridia and sulfate 
reducers (Falony, Vlachou et al. 2006; Flint, Bayer et al. 2008; Marquet, Duncan et al. 2009), 
provides support for the secondary conversion of lactate and succinate by these bacteria. These 
later stage developments in the microbiota community are paralleled by prominent changes in 
the colon-mucosa transcriptome- and metabolite-profiles. One gene of which the expression 
showed a reasonable association with the microbial colonization was Gpr43 , a gene encoding 
a GPCR that can recognize SCFAs (Brown, Goldsworthy et al. 2003) , and has been proposed 
to constitute a molecular link between diet, microbiota, and immune responses (Maslowski, 
Vieira et al. 2009). Gpr43 play a key-role in the resolution of inflammatory responses, which is 
in agreement with our previous findings that highlighted the development of adaptive immune 
responses, including the development of tolerance that accommodated the microbiota by day 
16 post-conventionalization (Chapter 2). The established homeostasis was also associated with 
the appearance of butyrate in the colon where it has been proposed to serve as the primary 
energy source for colonocytes (Donohoe, Garge et al. 2011) and plays an important role in 
regulation of fatty acid oxidation (Vanhoutvin, Troost et al. 2009).  The mitochondrial hydroxy-
3-methylglutaryl-CoA synthase (Hmgcs2), which is involved in fatty acid oxidation (Scheppach 
W 1995) has been shown to be regulated by butyrate production by the intestinal microbiota 
(Cherbuy, Andrieux et al. 2004). The temporarily decreased expression of Hmgcs2 at day 4 
post-conventionalization but not at later time-points may illustrate a transient impairment in 
β-oxidation. 
The decreasing concentrations of inositol metabolites was strongly correlated with the decreased 
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expression of genes encoding enzymes involved in metabolism of inositol, choline, and related 
metabolic pathway involved in the assimilation of sarcosine, glycine, and betaine. These 
modulations of the inositol- and related metabolic pathways could also be associated with the 
intestinal colonization by bacteria that can metabolize choline into methylamines (Kiene 1998). 
This may be reflected  by the increased levels of its derivative-metabolites, TMA and TMAO 
that were identified in the urine samples of conventionalized mice which is in agreement with 
previous reports (Nicholls, Mortishire-Smith et al. 2003). Interestingly, TMA and subsequent 
TMAO production by gut microbiota has recently been reported to promote atherosclerosis and 
cardiovascular diseases (Wang, Klipfell et al. 2011). This further supports the importance of 
improved understanding of the microbe-host metabolic interaction in view of its link to risk of 
disease of the host. 
This study also identified a statistical correlation between the transiently increased abundance 
of alpha- and epsilon-proteobacteria, and alterations in tissue and luminal metabolite levels 
(increased levels of glutamate, alanine, lactate, and glycine, decreased levels of glucose) as well 
as specific changes in expression of metabolic pathways genes (increased expression of genes 
involved in the rate limiting steps of glycolysis, amino acid, and nucleotide metabolic pathways). 
This association appears to be of biological relevance in that it suggests that the colonic 
metabolism is shifting towards increased energy production via glycolysis and assimilation, 
via anabolic metabolism, of novel cell components starting at day 4 onward. This proposed 
assimilation and production of novel cell components correlates well with the morphological 
changes observed in the tissue during later time-points of conventionalization (Chapter 2). 
In conclusion, the time-resolved, multi-variate analysis applied in this study demonstrated 
statistically significant and biologically relevant correlations between the dynamics of microbiota 
establishment and the corresponding local host responses in terms of colon tissue transcriptomes 
and –metabolite profiles as well as systemic adaptations of host metabolism as detected in urine 
metabolite profiles. We inferred from these correlations that the changes in host transcriptomes 
and metabolites are exemplary for the establishment of a novel homeostasis that accommodates 
the microbiota. Based on changes in gene expression and metabolite concentrations, homeostasis 
was reached in the colon of the mice after 16 days post-conventionalization (Figure 4.6). The 
transient phases prior to this novel state of homeostasis appeared to include a transient state of 
dysbiosis apparent from the inefficiency of early colonizing communities to effectively extract 
energy from the dietary components, leading to accumulation of “high energy metabolites” and 
impaired fatty acid oxidation. After this initial, transient state, establishment of later colonizers 
depleted the high-energy metabolites and generated second-stage fermentation SCFAs that 
can be efficiently metabolized by colonic epithelia. We propose that the dynamic molecular 
interactions between the microbiota and their hosts presented here revealed metabolic pathways 
and processes that contributed to the molecular definition of symbiotic, homeostatic interrelations 
between intestinal microbiota and the colon mucosa. 
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EXPERIMENTAL PROCEDURES
Animals, Experimental Design, and Sampling
All procedures were carried out as previously described (Chapter 2). In brief, germfree 
and conventionalized mice (male, C57 BL/6 J) were maintained in sterile conditions, on a 
commercial laboratory chow diet. Two independent biological experiments were performed 
using mice of different age after 2 weeks of acclimatization and diet adaptation. The first and 
second experiments included 36 mice obtained in 2 biologically independent batches of 18 
mice each, aged 8 and 10 weeks, respectively. The colon from each mouse was removed and 
divided into 2 cm segments that were immediately: stored in RNAlater® at room temperature 
for 1 h prior to storage at -80°C for RNA isolation or snap frozen and stored at -80°C for 
metabolic profiling. Luminal content from colonic segments and cecum was removed by gentle 
squeezing, snap frozen, and stored at -80°C for microbiota analysis and SCFAs HPLC analyses, 
respectively. Urine samples (50-70 µl) were collected from the bladder directly after sacrifice 
and stored at -80°C for metabolites analysis. 
Microbial Profiling of Colonic Contents
Luminal contents from colon were analyzed by Mouse Intestinal Tract Chip (MITCHip), a 
diagnostic 16S rRNA arrays that consists of 3,580 unique probes especially designed to profile 
murine gut microbiota as previously described and in analogy to the human intestinal tract 
(HIT)Chip (Rajilic-Stojanovic, Heilig et al. 2009; Geurts Lazarevic et al. 2011). Statistical 
analysis was performed as previously mentioned (Chapter 2) between all conventionalization 
days using Kruskal Walis executed in SPSS Statistics 17.0 (SPSS Inc., Chicago, IL).  
Quantitative PCR analyses included quantification of total bacteria using 16 S rRNA-specific 
Figure 4.6. Dynamics of the colonizing microbiota and the associated host response. A schematic model 
of the time-resolved colonic mucosal and urine metabolites changes showing significant correlations with the 
microbial community. Green color depicts lower levels, red color depicts high levels compared with the germfree 
measurements . Shades of red depicts the degree of increase (darker = more pronounced effect). 
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primers and gene-specific qPCR, targeting bacterial groups with the following capacity: sulfate 
reduction, methane production, or butyrate production. QPCR was performed using an IQ5 
Cycler apparatus (Bio-Rad, Veenendaal, The Netherlands). Reactions were performed in 
triplicate in a single run. Samples were analyzed in a 25 µl reaction mixture consisting of 12.5 
µl Bio-Rad master mix SYBR Green (50 mM KCl, 20 mM Tris-HCl, pH 8.4, 0.2 mM of each 
dNTP, 0.625 U iTaq DNA polymerase, 3 mM MgCl2, 10 nM fluorescein), 0.1 µM of each 
primer (Table S4.2) and 5 µl of template colonic DNA diluted 100 or 1000 times. Standard 
curves of 16 S rRNA PCR product from pure cultures were created using serial 10-fold dilution 
of the purified PCR product corresponding to 108 to 100 16 S rRNA or specific gene. Standards 
included Lactobacillus casei (total bacteria), Methanobrevibacter arboriphilus (methanogen), 
Desulfovibrio spp. (sulfate reducer) and Faecalibacterium prausnitzii (butyrate producer). The 
following qPCR conditions were used: 95°C for 10 min, followed by 35 cycles of denaturation 
at 95°C for 15 sec, annealing temperature for 20 sec, extension at 72°C for 30 sec and a final 
extension step at 72°C for 5 min. A melting curve was determined at the end of each run to 
verify the specificity of the PCR amplicons. Data analysis was performed using the Bio-Rad 
software supplied with the IQ5 Cycler apparatus. 
Microbial fermentation product analysis. Cecal content samples were analyzed for SCFAs 
profiles, including the quantitative detection of acetate, butyrate, propionate as well as lactate and 
succinate using HPLC (Spectra System, RI-150). Samples of intestinal content (approximately 
0.1 g) were thoroughly mixed with four volumes of distilled water. Insoluble residue was 
removed by centrifugation (15 min at 13,000 g, 4°C). The subsequent supernatant was mixed 
with the same volume of 1M HCLO4 and mixed organic acid analyses by HPLC as previously 
described (Starrenburg and Hugenholtz 1991).
Transcriptome Analysis
High quality total RNA was isolated from a 2 cm segment colon by extraction with TRIzol 
reagent, followed by DNAse treatment and column purification. Samples were hybridized on 
Affymetrix GeneChip Mouse Gene 1.1 ST arrays. Quality control and statistical analysis were 
performed using Bioconductor packages integrated in an on-line pipeline (Lin, Kools et al. 
2011) as previously described (Chapter 2). Probesets were redefined according to (Irizarry, 
Bolstad et al. 2003; Heber and Sick 2006). Several complementary methods were used for the 
biological interpretation for the transcriptome data; gene clustering using Multi-experimental 
Viewer (MeV) (Saeed, Hagabati et al. 2006) , overrepresentation analysis of Gene Ontology 
(GO) terms using temporal and location comparative analysis using STEM (Ernst and Bar-
Joseph 2006), and construction of biological interaction networks using Ingenuity Pathways 
Analysis (for detailed descriptions see supplemental material of Chapter 2).
Metabolite Profiling
Urine samples (25-30 μl) were added to 50 μL of phosphate buffer 0.2 M (pH 7.4) in D2O 
plus 0.05% 3-(tri-methylsilyl) propionate-2,3-d4 (TSP) before transferring to capillary tubes 
for analysis by 1H NMR spectroscopy. Tissue samples were homogenized and extracted in 
acetonitrile/water (1:1), as previously described (Waters, Holmes et al. 2002). The supernatant 
containing the aqueous phase was collected, freeze-dried and dissolved in 600 µl of D2O. Samples were centrifuged for 10 min at 15,000 g, and 500 µl of the supernatant and 50 µl 
of water were transferred into 5mm (outer diameter) NMR tubes for analysis by 1H NMR 
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spectroscopy.  All spectra were acquired on an Avance II 600MHz NMR spectrometer (Bruker 
Biospin, Rheinstetten, Germany) equipped with a Bruker 5mm TXI triple resonance probe 
operating at 600.13 MHz, and using a BACS auto-sampler. Spectral acquisition of the aqueous 
phase was performed using the first increment of a standard nuclear Overhauser enhancement 
scpectroscopy (NOESY) 1-dimensional 1H NMR experiment ((noesypr1D)(RD-90°-t1-90°-tm-
90°-acquisition), where RD is a relaxation delay, t1 is a short delay of 2 μs and tm is a mixing 
time of 100 ms.  Water suppression was applied during the RD and a 90° pulse set at 10 μs. For 
each spectrum, a total of 256 scans (16 dummy scans) were collected into 64k data points over 
a spectral width of 20 ppm. 
Data were analyzed by applying an exponential window function with a line broadening of 
0.3 Hz prior to Fourier transformation to all 1D NMR spectra.  The resultant spectra were 
phased, baseline corrected and calibrated to lactate (δ 1.33) (for tissue samples) and TSP (δ 
0.00) (for urine samples), manually using Topspin (2.0a, Bruker BioSpin 2006).  The spectra 
were subsequently imported into MatLab (R20010aSV, The MathsWorks inc.) where the region 
containing the water resonance (δ 4.6-5.2) was removed.  The data were then normalized to 
the probabilistic quotient (Dieterle, Ross et al. 2006) to minimize the effects of inter-sample 
variation due to phenomena such as disparate sample volume, although every effort was made 
to keep this constant during sample preparation. 
Metabonomic data were visualized by Principal Component Analysis (PCA). OPLS-DA models 
(Trygg and Wold 2003) were then fitted between successive time-points in order to highlight 
discriminant metabolites. PCA, O-PLS, O-PLS-DA and Statistical total correlation spectroscopy 
(STOCSY) were performed in Matlab (using an in-house routine)(Barnes 2009). Permutation 
testing of the Y matrix for O-PLS/PLS models was conducted using an in-house algorithm 
(Barnes 2009) to determine whether the Q2Y (predictive ability) of the model was significantly 
different from the Q2Y calculated from 100 random permutations of Y.  Assignments were made 
using additional two-dimensional NMR experiments and reference to databases of spectra of 
authentic compounds.
O2-PLS models were used to integrate metabonomic, transcriptomics, and microbiota datasets 
as described by Li et al (Li, Wang et al. 2008). O2-PLS models were calculated for pairwise 
datasets. Significant variables were then selected based on their correlation with the scores of 
the model (p < 0.01).
Accession Numbers
The mouse microarray dataset was deposited in the Gene Expression Omnibus (GEO) with 
accession number GSE32513.
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SUPPLEMENTAL FIGURES
Figure S4.2. Transcriptome-
metabolite correlations. Heat 
maps of (A) downregulated 
genes of which the expression 
was positively correlated with 
the concentrations of  myo- and 
scyllo-inositol, (B) upregulated 
genes of which expression was 
positively correlated with the 
concentrations of glutamate, 
alanine, and glycine. 
Figure S4.1. Association of early colonizers and 
urine metabolites. Correlation heat map between 
urine metabolites and the bacterial taxonomical 
level from MITChip data (level 2-genus like). The 
heat map represents correlations across 16 days 
of conventionalization. Red color depicts positive 
correlation. Black color indicates no change 
compared to the control (germfree) mice.
A B
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Figure S4.3. Microbiota-transcriptome-metabolite correlations. Correlation heat maps showing (A) Model 
(1):Correlation computed between transcriptome and I-Bacilli (positive correlation), II-scyllo- and myo-
inositol (positive correlation). (B) Model (2):Correlation computed between transcriptome and I-alpha and 
epsilonproteobacteria (positive correlation) and II-glutamate (Glu), glycine (Gly), and alanine (Ala) (positive 
correlation). 
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Table S4.1. Relative contribution of significant (Kruskal Walis) level 2 groups between early (days 1 and 2) and 
later (days 4, 8, and 16) time-points superior to 0.1%. Light grey filling of the taxonomic level represents early 
colonizers while dark grey represent late colonizers.
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Table S4.2. Primers used for the quantification of butyrate producers (ButyrilCoA gene), sulfate reducers (dsr 
gene), and Methanogens (McrA gene), by qPCR.     
Primer name Primer sequence (5’-3’) Annealing
temperature
References
Methanogens mlas F                
mcrA-R 
GGTGGTGTMGGDTTCAC MCARTA
CGTTCATBGCGTAGTTVGGRTAGT
55°C (Steinberg and 
Regan, 2008)
Sulfate reducers RH1dsr-F 
RH3-dsr-R 
GCCGTTACTGTGACCAGCC
GGTGGAGCCGTGCATGTT
60°C (Ben-Dov et al., 
2007)
Butyrate 
producers
BcoATscr-F 
BcoATscr-R 
GCIGAICATTTCACITGGAAYWSITGGCAYATG
CCTGCCTTTGCAATRTCIACRAANGC
53°C (Louis and Flint, 
2007)
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ABSTRACT
Gut microbiota is increasingly recognized as a key-player in defining the health status of the 
gastrointestinal tract. Recently we demonstrated that conventionalization of germfree mice 
with normal fecal microbiota elicits the temporal and region-specific dynamic host-microbe 
communication pathways that establish a homeostatic state of tolerance towards the microbiota 
in healthy mice within 30 days post-conventionalization. To decipher the specific features of 
the time-point that showed the largest shift in mucosal response during this process at four 
days post-conventionalization, multi-variate mining of a combination of colon transcriptome 
data, plasma cytokines, and amine metabolites, and gut microbiota profiling were employed. 
Transcriptome analyses highlighted the strong induction of genes involved in innate immune 
functions, pro-inflammatory responses, and cell cycle regulation, suggesting that day 4 post-
conventionalization represents a transient state of inflammation that is necessary to stimulate 
development of adequate innate and adaptive immunity. This transient state of inflammation 
was characterized by the expression of inflammatory cytokines and amines, in response to a 
temporal domination of the microbial genera Helicobacter, Sphingomonas, and Mucispirillum. 
Helicobacter and Sphingomonas are known as so-called “pathobionts” and can activate 
specific immune cells and could bring about a state of dysbiosis, or a state with an imbalanced 
representation of microbial taxa in the intestine. Our results propose that the mucosal parameters 
measured at day 4 post-conventionalization of germfree mice reflect the boundary of homeostasis 
and dysbiosis in host-microbe interplay and that certain microbial genera are potent stimulators 
of the developing immune system. 
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INTRODUCTION 
The intimate contact between the microbiota and host provides vital functions for the host 
including the digestion of complex dietary compounds, and resistance to colonization of 
pathogens (Bäckhed, Ley et al. 2005). The gastrointestinal (GI) tract is the initial site of interaction 
between the host immune system and its colonizing microbiota (Macpherson, Geuking et al. 
2005) . To preserve homeostasis, immune responses need to be tightly controlled (O’Connor, 
Taylor et al. 2006) so that the immune system mounts appropriate, tolerant responses to the 
colonizing gut microbiota.  During the past decade, several studies in humans, mice, and other 
mammals have supported the role of gut microbiota especially its Gram-negative members in 
activating the immune system and eliciting inflammatory responses that may lead to disease 
in genetically predisposed persons (Solnick and Schauer 2001; Fox 2002; On, Hynes et al. 
2002; Manco, Putignani et al. 2010). Representative examples of commensals that promote 
gut inflammatory responses are segmented filamentous bacteria (Stepankova, Powrie et al. 
2007) , Helicobacter species (Erdman, Rao et al. 2009), Clostridium difficile (Palmer 2011), 
Prevotellacae, TM7, and  Klebsiella pneumoniae (Elinav, Strowig et al. 2011). These potential 
pathogenic symbionts were previously termed “pathobionts” referring to their ability to induce 
tissue damage under certain conditions (Chow and Mazmanian 2010). “Pathobionts” are 
prominent species in the GI tract of healthy humans and animals that trigger disease in response 
to changes in the environment, including the diet and shifts in microbial composition, and/or a 
transiently weakened immune response. Inappropriate shifts in the composition of the intestinal 
microbial community, termed dysbiosis, can deplete the microbiota from competing symbionts, 
some of which promote intestinal anti-inflammatory responses (Sokol, Pigneur et al. 2008). 
Studies looking into the complex interactions between hosts and changes in the microbiota 
have been extremely challenging since such studies required a genome-wide determination 
of host responses to simultaneous changes in the microbiota. Moreover, the host response to 
changes in the microbiota contains local and systemic changes in metabolism and immunity. 
Systemic responses include both mobile chemical signals such as hormones and chemokines 
carried by the blood, but also immune cells that respond to changes in chemokine gradients. 
The rapid technological development of functional genomics provides novel opportunities for 
the identification of molecular signatures that represent homeostasis and dysbiosis situations. 
Therefore, the application of transcriptomics in colonic tissues, combined with simultaneous 
microbiota characterization and analysis of blood analytes such as cytokines and amines, should 
allow us to unravel the molecular mechanisms underlying gut homeostasis or dysbiosis. 
This notion prompted us to employ a germfree mouse model to study the dynamics of the 
regulated mucosal responses to the microbiota during conventionalization (Chapter 2). This 
study comprehensively analyzed how microbiota accommodating homeostasis is established. 
In this study, we found at four days post-conventionalization, a strong induction of innate 
immunity including the production of antimicrobial molecules. These innate immune-related 
responses appeared to have stabilized from day 8 onward in the colon. Stabilization of innate 
immunity coincided with activation of adaptive immunity (Chapter 2).  Here, we focus on 
the features of the transient state of  inflammation observed four days after the initiation of 
conventionalization. Parallel determination of colon tissue transcriptomes, gut microbiota 
composition, and systemic plasma cytokines and metabolic markers enabled the characterization 
of this transient state. We propose that the early colonizing genera activate specific parts of the 
innate (days 1-4) and adaptive (days 8-16) immune system and that these immune responses 
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elicit subsequent tolerant immune responses to the commensal microbiota. We further propose 
that day 4 marks a stage of strong “physiological” inflammation (Sansonetti and Di Santo 2007; 
Medzhitov 2008) that activated the immune (mainly T) cell development pathways that were 
observed from days 8 onward.
RESULTS
Comprehensive Colon-Transcriptome Analysis of a Transient Conventionalization State 
that is Characterized by a Gene Regulatory Network Associated with Pro-Inflammatory 
Responses 
Recently we established that relatively short term conventionalization (4 days) of germfree mice 
was characterized by a drastic transcriptome pattern shift, where some genes stopped being 
expressed while others were induced for the first time (Chapter 2). The functional annotations 
of the genes involved in the transcriptional shift suggested that day 4  may mark a distinct 
transient state that occurs during conventionalization. To characterize the biological processes 
associated with this transcriptomic shift, the Short Time Series Expression Miner (STEM) 
software (Ernst and Bar-Joseph 2006) was employed in this study to identify genes that display 
their highest expression at day 4 post-conventionalization. The genes that met this criterion 
were used to construct a protein-protein interaction network in ingenuity pathway analysis 
(IPA) software (www.ingenuity.com). Gene-function annotation of the resulting network 
(Figure 5.1A) showed that most genes belonged to two major biological processes: induction of 
pro-inflammatory responses and cell cycle regulation. The pro-inflammatory response network 
part included genes that play a key role in the induction of T helper (Th1) responses, such 
as lipopolysaccharide recognition (Cd14), pro-inflammatory cytokines, tumor necrosis factor-
alpha (Tnf-α) and interferon gamma (Ifn-γ), chemokines (Ccl5, Ccl7, Ccr5, Cxcl9, Cxcr3, and 
Ccl8), and activators of MHC Class I, transporters 1,2 (Tap1 and 2), and the proteasome subunit 
beta, type 8, 9 (Psmb8 and 9). The cell cycle control and proliferation network part also included 
genes encoding “hub” proteins with key-functions, like Aurora kinase A (Aurka), Cyclin a, 
b, and d (Ccna, b, and d), Pim-1 oncogene (Pim1), and Baculoviral IAP repeat-containing 5 
(Birc5) (Figure 5.1A). Notably, all the genes in this network were induced. Statistical analysis 
of GO annotation enrichment for genes that were differentially expressed at day 4 post-
conventionalization confirmed that the majority of the modulated biological processes were 
involved in cell signaling including cell cycle control and inflammatory responses (Figure 
5.1B). Among the most significantly (p <0.05) altered signaling pathways were two pathways 
involved in an inflammatory response: Ifn-γ signaling and cross talk between dendritic cell 
and natural killer cells, and cell cycle regulation (Figure 5.1C). IPA found significant (p <0.05) 
associations of the regulatory network genes with disease: 37 associated core genes in the 
regulatory network are known to promote or co-mediate gastrointestinal disorders including 
inflammatory bowel disease and colon cancer (indicated with red arrows in Figure 5.1A). In 
summary, the biological and functional annotations of the genes modulated at the identified 
intermediate state and the network shown in Figure 5.1 (A) support the hypothesis that this 
transient state during conventionalization marks the boundaries of balanced physiological 
responses, typical of healthy hosts, to gut microbiota. 
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Figure 5.1. The core regulatory network that is specifically modulated during day 4 post-conventionalization 
and associates with inflammatory cascades. (A) The core regulatory network that is based on IPA protein-
protein interaction network reconstruction that is characteristic for day 4 post-conventionalization. This network 
exemplifies the transition towards a new state of intestinal homeostasis during the process of conventionalization. 
Arrow heads indicate genes associated with human inflammatory bowel disease and colon cancer. (B) Cellular 
functions and disease annotations calculated using IPA. (C) Cellular pathways significantly modulated in the colon 
at day 4 post-conventionalization. Pathways were determined using IPA and significance of pathway modulation 
was calculated via a one-tailed Fisher’s Exact test in IPA and represented as -log (p value); -log values exceeding 
1.30 were significant (p <0.05).
A
B C
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Distinct Microbial Diversity Features the Transient State of Mucosal Response in the 
Colon
Previous experiments have shown that the gut  microbiota composition is succeeding in time 
after the initiation of conventionalization, and that a microbiota resembling that of conventional 
mice is established already after approximately eight days post-conventionalization (Chapter 
2). Based on the transcriptome findings (presented above), we assumed that also the changes 
in microbiota composition during conventionalization may pass through a transient state, 
analogous to the mouse transcriptomic changes. To explore this possibility, the composition of 
the luminal colon microbiota at day 4 post-conventionalization was compared to earlier and later 
time-points using a 16S rRNA based phylogenetic array, mouse intestinal tract (MIT) chip. The 
microbiota composition at day 4 post-conventionalization differed significantly (p <0.01) from 
all other time-points analyzed in the experiment (Figure 5.2). The bacterial genera that were 
significantly and specifically associated with day 4 were predominated by Gram-negative groups, 
belonging mainly to the Proteobacteria with high abundance of Helicobacter (7.42%±4.46) 
(Epsilonproteobacteria), Sphingomonas (1.93%±1.28) (Alphaproteobacteria), Mucispirillum 
(2.37%±0.50) (Deferribacteres). Next to these changes, the relative abundance of Streptococcus 
(Firmicutes) also appeared to increase specifically on day 4 post-conventionalization, but this 
group only appeared at low abundance (<0.001%), suggesting that this reflects only a marginal 
modulation. Several additional genera appeared to be more abundant in the microbiota on 
day 4 post-conventionalization (Desulfovibrio; 0.11%±0.03 and Bilophila 0.38%±0.14), but 
these groups remained present in the microbiota at higher levels also on later time-points 
post-conventionalization (i.e., days 8 and 16). Taken together, the increased absolute and 
relative abundance of the genera Helicobacter, Sphingomonas, and Mucispirillum specifically 
characterized the microbiota found at day 4 post-conventionalization. 
Increased numbers of Proteobacteria and Deferribacteres are correlated with pro-
inflammatory cytokine expression networks
Possible association of colon microbiota members with colonic gene expression patterns were 
explored using a false discovery rate (FDR) method (details are presented in the experimental 
procedures). Colonic gene expression profiles that peaked at day 4 post-conventionalization as 
identified by STEM analysis were correlated to the changes in the composition of colonizing 
microbiota members identified by MITChip over the first 16 days of conventionalization. 
Significant correlations (corrected FDR <0.01; Benjamini–Yekutieli correction) between 
microbiota members and specific mucosal genes expression changes were only detected for 
Helicobacter, Sphingomonas, and Mucispirillum that displayed a positive correlation with 
several inflammation-related cytokines such as matrix metallopeptidase 3 and 10 (Mmp3 and 
10), metallopeptidase inhibitor 1 (Timp1), transglutaminase 2 (Tgm2), chemokine (C-X-C 
motif) ligands 10 and 11, (Ip-10 or Cxcl10),  (Cxcl11), suppressor of cytokine signalling 1 
(Socs1), monocyte chemoattractant protein 3 (MCP-3 or Ccl7), and C-type lectin domain 
family 4 (Clec4e) (Figure 5.3). Notably, the genes with peak expression at day 4 that show 
significant correlations with microbiota were also part of the regulatory network identified by 
IPA analysis (Figure 5.1A). In addition, the correlated microbial groups were also shown to be 
most abundant at day 4 post-conventionalization (Figure 5.2), strongly supporting the validity 
of these  correlations between colonic gene expression and colonic microbiota members. 
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Changes in the plasma levels of pro-inflammatory cytokines and amines at day 4 post-
conventionalization 
To investigate whether the specific status of day 4 post-conventionalization had a systemic 
impact on the overall host physiology and could be determined in the blood cytokines and 
amine metabolites,  analytes  levels were determined in the blood plasma from germfree mice 
(germfree homeostasis), at day 4 (transient state) and day 30 (homeostasis as described in Chapter 
2). Plasma cytokine levels of Ifn-γ, IP-10, monocyte chemo attractant proteins 1, 3, 5 (MCP-1 
or Ccl2, MCP-3, MCP-5 or Ccl12), macrophage inflammatory proteins 2, 3β (MIP-2 or Ccl3, 
MIP-3β), growth-regulated alpha protein (KC/GRO), colony stimulating factor 2 (granulocyte-
macrophage) (GM-CSF or Csf2), and oncostatin M (OSM) were significantly elevated at day 
4 in comparison with germfree and day 30 post-conventionalization mice (p <0.05) (Figure 
5.4; Figure S5.2A).  The transient elevated level of the plasma cytokines is in agreement with 
Figure 5.2. Selected microbial genera marks the transient state of mucosal response in the colon. Redundancy 
analysis triplot of the colonic lumen microbiota composition, as measured by MITChip analysis (level 2 data). 
Days of conventionalization are represented as centroids, (•= samples of day 1, •=samples of day 2, = samples 
of day 4, ♦=samples of day 8, and ♦=samples of day 16). Microbial groups that contributed to at least 70% to the 
explanatory axes are represented as vectors. Monte Carlo Permutation Procedure (MCPP) revealed that day 4 post-
conventionalization is characterized by a distinct microbial groups (p=0.003) indicated within the black framed 
rectangle.
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a transient increase in the level of the corresponding transcripts that were also included in 
the day 4 post-conventionalization gene-regulatory network (Figure 5.4). Collectively, the data 
illustrated that the plasma cytokine profile of the transient state of mucosal response during 
conventionalization exemplifies that of an inflammatory state, with elevated levels of pro-
inflammatory cytokines. This state is transient and clearly distinct from the germfree and day 
30 post-conventionalization homeostatic states (see discussion). In addition to the cytokines, amine metabolites were determined in the plasma samples. A specific 
subset of these metabolites appeared to be significantly (p <0.05) and specifically elevated on 
Figure 5.3. Association of specific Proteobacteria groups with pro-
inflammatory genes. (A) Expression levels of the colonic genes that are 
positively correlated with microbiota in germfree and conventionalized 
mice after the indicated number of days of conventionalization. Values 
are depicted as box  and whisker diagram (top-to-bottom, maximum 
value, upper quartile, median, lower quartile, and minimal value, 
respectively). Any data not included between the whiskers is plotted 
as outlier with a dot. Significant differences between time-points are 
indicated by distinctive characters above the measurement groups 
(p <0.05). Consistency between the gene expression patterns in the 
above two experiments and experiment 3 are shown in Figure S5.1. 
(B) Correlation heat map showing the positive association between 
level 2 (genera-like) microbiota as identified by MITchip and the 
genes identified by STEM analysis. 
A
B
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Figure 5.4. Plasma cytokine profile 
of day 4 post-conventionalization 
displays properties that are found 
in tissues in a state of inflammation. 
Plasma levels of inflammation-
associated cytokines measured by 
Mouse MAP multiplexed immunoassay 
systems. The elevated level of 
inflammation-associated cytokines 
detected in the plasma obtained on 
day 4 post-conventionalization is 
corroborated by the expression levels 
of the corresponding transcripts as 
shown in the dot-plots where individual 
expression values obtained for 
individual mice are plotted for each of 
the experiments. Significant difference 
between time-points are indicated 
by distinctive characters above the 
measurement groups (p <0.05). 
day 4 relative to germfree and day 30 post-conventionalization mice. These metabolites included 
elevated levels of o-phosphoethanolamine, cystine, taurine, L-kynurenine-to-tryptophan (Kyn/
Trp) ratio, and L-glutamine (Figures 5.5 and S5.2B). In contrast, citrulline, L-serine, and 
L-tryptophan were present at lower levels (Figures 5.5 and S5.2B). The altered concentrations 
of these amine metabolites correlated strongly with the colonic tissue transcriptome, plasma 
cytokines, and microbiota composition observed on day4 post-conventionalization. For 
example, the transient increase in Kyn/Trp ratio which determines the activity of indoleamine 
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2,3-dioxygenase (IDO) enzyme corroborates the induction of the gene expression level of Ido 
which catalyzes the rate limiting step of tryptophan degradation along the kynurenine pathway 
(Suzuki, Suda et al. 2010) (Figure 5.5A).  In addition, the altered plasma levels of citrulline 
and L-glutamine, a precursor of arginine and nitric oxide production through citrulline in the 
Figure 5.5. Modulation of amine 
metabolites in plasma samples of 
day 4 post-conventionalization. 
Relative intensities of amine 
metabolites, determined by LC-
MS/MS. Comparisons are shown 
for plasma samples of germfree 
(day 0), days 4 and 30 post-
conventionalization (mean ± SD 
values). The transient significant 
increase of Kyn/Trp ratio (A) 
which determine the activity of 
indoleamine 2,3-dioxygenase 
(IDO) enzyme corroborates the 
induction of the gene expression 
level of Ido as depicted by dot-
plots where individual expression 
values obtained for individual 
mice are plotted for each of the 
experiments. The modulated levels 
of citrulline and L-glutamine (B), 
which are involved in nitric oxide 
production coincided with the 
transient induction of Nos2 gene, 
which encodes for nitric oxide 
enzyme. Significant difference 
between time-points are indicated 
by distinctive characters above the 
measurement groups (p <0.05). 
The unit of the Y-axis (relative 
intensity) a.u. “arbitrary unit”.
A
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intestine (Bellows and Jaffe 1999), coincided with the induced gene expression level of inducible 
nitric oxide (Nos2) (Figure 5.5B). Taken together, the measured changes in accumulation of 
specific metabolites supports the hypothesis that day 4 post-conventionalization represents a 
transitional state between physiological and pathological inflammation.
DISCUSSION
It is widely accepted that the use of simplified model systems can enable the comprehensive 
analysis of extremely complex biological processes including the intestinal homeostatic 
mechanisms. Previously, it has been established that conventionalization of germfree mice 
is associated with a transient inflammation that, on histology, has similarity to ulcerative 
colitis (Fukushima, Sasaki et al. 1999). The present study demonstrates that mining of multi-
variate datasets in a similar germfree mouse conventionalization model provides an attractive 
reductionist-model to identify the molecular events underlying the transient changes that reflect 
the transient state of “inflammation” by dysbiosis of host-microbe interplay. The analysis of 
colonic transcriptome data, plasma cytokines, and amine metabolites, as well as gut microbiota 
composition consistently indicated that a transient state (day 4) during conventionalization 
precedes the establishment of a novel state of microbiota accommodating homeostasis reached 
at day 30 post-conventionalization (Chapter 2).
The microbial communities that were specifically associated with the transient state of 
inflammation included Helicobacter and Sphingomonas. These genera were shown to have 
specific characteristics that enable them to colonize the intestinal mucus layer and tolerate the 
strong innate immune response (Sarma-Rupavtarm, Ge et al. 2004) observed at this time-point 
(this study and Chapter2). Helicobacter species have been found in close proximity to the 
intestinal mucosal epithelium in crypts of the mouse colon and cecum, thereby are capable 
of evading the innate immune system (Sarma-Rupavtarm, Ge et al. 2004). Although they are 
among the natural inhabitants of the intestine of mice (Sterzenbach, Lee et al. 2007), and can 
peacefully co-exist with the host, they still retain pathologic potential via their ability to induce 
inflammatory responses and were therefore designated “pathobionts” (Chow and Mazmanian 
2010; Lee and Mazmanian 2010; Chow, Tang et al. 2011). Helicobacter hepaticus has been 
associated with dysbiosis (Dieleman, Arends et al. 2000) and is capable of inducing T-cell 
dependent (induction of Th1 and Th17)  and T-cell independent (via TLRs)  inflammatory 
responses  in immunocompromised and IL 10 -/- and lymphocyte-deficient Rag -/-, Myd88 -/- mice 
but not in wild-type mice (Erdman, Rao et al. 2003; Kullberg, Jankovic et al. 2006; Erdman, 
Rao et al. 2009). The abundance of Sphingomonas could be linked to the subsequent induction 
of natural Killer T cells as previously described (Chapter 2), since Sphingomonas has been 
associated with activation of natural killer T cells in humans via their glycosphingolipids 
(Mattner, DeBord et al. 2005). Interestingly, glycolipids produced by Sphingomonas induced 
an increased production of typical Th1 chemokines in human and mouse (Chang, Huang et al. 
2007) which was also observed in our study.  
The correlation between expansion of Helicobacter and Sphingomonas and a Th1-type immune 
response was also exemplified by a gene regulatory network where the typical gamma-interferon 
activated-Th1 type chemokines Cxcl10 (IP-10), Cxcl11, Clec4e, Tgm2, and Mmp3, 10 constituted 
an important part of the total network. The Th1 part of the network represented a characteristic 
gene-expression signature for day 4.  This particular transient response was also observed in 
bacterial infections where peak expression of the pro-inflammatory chemokine Cxcl10 preceded 
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T cell infiltration by four days prior to the activation  of Cd8+ T cells  (Valbuena, Bradford et 
al. 2003). Importantly, two major negative regulators of the  pro-inflammatory genes, Socs1, 
a potent negative regulator of cytokines including Ifn-γ and downstream target genes (Kinjyo, 
Hanada et al. 2002), and Timp-1, the natural inhibitor of Mmp3 (Heuschkel, MacDonald et al. 
2000) were co-induced with their target genes. Asynchronous expression of Socs1 and Timp1 
has been shown in chronic inflammatory bowel disease in humans (Heuschkel, MacDonald 
et al. 2000; Chinen, Kobayashi et al. 2006) and the induction of Socs1 was proposed to be a 
potentially effective treatment (Chinen, Kobayashi et al. 2006) . The co-induction of Socs1 and 
Timp1 inhibitor genes together with the pro-inflammatory cytokines that are antagonized by 
Socs1 and Timp1 might have contributed to the controlled state of inflammation that did not 
lead to tissue damage, as concluded from the histological staining (Chapter 2).
This absence of tissue damage throughout the intestine at day 4 comes as no surprise since 
our study used healthy mice, with mucosa that apparently possessed sufficient plasticity to 
tolerate the microbiota. Mild inflammatory responses to commensal bacteria while maintaining 
the integrity of the intestinal barrier is a major hallmark of physiological inflammation 
(Sansonetti and Di Santo 2007). These findings, together with the expansion of T cells and the 
corresponding increased T cell-specific gene expression profiles propose that this transient state 
of inflammation was pivotal for appropriate immune system development. It is conceivable that 
the correlating genetic regulation of expansion of tolerant T cells is somehow lost in patients that 
suffer from inflammatory bowel diseases. Supporting this hypothesis are reports that link the 
transiently elevated pro-inflammatory cytokines that we measured in plasma to inflammation 
in experimental animals and in human inflammatory bowel disease (e.g.; Mip-1,-2 Ifn-γ, Ip-10, 
Mip-3β, and Mcp-3) (Dieleman, Ridwan et al. 1994; Banks, Bateman et al. 2003; Demierre, 
Higgins et al. 2005; Singh, Venkataraman et al. 2007; Torrence, Brabb et al. 2008; Nishimura, 
Kuboi et al. 2009; Wang, Pezo et al. 2010). 
Evidence for a regulation of immune cell numbers (proliferation) and behavior (immune 
suppression) was also found at the metabonome level. Among the detected plasma amines 
specifically induced on day 4 post-conventionalization were L-kynurenine and L-tryptophan, 
metabolites that potentially inhibit immune cell proliferation and induce apoptosis and immune 
suppression  (Suzuki, Suda et al. 2010). We also observed an increased plasma glutamine level 
that, under conditions of cell proliferation and growth as observed during conventionalization 
(Chapter 2), plays a crucial role in T cell activation and nucleic acids biosynthesis (Wu 1998), 
and the elevation of nitric oxide levels (Akobeng, Miller et al. 2000). Nitric oxide is a reactive free 
radical which acts as a messenger in several processes including antimicrobial and antitumoral 
activities. A drop in citrulline levels was observed at day 4 (Figure 5.5). The changes in plasma 
levels of glutamine and citrulline were associated with a correlating transient increase in the 
colon in the expression level of the expression of Nos2 (also known as iNos) that is induced by 
bacterial LPS and cytokines such as Ifn-γ, Tnfα and Il-1β. We did not determine if nitric oxide 
did accumulate since its short half-life (minutes) precluded its detection in our experiments. 
In conclusion, the transient peak of three microbial genera, the corresponding initiation of 
inflammatory cascades, and the temporal induction of identified plasma analytes, illustrates 
that day 4 post-conventionalization of mice by their natural microbiota marks a stage where 
resilience of healthy mice to inflammatory stimuli is most strongly challenged. The changes 
in gene expression and plasma metabolites at day 4 show very strong correlations with a 
transient expansion of the three microbial genera and an activation and expansion of innate 
but especially, adaptive immune (T) cells from day 8 onward (Chapter 2). Especially microbes 
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belonging to two of these thee genera, Helicobacter and Sphingomonas, are known to promote 
activation of multiple T cell types, including NK T cells,  by glycolipids that increase tissue 
concentrations of Th1 cytokines. We propose that the strong Th1 response that we measured 
at day 4 and the concurrent expansion and activation of T cells that we measured from day 8 
onward were induced by at least these two microbial genera, but may also include others like 
Mucispirillum, which is known to colonize the mucus layer (Robertson, O’Rourke et al. 2005). 
This activation of the (adaptive) immune system is in good agreement with the pathobiont 
hypothesis of (Lee and Mazmanian 2010). Our study provides an extensive resource of genes, 
pathways, and metabolites that together very well illustrate how this activation is regulated at 
the tissue level. In the healthy mice that we used, the transient inflammatory responses that led to 
expansion and activation of T cells did not lead to tissue damage but rather, to a state of apparent 
physiological inflammation and homeostasis. It is of interest that the identified regulatory gene 
expression profiles and concentrations of several blood plasma metabolites show similarities 
with loss of homeostasis as it has been described in mouse models of inflammation as well as 
in patients with inflammatory disorders. Of note,  in our study these molecules and regulatory 
gene expression profiles were identified in a context of mucosal and physiological responses 
to commensal microbiota in ex-germfree but otherwise healthy animals, with no genetic 
background for inflammatory diseases. In this context, it is of interest that the multi-variate 
approach chosen here shows that a combination of genomics (transcriptomics), plasma analytes 
measurements (metabolomics and immune cytokines), and microbial profiling techniques can 
provide potential human inflammation risk indicators of the intestinal mucosa.
EXPERIMENTAL PROCEDURES
Animals, Experimental Design, and Sampling
All procedures were carried out as previously described (Chapter 2). In brief, germfree 
and conventionalized mice (male, C57 BL/6 J) were maintained in sterile conditions, on a 
commercial laboratory chow diet. Three independent biological experiments were performed 
using mice of different age after 2 weeks of acclimatization and diet adaptation. The first and 
second experiments of the three performed independent biological experiments included 36 
mice obtained in 2 biologically independent batches of 18 mice each, aged 8 and 10 weeks, 
respectively. The third experiment included 14 mice, aged 10 weeks old. The colon from 
each mouse was removed and divided into 2 cm segments that were immediately: stored in 
RNA-Later at room temperature for 1 h prior to storage at -80°C for RNA isolation. Luminal 
content from colonic segments was removed by gentle squeezing, snap frozen, and stored at 
-80°C for microbiota analysis. Plasma samples (150-300 µl) were collected from germfree 
and conventionalized  mice directly after sacrifice and stored at -80°C for cytokine and amine 
measurements. 
Transcriptome Analysis
High quality total RNA was isolated from a 2 cm segment colon by extraction with TRIzol 
reagent, followed by DNAse treatment and column purification. Samples were hybridized 
on Affymetrix GeneChip Mouse Gene 1.1 ST arrays. Several complementary methods were 
used for the biological interpretation for the transcriptome data; gene clustering using Multi-
experimental View (MeV) software (Saeed, Hagabati et al. 2006), overrepresentation analysis 
of Gene Ontology (GO) terms using temporal and location comparative analysis using STEM 
(Ernst and Bar-Joseph 2006), and construction of biological interaction networks using Ingenuity 
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Pathways Analysis (for detailed descriptions see supplemental material of Chapter 2).
Microbial Profiling of Gut Contents
Colon content was analysed by Mouse Intestinal Tract Chip (MITChip), a diagnostic 16S rRNA 
arrays that consists of 3,580 unique probes especially designed to profile murine gut microbiota 
(Geurts, Lazarevic et al. 2011) in analogy to the human intestinal tract (HIT)Chip (Rajilic-
Stojanovic, Heilig et al. 2009) (for detailed descriptions see supplemental material of Chapter 
2). Correlation analysis of MITChip and transcriptome datasets was performed as previously 
described (Swann et al., 2011). In brief, a correlation matrix between the MITChip level 2 
(genera-like) data and the transcriptome was computed using the absolute expression values. 
To reduce the probability of type I errors (false positives) for multiple testing, the Benjamini–
Yekutieli method (Benjamini and Yekutieli 2001) was employed and the data were corrected for 
multiple testing using an FDR method. FDR was set at < 0.05 % for expected proportion of 
false positive correlations in the multiple comparison testing.
Plasma Measurements
Cytokines were determined in 70 µl plasma samples using the Mouse MAP multiplexed 
immunoassay standard operating procedures established at Rules-Based Medicine laboratory 
(Austin-USA) (www.rulesbasedmedicine.com); (for more detailed descriptions, see 
supplementary methods). Plasma aliquots of 5 µL were used for quantitative analysis of 
primary and secondary amines using LC-MS/MS after derivatization using the AccQ∙Tag Ultra 
Derivatization Kit (Waters, UK) as described by Shi et al. (unpublished data). The acquired 
data was analyzed using Quanlynx (Waters, UK). The quality of the measurements for the 
individual metabolites was assessed by means of the relative standard deviation (RSD) on the 
quality controls and replicates (see supplementary methods for detailed procedure description). 
For data analysis, ANOVA was executed in SPSS Statistics 17.0 (SPSS Inc., Chicago, IL). To 
correct for multiple testing a Benjamini-Hochberg correction was applied to generate corrected 
p values. When significant differences (p <0.05) were detected, a Tukey Honestly Significant 
Difference test was performed to determine which groups were significantly different from each 
other. 
Accession Numbers
The mouse microarray dataset was deposited in the Gene Expression Omnibus (GEO) with 
accession number GSE32513.
ACKNOWLEDGMENTS
The authors thank the technical staff in the animal facilities in the lab of J. Doré (INRA, Jouy 
en Josas) for assistance with animal sacrifice and sampling, J. Jansen, M. Grootte-Bromhaar, 
M. Boekschoten and P. de Groot (Division for Human Nutrition, Wageningen University) for 
their technical support in microarray hybridization and microarray data-quality control and 
processing. We are also grateful to E.E.S.Nieuwenhuis (Utrecht medical center, Utrecht) 
and J.Samsom (Erasmus University Medical Centre, Rotterdam) for critical reading of the 
manuscript, and  T. Hankemeier for providing access to the excellent technical facilities and 
expertise at the Netherlands Metabolomics Centre, Leiden. 
                                                              
                                                     CHAPTER 5
                                                                                 Supplemental Material
A Transient State of Microbial Dysbiosis and Inflammation is Pivotal in the Establishment of Homeostasis during Conventionalization of Mice
132
CHAPTER 5
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Plasma Measurements of Amine Metabolites
Quantitative analysis of primary and secondary amines was performed with an aliquot of 
5 µL plasma using LC-MS/MS after derivatization using the AccQ∙Tag Ultra Derivatization Kit 
(Waters, UK) as described by Shi et al. (unpublished data). Briefly, this method involves the 
reaction of primary and secondary amines present in protein precipitated mouse plasma with 
the AccQ∙Tag Reagent, to form stable ureas. The samples were injected onto the AccQ∙Tag 
column (Waters, UK) and 59 primary and secondary amines were detected using the XevoQqQ 
MS (Waters, UK) in MRM mode. A binary gradient of water – eluent A (10:1, v/v) (AccQ∙Tag, 
Waters) and 100% eluent B (AccQ∙Tag, Waters), was used. Elution of the amines was achieved 
by ramping the percentage of eluent B from 0.1 to 90% in approx. 9.5 minutes.  The flow rate was 
0.7 ml min-1. An ACQUITY ultra pressure liquid chromatography (UPLC) system (Waters, UK) 
was hyphenated to a XevoQqQ mass spectrometer, which was operated in positive-ion mode. 
The desolvation gas flow was 1000 l h-1, and the desolvation temperature was set at 450 °C. The 
cone gas flow was set at 50 l h-1 and the source temperature was 140°C.  The cone voltage was 
set at 52V. The capillary voltage was 3.20 kV.  Collision energy and collision gas (Ar) pressure 
were 22eV and 2.5 mbar, respectively. The samples were analyzed in one batch. Nine samples 
were at random chosen to be analyzed in duplicate. All samples (including the 9 replicas) were 
randomized and divided into blocks of 5. Between each block a quality control (QC) sample 
was analyzed. These QC samples were created by pooling an aliquot of all the samples. Each 
sample was injected twice in a row.  The acquired data was analyzed using Quanlynx (Waters, 
UK). The automated peak integration was checked manually and when necessary corrected by 
hand. All peak areas were corrected for system trends by using the QC samples as described by 
van der Kloet et al. (van der Kloet, Bobeldijk et al. 2009) The data was normalized by dividing 
the intensity of a compound by the mean intensity of all compounds and globally checked 
on inconstancies. There were no unexpected differences between duplicate samples and the 
duplicate injections were within range of each other. The quality of the measurements for the 
individual metabolites was assessed by means of the relative standard deviation (RSD) on the 
QCs and the replicates. In general, we consider metabolites with RSD values on both below 
15% as measured with enough precision.  
Plasma Measurements of Cytokines
All samples were stored at -80°C until tested. The samples were thawed at room temperature 
(RT), vortexed, spun at 13,000 x g for 5 minutes for clarification and 35 µL was removed for MAP 
analysis into a master microtiter plate. Using automated pipetting, an aliquot of each sample was 
introduced into one of the capture microsphere multiplexes of the Mouse CytokineMAP A v1.0, 
Mouse CytokineMAP B v1.0, Mouse CytokineMAP C v1.0 and Rodent CustomMAP: RAMB1, 
RAMB2 and RAMB5. The mixture of sample and capture microspheres were thoroughly 
mixed and incubated at RT for 1 h. Multiplexed cocktails of biotinylated, reporter antibodies 
for each multiplex were then added robotically and after thorough mixing, were incubated 
for an additional hour at RT. Multiplexes were developed using an excess of streptavidin-
phycoerythrin solution which was thoroughly mixed into each multiplex and incubated for 
1 h at RT. The volume of each multiplexed reaction was reduced by vacuum filtration and 
the volume increased by dilution into matrix buffer for analysis. Analysis was performed in a 
Luminex 100/200 instrument and the resulting data stream was interpreted using proprietary 
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data analysis software developed at Rules-Based Medicine (www.rulesbasedmedicine.com). 
For each multiplex, both calibrators and controls were included on each microtiter plate. Eight-
point calibrators were run in the first and last column of each plate and three-level controls were 
included in duplicate. Standard curve, control, and sample QC were performed to ensure proper 
assay performance. Unknown values for each of the analytes localized in a specific multiplex 
were determined using 4 and 5 parameter, weighted and non-weighted curve fitting algorithms 
included in the data analysis package. 
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SUPPLEMENTAL FIGURES
Figure S5.1. Consistency between the gene expression patterns in the three independent conventionalization 
experiments. Expression levels of the colon genes that are positively correlated with microbiota in germfree 
and conventionalized mice at indicated days of conventionalization. Values are depicted as dot plots. Significant 
differences between time-points are indicated by distinctive characters above the measurement groups (p <0.05). 
The expression levels confirm the similar modularity of transcriptome in experiments 1, 2, and 3 and the consistence 
presence of transient state of compromised mucosal response during the 30 days of conventionalization. Among 
the mice sacrificed at day 16, one mouse was excluded as an outlier because the gene expression levels for this 
mouse were more than 600 SD from the rest of the data for all the pro-inflammatory cytokines. Interestingly, the 
MITChip data analysis of the same mouse indicated the dominance of Helicobacter (17.03%) compared to (0.51% 
± 0.08) in the rest of the mice at day 16 post-conventionalization.
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Figure S5.2. Changes in the plasma levels of pro-inflammatory cytokines and amines at day 4 post-
conventionalization. Additional plasma analytes including  (A)  KC/GRO, GM-CSF, MIP-3β, and OSM and (B) 
o-phosphoethanolamine, Taurine, and Cystine were significantly increased at day 4 when compared to germfree 
and day 30 post-conventionalization. (*= p <0.05). Although the plasma cytokines (A) are induced upon exposure 
to inflammatory stimuli  as reported in previous studies (Torrence, Brabb et al. 2008; Mentor-Marcel, Bobe et al. 
2009), their elevated profile did not correlate with the trend of expression of corresponding genes because the 
expression level of these genes was very low on the Affymetrix GeneChip Mouse Gene 1.1 ST arrays at all time-
points of conventionalization suggesting it could be a background.
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GENERAL DISCUSSION 
The importance of the interplay between gut microbiota, diet, metabolism, and immune system 
for the human health status has become generally accepted during the last five years. Nonetheless, 
there is a large gap in our knowledge on the genetic regulation of immune tolerance towards 
the gut microbiota and regulation of homeostasis during simultaneous changes in microbiota 
composition and intestinal metabolism. The work described in this thesis reports on the outcome 
of conventionalization studies where a germfree mouse model was used to explore the time- and 
region-dependent host response, with respect to metabolic and immune processes, to changes in 
the composition of a de novo introduced microbial community. 
The major findings described in the experimental chapters of this thesis and their future 
perspectives will be discussed in the following chapter. 
Colonization of Mouse Gut Microbiota Rapidly Establishes a Full-sized, Low Diversity 
Microbial Community 
The basis for this thesis was conventionalization experiments, where healthy germfree mice 
were inoculated with a standard mouse microbiota at eight-ten weeks of age. The total number of 
colonizing microbial community very rapidly reached the densities that are normally encountered 
in conventional mice. Quantitative PCR determination of 16S rRNA gene copies in jejunal, 
ileal, and colonic luminal samples, indicated that already one day after conventionalization, the 
estimated copy numbers increased from 4.9 ± 0.3 in the jejunum, to 8.25 ± 1.1 in the ileum, and 
10.7 ± 1.2 in the colon ( mean ± SD Log10 copy number of 16S rRNA/g content), and these 
numbers did not drastically change upon prolonged conventionalization periods. As anticipated, 
the total number of bacteria and the community composition diversity (Figure 6.1) increased 
significantly along the length of the GI tract. In this thesis research, the extensive microbial 
profiling throughout the GI tract suggested that the establishment of gut microbiota occurred 
in two phases (Chapter 4). The microbial population at days 1 and 2 was characterized by a 
low diversity and mainly consisted of bacteria that failed to efficiently extract energy from the 
diet. This was inferred from the rapid (after one day) accumulation of fermentation metabolites 
with a high energy content, such as lactate and succinate, in the lumen of the cecum as well 
as high concentrations of TCA cycle intermediates in the urine. The latter finding implies that 
these early bacterial colonizers have a profound effect on systemic metabonomics. Remarkably, 
this early stage of conventionalization was not reflected in prominent transcriptome or tissue 
metabolite profile changes in the ileum or colon, suggesting that the microbiota associated 
metabolites passed the intestinal epithelium without influencing the local intestinal tissues in 
these intestinal compartments. However, this was not the case in the proximal part of the small 
intestine, the jejunum, where prominent tissue responses could be detected acutely (one day 
after introduction of the microbiota) upon conventionalization (Chapter 3). 
Jejunum is the Initial Sensor of the Colonizing Microbiota
Despite the relatively low microbial densities in the jejunum, the bacterial presence appeared 
to elicit “danger signal” responses in the jejunal mucosa (Chapter 3). This may involve 
their metabolites (including some typical TCA-cycle intermediates) that could arise from 
their interaction and utilization of compounds within the nutrient flow (Chapter 3). The 
induction of canonical pathways associated with “danger signal” responses in the jejunal tissue 
transcriptome after one day of conventionalization was paralleled by the initiation of repression 
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Figure 6.1. Hierarchical clustering analysis of MITChip fingerprints generated from the inoculum (Ino),  jejunal 
(J), ileal (I), and colonic samples collected from the indicated days (d) post-conventionalization. The highest 
phylogenetic assignments are provided at the right side of the gel-view dendogram. 
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of genes involved in lipid uptake, transport, and oxidation, including the main regulator of lipid 
metabolism Ppar-α and its downstream target genes. These responses included the repression 
of Angptl4, the gene which is essential for the induction of de novo hepatic lipogenesis and 
elevation of circulating leptin levels (Bäckhed, Ding et al. 2004). By suppressing Angptl4, the 
microbiota indirectly promotes storage of calories harvested from the diet into fat in the liver 
(Bäckhed, Ding et al. 2004). Since the jejunum is regarded as the main absorptive site in the GI 
tract, this modulation of energy (fat) storage  is intriguing in the light of recent studies that link 
the gut microbiota to the development of metabolic disorders in genetically susceptible persons 
(Bäckhed, Ding et al. 2004; Korner, Bessler et al. 2005; Delzenne and Cani 2010; Claus, Ellero 
et al. 2011).
A Transient State of Inflammation during Conventionalization
The simple composition of the early bacterial community in the colon was succeeded 
by a transiently increased abundance of particular Gram negative bacteria at day 4 post-
conventionalization, which included the genera Helicobacter and Sphingomonas. These 
two genera have previously been designated “pathobionts” (Chow and Mazmanian 2010) to 
emphasize their dualistic role as typical commensals with pathogenic potential (Chapter 5). 
They are of particular interest since glycosphingolipids produced by members of these genera 
promote (natural killer) T cell development (Kinjo, Wu et al. 2005; Mattner, DeBord et al. 
2005; O’Keeffe and Moran 2008). Intriguingly, at the same time-point, the major changes in 
intestinal physiology and morphometry were observed throughout the GI tract: a reduction 
of the cecal size, an increased epithelial cell proliferation, the highest level of antimicrobial 
peptides production, alterations in the chemical composition of the goblet cells, and the drastic 
transcriptome shift, in particular for innate immune-associated genes (Chapter 2). Interestingly, 
RegIIIγ, a secreted C-type lectin with antimicrobial activity was among the protective innate 
molecules that peaked at day 4 post-conventionalization throughout the GI tract. This finding 
corroborates the recent notion that RegIIIγ is required to keep the microbiota at bay by 
maintaining a spatial segregation between the microbiota and host to prevent the activation of 
excessive cytotoxic adaptive immune responses in the small intestine (Vaishnava, Yamamoto 
et al. 2011). 
Day 4 post-conventionalization also marked a metabolic shift towards an anabolic metabolism 
throughout the GI tract (Chapters 3 and 4). The jejunum in particular was characterized by 
a strong repression of fatty acid uptake, transport, and oxidation that was already initiated 
at  day 1 post-conventionalization (Chapter 3). Moreover, a transient impairment of the fatty 
acid oxidation was observed in the colon at day 4 post-conventionalization (Chapter 4). 
This drastic metabolic change pointed to a shift towards an anabolic metabolism that favors 
glucose utilization, which was confirmed by the increased levels of glutamine, glutamate, and 
asparate throughout the GI tract and the decreased levels of tissue glucose in the colon.  The 
drastic changes in intestinal morphometry and the cell proliferative phenotype did resemble 
the highly proliferating tumor cells, which depend on glycolysis as their main source of 
energy (Heiden, Cantley et al. 2009). It is possible that this metabolic shift correlated with 
the increase of connective tissue and the simultaneous accumulation of (activated) T cells and 
innate immune cells in the lamina propria, in that the glycolytic metabolism was necessary 
to support the activated immune cells.  The correlation between the metabolic shift and the 
activation and accumulation of innate and adaptive immune cells highlights the strong link 
between metabolism and the immune system. The shifts in the microbiota composition during 
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the first four days strongly suggest that the changes in metabolism and immunity were driven 
by the colonizing microbiota.
Intriguingly, a statistical correlation was found between alpha- and epsilon-Proteobacteria classes 
to which  Helicobacter and Sphingomonas spp. belong, elevated levels of metabolites known to 
play a key role in anabolic metabolism (glutamate, glycine, and alanine) (Wu 1998), and peak 
induction of genes involved in nucleotide biosynthesis (Chapter 4). This correlation could be 
of biological relevance in that it suggests the high requirement of anabolic metabolism during 
the transient state of inflammation, when the abundance of Helicobacter and Sphingomonas 
was specifically enhanced. Helicobacter spp. are among the natural inhabitants of the mouse 
intestine (Sterzenbach, Lee et al. 2007), but can also occur as pathobionts that promote intestinal 
inflammation (Erdman, Rao et al. 2009; Chow and Mazmanian 2010). Helicobacter can 
induce Th1 type inflammatory responses and can promote the production of Tnf-α in immuno-
compromised mice (Kullberg, Ward et al. 1998). At day 4 post conventionalization, the induction 
of a Th1 type immune response was also detected. Sphingomonas was shown to activate 
natural killer cells that promote adaptive immune system activation by its glycoshingolipids, 
via induction of a T cell receptor (TCR) signalling cascade that involves the MHC class I 
molecule, Cd1d1 (Mattner, DeBord et al. 2005). These particular features suggest that the 
transient expansion of the two bacterial genera were instrumental in activating an inflammatory 
Th1 type immune response at day 4 post-conventionalization. The Th1 response was inferred 
from a gene regulatory network that included typical Th1 specific genes and the correlated 
pro-inflammatory Th1 cytokines and the increased levels of several plasma markers, including 
inflammatory cytokines and some amines (Chapter 5). The transient features that marked day 
4 post-conventionalization, revealed a consistent association with inflammation. Collectively, 
these findings suggested that the transient state at day 4 marked a transient state of dysbiosis 
and inflammation where the resilience of the healthy mice to inflammatory stimuli was most 
strongly challenged. Here it is proposed that the molecules that characterize this transient 
state could provide useful risk indicators for the loss of homeostasis that is associated with 
progressive inflammation in individuals that suffer from inflammatory diseases. 
During the conventionalization experiments, the mice remained healthy and the integrity of the 
intestinal mucosal barrier remained intact, as apparent from histological examinations (Chapter 
2). The results therefore imply that the transient state described above and in Chapter 5  activated 
the development of the lamina propria immune function without actual loss of homeostasis. 
The regulatory network that was induced during the transient dominance of Helicobacter and 
Sphingomonas included activators of MHC class I and chemokines. Interestingly, these same 
chemokines were previously observed to peak at  4 days  after bacterial infection in mice 
and preceded infiltration by activated Cd8+ T cells (Valbuena, Bradford et al. 2003). These 
results indicate that the induction of pro-inflammatory cytokines and chemokines during the 
transient dominance of Helicobacter and Sphingomonas (Chapters 2 and 5) without loss of 
mucosal barrier integrity was part of a natural process leading to the activation and maturation 
of adaptive immune responses that was measured at days 8 and 16 (Chapter 2)(Figure 6.2).
Establishment of Microbiota Accommodating Homeostasis 
Day 8, four days following the transient state of dysbiosis and inflammation, was marked by 
activation of adaptive immunity, in particular T cell activation. At day 8, a gradual increase 
in T cells that express the surface markers Cd4, Cd8, and the T cell maturation marker Cd3ε 
was observed. These activated T cells accumulated in the lamina propria over the period of 
144
CHAPTER 6
Figure  6.2.  Dynamic changes in the regulation of intestinal homeostasis during microbial colonization.
The major molecular changes measured in terms of transcriptomes, IHC, and microbiota composition were 
initiated at day 4 of conventionalization along the GI-tract. These changes correlated with a strong induction of 
the innate immune response, production of antimicrobial peptides and altered functionality of mucin secreting 
goblet cells (more sialylated mucins specifically in the colon). Stimulation of adaptive immune response, local 
immune cell recruitment (in particular T cell development), as well as their regulators followed between days 8 
and 16 of conventionalization in the colon, and later between days 16 and 30 in the small intestine. In parallel, 
establishment of the colonizing microbiota started with a relatively low diversity and higher abundance of Gram-
negative bacteria, followed by a transient intermediate diversity and peak of Gram-negative between days 2 and 
4 in the colon and days 4 and 8 in the small intestine. This intermediate stage eventually shifted towards high 
diversity and stable microbial composition (in comparison to the inoculum) between days 8-16 in the colon and at 
day 16 in the small intestine.
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days 8-30 post-conventionalization and displayed the largest abundance in the small intestine 
(Chapter 2). In parallel, the initial low diversity microbial populations shifted to a high diversity, 
relatively stable community (Chapter 4). This shift closely resembles the dynamic shift during 
acquisition of gut microbiota in infants (Pamer 2007; Adlerberth and Wold 2009). The newly 
established microbiota comprised members that could efficiently deplete the “high energy 
content metabolites” that were accumulating during the early stages of conventionalization, 
by converting these metabolites into short chain fatty acids (SCFAs) that can be efficiently 
used by the host intestinal cells. This scenario was inferred from the high concentrations of 
the SCFAs butyrate, propionate, and acetate in the large intestinal lumen at days 8 and 16 
post-conventionalization. The statistical correlation found between the decreased level of Myo-
inositol and the repression of host genes involved in choline metabolism could point to the 
colonization by microbial groups that can metabolize choline and convert it into its derivative 
metabolites (TMA and TMAO), which were detected in the urine metabolic profiles (Chapter 
4). The expansion of Gram- positive Firmicutes, in particular, Clostridium clusters IV and XIVa 
characterized the second stage of conventionalization. These spore-forming Clostridia groups 
have previously been shown to stimulate regulatory T cell (Treg) population in the colon of mice 
(Atarashi, Tanoue et al. 2011), which is corroborated by the current finding that Treg population 
development in the colon mucosa coincided with the abundant colonization of the colon 
microbiota by the Clostridium groups. Expansion of the Treg population was apparent from 
the increased expression of typical Treg markers, Il10, Tbx21, Foxp3, and Tgfβ1. Importantly, 
expansion of Treg continued also during later time-points of conventionalization, illustrating 
the requirement of Treg to establish tolerance and to maintain microbiota accommodating 
homeostasis in the intestine. 
Establishment of Homeostasis Occurred Earlier in the Colon than in the Small Intestine 
Combined analysis of transcriptomics and histological data as shown in Chapter 2 suggested 
that a novel state of microbiota-accommodating homeostasis was reached in the colon during 
the time course of 8 to 16 days post-conventionalization. In contrast, homeostasis was 
reached in the small intestine after 16 to 30 days post-conventionalization (Figure 6.2). This 
was supported by the transient changes in small intestinal versus colonic tissue morphology, 
differences in expression pattern of genes regulating the innate responses, as well as tissue 
metabolites. Importantly, these molecular differences coincided with the expected (based on 
gene expression) microscopic differences in the microarchitecture of the small intestine versus 
colon mucosa (Chapter 2). For instance, the colonic morphology (most notably, crypt depth) 
and the expression pattern of the antimicrobial RegIIIγ returned to the germfree level at 30 days 
of conventionalization, while small intestinal morphology and elevated RegIIIγ expression was 
maintained throughout the 30 day period, albeit to a lesser extent as compared to days 8 and 
d16 post-conventionalization. In addition, increases in T cell numbers and the expression of 
specific chemokines and their receptors increased continuously in the small intestine, while 
these activities reached a steady level in the colon after eight days of conventionalization. 
The earlier establishment of a homeostatic state in the colon coincided with the expansion of 
SCFAs producing bacteria and the parallel increased concentrations of SCFAs, in particular 
butyrate, in the lumen of the large intestine (Chapter 4). The production of SCFAs could have 
activated the Gpr43 (Ffar2) receptor, a gene encoding a GPCR that plays a crucial role in 
modulating inflammatory responses (Maslowski, Vieira et al. 2009). Moreover, the increased 
levels of aspartate, glutamate, and glutamine remained higher than the germfree levels in the 
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small intestine during the 16 days of colonization (Chapter 3). In contrast, the level of these 
metabolites returned to the germfree level after 8 days in the colon (except for glutamate whose 
expression levels remained higher than in the germfree animals) (Chapter 4). These results 
coincided with the continuous changes in tissue composition and development in the small 
intestine. Such regional differences may relate to the higher density of the colon microbiota and 
could be a prerequisite for the establishment of a microbiota-accommodating homeostasis in 
this densely populated part of the GI tract. 
Establishment of Conventionalized Immune and Metabolic Homeostasis is Governed by 
Gene Regulatory Networks
Proper regulation of animal physiology relies for an important part on gene regulatory 
networks (Davidson 2010). The reconstructed gene regulatory networks in Chapters 2, 3, and 
5 appeared to be involved in regulation of the dynamic immune and metabolic adaptation of 
the intestinal mucosa to the colonizing microbiota. The central regulatory network identified 
in this study throughout the GI tract may therefore serve as a genetic signature for control of 
intestinal homeostasis in healthy mice and could be used as a hypothesis generating model 
for further studies into diseases with a clear genetic basis that includes the network genes. 
Such studies should then investigate the modulations and dysregulation of these networks in 
patients. Moreover,  the intriguing link between the genes in the regulatory network identified 
for the jejunum in Chapter 3 and the possible mechanisms by which gastric bypass surgery 
rapidly improves insulin sensitivity (Troy, Soty et al. 2008) appears to suggest that exclusion 
of the proximal small-intestine from the nutrient flow and/or the normal microbiota affects 
the regulation of systemic glucose homeostasis and insulin sensitivity. It is likely that the 
microbiota-induced changes in the jejunal metabolic profile, more specifically the very low 
accumulation of glucose compared to the germfree state (Chapter 3), may underlie the health 
promoting effect of the human duodenal-jejunal by-pass surgery.
FUTURE PERSPECTIVES
The time series approach implemented in the design of this study has brought new insight 
in the dynamics of host responses to microbial colonization and thereby complements other 
studies that dissected the intestinal-microbiota interactions in similar models. The vast majority 
of these studies used only a single time-point for analysis or included only extended periods 
of conventionalization or colonization to evaluate the host responses. Especially the unique, 
transient state identified at day 4 post-conventionalization of the mice makes it attractive to 
design finer sampling strategies (e.g. to include days 3, 5, 6, and 7), to more precisely monitor 
the molecular dynamics that enable the mucosa to proceed from a transient state of partial 
dysbiosis and inflammation to a state of homeostasis without loss of barrier function. Such 
study would also allow further deciphering of the processes involved in the establishment of the 
“normal” mucosal defense mechanisms that underlie homeostasis in the presence of microbiota. 
The microbiota studied here appeared to lack the presence of segmented filamentous bacteria 
(SFB), which have been reported to play a prominent role in the maturation of the immune 
system. As a consequence our measurements failed to identify differential expression of Il-17 
and the corresponding accumulation of Th17 cells in the mucosa. This is due to the mouse 
strain used in this study (C57/ BL6 J), which lack SFB in their normal microbial community. 
The use of other mouse strains that do contain SFB in their microbiota, such as C57/ BL6 
supplied by Taconic, in combination with the application of finer sampling time lines could be 
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of great interest. Such experiments would unravel the impact of colonization by a microbiota 
that includes SFB on Th17 development, which may drastically affect the typical transient state 
of dysbiosis and inflammation observed on day 4 post-conventionalization in C57/BL6 J mice. 
In this study, no tissue damage was observed in the mucosa of the mice during the transient state 
of inflammation, which may relate to the relatively high resistance to inflammation of C57/BL6 
J mice, and could be significantly different in other mouse strains with a higher susceptibility 
to inflammation. 
A Role of the Gut Microbiota in Gut-Brain Interaction? 
Recently, a profound interest emerged in the role of intestinal microbiota in brain development 
and behavior, which was stimulated by observations that showed decreased motor-activity but 
increased anxiety in conventional mice compared to their germfree counterparts (Husebye, 
Hellstrom et al. 1994; Heijtza, Wang et al. 2011; Neufeld, Kang et al. 2011). In addition, the 
bidirectional cross-talk between the immune- and nervous systems, which is influenced by the 
microbiota, is involved in several neuropsychiatric diseases including autism and depression 
that were linked to the “compromised gut barrier”(Maes, Kubera et al. 2008; Theoharides and 
Doyle 2008; de Magistris, Familiari et al. 2010; Yap, Angley et al. 2010). The time-resolved 
transcriptome analysis performed in this thesis highlighted some intriguing changes in the 
expression of genes associated with the cholinergic and the adrenergic systems (Figure 6.3A). 
Surprisingly, conventionalization elicited significant down regulation of the expression of 
genes involved in nerve growth, neurotransmission, dopamine, histamine, γ-amino butyric acid, 
serotonin, and acetylcholine synthesis, throughout the GI tract (Figure 6.3A). 
The genes encoding Substance P (SP) receptor (also known as tachykinin receptor, Tacr), 
and to lesser extend SP were among the modulated genes during conventionalization (Figure 
6.3B). SP plays different roles in the GI tract, including the induction of intestinal secretion of 
water and electrolytes (Riegler, Castagliuolo et al. 1999) and the inhibition of gastric secretion 
(Martensson HG 1984). SP also has a major role as an excitatory transmitter that stimulates 
muscle contraction and intestinal transit (Riegler, Castagliuolo et al. 1999).  To evaluate the 
impact of microbial colonization on substance P , IHC staining of SP in the myenteric plexus 
(the major nerve supply to the GI tract that also controls GI tract motility), was performed 
as previously described (Verdu, Bercik et al. 2006). The results showed few (non-significant) 
differences between the stained myenteric plexus SP from germfree and conventionalized 
mice at days 4, 8, and 16 post-conventionalization, which seemed to corroborate the slight but 
non-significant differences observed at the Tac transcription level (Figure 6.3A). Strikingly, 
30 days after conventionalization a large increase was observed in the level of SP  in the 
myenteric plexus of the colonic mucosa in comparison to germfree mice and other time-
points post-conventionalization (Figure 6.4A,B). This finding confirms that the microbiota 
can significantly influence the development of the enteric nervous system, and may explain 
its postulated role in modulating the GI tract motility and intestinal transit (Silkoff, Karmeli 
et al. 1988). Interestingly, Goldin and colleagues reported that elevated levels of SP were 
observed in patients with ulcerative colitis, which may be correlated with the disease’s effect 
on intestinal transit (Goldin, Karmeli et al. 1989). This tentative link between the intestine 
microbiota and enteric nervous system modulation may eventually influence the functional 
properties of the gut-brain axis, which could potentially influence brain function and have some 
intriguing consequences. Moreover, these findings also support that microbial dysbiosis and/or 
gastrointestinal inflammatory diseases may influence the gut-brain axis function. 
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Figure 6.3. Colonizing microbiota impacts the expression level of gut neuropeptides. (A) Heat map generated 
from the expressed genes involved in neurotransmission and nerve growth, dopamine, epinephrine, serotonin, 
acetylcholine, nitric oxide (NO), hydrogen sulfide (H2S), and carbon monoxide (CO) synthesis as well as substance 
P (SP) and its receptors, between germfree and conventionalized mice at the indicated time-points throughout the 
GI tract. (B) Gene expression level of SP receptor (Tacr2) depicted as box and whisker diagram  (top-to-bottom, 
maximum value, upper quartile, median, lower quartile, and minimal value, respectively). Any data not included 
between the whiskers is plotted as outlier with a dot. Significant difference between time-points are indicated by 
distinctive characters above the measurement  group (p <0.05). 
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Figure  6.4. Microbiota and gut-brain interaction. (A) Representative immunostaining of substance P. The 
staining was performed as previously described (Verdu, Bercik et al. 2006). In brief, 4 µm-thick paraffin embedded 
cross sections from jejunum, ileum, and colon of germfree and conventionalized mice were incubated with Rabbit 
anti-substance P (1:1000) antiserum (Chemicon international, California, USA) as a primary antibody. Negative 
controls were performed by omitting the primary antibody. Vectastin Elite ABC kit was used for secondary anti 
substance P antibody and solutions (Vector, Burlingame, California, USA), using the manufacturer’s instructions. 
Stained sections were analysed using light microscopy (Carl Zeiss, Axio 3.1), and quantification of immunostaining 
was performed on computer using computer software (image J) selecting the area of the myentric and submucous 
plexus and positive staining was expressed as percentage of total tissue area. (B) % of total surface area of 
substance P (SP) immunostaining in germfree and conventionalized mice at:   a (day 0), b (day 4), c (day8), d (day 
16), and e (day 30). M= mucosa; cm=circular muscle; lm=longitudinal muscle. The arrow indicates SP staining 
in the myenteric plexus. (C) Plasma levels of adrenocorticotrophic hormone (ACTH) measured by Mouse MAP 
multiplexed immunoassay systems. **=p value <0.001, ***= p value <0.0001.
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The plasma analysis performed in germfree mice and after 4 and 30 days of conventionalization 
revealed the significant up-regulation of adrenocorticotrophic hormone (ACTH) at day 30 
of conventionalization when compared to the other mice (germfree and 4 days after mice 
conventionalization) (Figure 6.4C). ACTH is secreted by the anterior pituitary gland in response 
to biological stress and is a main component of the hypothalamic-pituitary-adrenal (HPA) axis. 
Our results are in very good agreement with the previous observations made by Sudo and 
coworkers, who reported on the role of the gut microbiota on the modulation of the levels of 
ACTH and HPA in mice (Sudo, Chida et al. 2004). These authors suggested that microbial 
colonization and the associated immune activation increases the HPA responsiveness via the 
release of cytokines, which subsequently affect the parts of the central nervous system involved 
in the HPA regulation (Sudo, Chida et al. 2004). Taken together, these preliminary results 
suggest that there is a detectable effect of the microbiota on the function and architecture of the 
enteric nervous system. Such modulations may promote alterations of gut function, including 
mucosal metabolism and immune repertoire, but may also affect the central nervous system as 
is suggested by the altered ACTH plasma levels.
In order to unravel the mechanisms of the proposed communication between the microbiota and 
the enteric nervous system (and the brain), it would be required to carry out dedicated sampling 
of tissue from the GI tract and other organs (including liver) that are known to participate in 
hormonal signaling to the brain. In this respect it would be of interest to also sample the mouse 
brain at different time-points after conventionalization. It has previously been reported that the 
intestinal microbiota may affect the behavior of its host by activation of the mucosal immune 
system and neuropeptides (Bercik 2011), which can modulate brain functions and may change 
mood and behavior. Moreover, O’Connor and colleagues showed that bacterial LPS resulted 
in depression-like behavior which was linked to cytokine-induced changes in tryptophan 
metabolism and production of kynurenine (O’Connor, Andre et al. 2009). In light of these 
observations, it seems interesting to correlate the results of the proposed time-resolved brain 
analysis to the changes in host metabolism- and immune responses, and also in this respect day 
4 post-conventionalization may be of particular interest on basis of the transient increase in the 
ratio of kynurenine/tryptophan at this time-point post-conventionalization. 
                                                                                   
Unraveling the Mechanism of Jejunal Control on Systemic Insulin Control
The striking role of the jejunum in perception of the microbiota-diet interplay proposes a crucial 
impact of the colonizing microbiota in altering host metabolic pathways including systemic 
glucose homeostasis and insulin control. It is likely that, after efficient microbial conversion 
of high-energy dietary compounds into low-energy compounds and after depletion of luminal 
glucose, epithelia store far less energy as fat and are accumulating far less glucose. Unfortunately, 
the present study did not allow a conclusive assessment of the effect of microbial colonization 
on gut hormones involved in the modulation of insulin secretion and the absorption of glucose 
in the proximal small intestine. Precise measurement of these gut hormones over time as well 
as glucose fluxes in the jejunum would help to explore whether the early microbial signaling 
seen in the jejunum is achieved through an endocrine mechanism and/or metabolic modulation. 
The intriguing connection that can be made to human duodenal-jejunal bypass surgery with 
the hormonal changes that occur prior to body weight modifications (Pories, Swanson et al. 
1995), supports the proposed role of the jejunum in nutrient sensing and systemic control. 
This connection is potentially of utmost importance in diagnostics and/or therapies related 
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to important emerging diseases in Western Societies like obesity and the associated insulin 
resistance and type 2 diabetes. The discovery of an “obese microbiota” is of relevance in this 
context; apparently some microbiota can promote fat storage and insulin resistance as previously 
reported by Turnbaugh and colleagues who showed that gut microbiota transplantation from 
obese donor (ob/ob genotype) to lean acceptor (wild-type) mice resulted in increased fat 
deposition and weight gain in the transplanted mice (Turnbaugh, Ley et al. 2006). The observed 
inability of the first-stage microbiota that we found at days 1-4 to sufficiently deplete high-
energy compounds might be seen as displaying characteristics of an “obese microbiota”. Of 
note, the gastric bypass avoids contact between the diet, jejunum microbiota and the intestine. 
It is attractive to speculate that one reason for the success of gastric bypass surgery to avoid 
obesity problems is by bypassing an “obese” microbiota but instead, translocating the diet 
immediately to a more “lean” microbiota that is capable of efficient depletion of dietary glucose 
and high-energy compounds.
Identifying the Bacterial Effector Molecules; Functional Microbiomics
The application of the MITChip enabled the efficient determination of the dynamics of the 
establishing gut microbiota throughout the GI tract. Combined with multi-variate correlation 
analysis the MITChip datasets allowed the identification of specific bacterial groups that 
correlated with specific host responses. However, the identification of the bacterial effector 
molecules that are involved in mediation of these host-responses remains a major challenge. 
To identify such effector molecules one may consider employing large-insert metagenome 
expression libraries in combination with high throughput screening systems that employ 
efficient reporter cell-lines. This approach has been shown to allow the detection of specific 
pathway-activating or pathway-repressing metagenome clones, which paves the way towards 
identification of specific microbial effector molecules (van der Kleij, Latz et al. 2002; Gloux, 
Leclerc et al. 2007; Lakhdari, Cultrone et al. 2010). The application of metagenomic screening 
approaches could for example be employed to search for the microbiota effector molecules that 
elicit the acute response on day 1 post-conventionalization in the jejunal mucosa. Alternatively, 
these microbial effector molecules may also be discovered via mono-association or colonization 
with simplified microbial communities of germfree mice (Hooper, Wong et al. 2001; Mahowald, 
Rey et al. 2009). Such models may answer the question whether the observed activation of 
“danger signals” associated responses may be elicited by the diffusion of bacterial secreted 
metabolites and their uptake by epithelia or may depend on direct interaction of the mucosal 
tissue with bacterial ligands and their wall components. Provided that the nutrient flow is of 
importance in eliciting these acute effects, the application of different diets could address their 
impact on bacterial and metabolic sensing in the proximal part of the small intestine. We therefore 
propose that more attention should be given to the role and functionality of the small intestine (as 
opposed to colon) in bacterial and metabolic sensing, including systemic communication to the 
liver and the brain. It should not be forgotten that the eventual mechanistic insight that one may 
obtain from animal models needs to be translated into human physiology of health and disease. 
This requires the design of targeted validation studies in healthy or compromised volunteers in 
which jejunum biopsies are sampled that can be employed for transcriptome profiling and/or 
IHC investigations (van Baarlen, Troost et al. 2009; van Baarlen, Troost et al. 2011). 
The application of metagenomic screening could also target the identification of microbial 
effector molecules involved in eliciting the transient state of inflammatory responses that 
preceded the establishment of tolerance and homeostasis. Such microbial effector molecules 
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could subsequently be administered to conventional mice, to explore their capacity to modulate 
the severity of induced inflammatory diseases, as they are applied in the TNBS and/or DSS 
ulcerative colitis models (Wirtz, Neufert et al. 2007). Another approach of interest could 
investigate the capacity of specific probiotic strains to modulate the transient inflammatory state 
that was measured at day 4 (Chapter 5), aiming to (partially) reverse the adverse effects of the 
transient shift in the microbial community on the host immune response. 
Relevance of the identified gene-regulatory networks as gene signatures for human 
This study identified several gene regulatory networks that appeared to be involved in regulation 
of the immune and metabolic adaptation of the mouse intestinal mucosa to the colonizing 
microbiota. However, the evaluation of the relevance of the identified gene regulatory networks 
to be used as molecular signatures to monitor the risk of disease in humans is yet a major challenge. 
This goal could be approached by performing comparative studies of the regulatory networks 
identified from the mouse model, which appeared to be driven by a core set of regulating genes, 
and the corresponding human biological and disease regulatory networks. Such comparative 
studies would tell whether the overlays include essential core or non-essential peripheral genes, 
and whether they represent known disease genes in humans. Although the existence of complete 
reliable human regulatory networks and their role in disease is debated (Barabasi, Gulbahce et 
al. 2011), the identification of common regulators in the mouse model used in this study  and 
of their human orthologues would confirm the validity of the animal-models for human studies. 
This in turn may inspire molecular hypotheses for human gastrointestinal disease, and may 
strengthen the accuracy of monitoring progressive clinical disease. 
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CONCLUDING REMARKS
The time-resolved mining of multi-variant datasets applied in this thesis provides a solid 
catalogue of genes, pathways, histology, metabolites, and plasma analytes that details the 
processes involved in the establishment of homeostasis in the germfree mouse model upon 
microbial conventionalization. This approach appears to have been very successful in delivering 
an important resource that complements previous studies that have targeted the colonization 
of the intestine in the same or a similar reductionist mouse model. The positive correlations 
identified in this thesis between the multi-variate datasets, including the linkages identified 
between microbial groups and specific host functions, support the prominent role of the 
microbiota in the modulation of the host’s physiology. The interplay that was most extensively 
explored in this thesis focused on mucosal immunity and metabolism, but some impact of the 
microbiota to other aspects of host physiology may also be of great relevance for the host’s 
health and well-being. 
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De dynamische interactie van microbiota en mucosa leidt tot vestging van 
homeostase in geconventionaliseerde muizen 
De interacties tussen ons, onze darmbacteriën en de voedingscomponenten die door de darm 
passeren zijn van cruciaal belang voor onze  gezondheid. Introductie van darmbacteriën in 
kiemvrije muizen (conventionalisering) resulteert in een cascade van strikt gereguleerde 
moleculaire mechanismen die zorgen voor homeostase en een tolerante respons van het 
immuunsysteem tegen deze bacteriën. Om  de dynamiek van deze communicatie tussen bacteriën 
en gastheer te bestuderen gedurende conventionalisering op verschillende locaties in de darm 
is een combinatie van transcriptomics, (immuun)histologie, metabonomics (tissue, plasma en 
urine) en microbiota profilering met behulp van een muis-specifieke fylogenetische microarray 
(MITChip) gebruikt. Voor deze studie werden C57/B6 J kiemvrije muizen geconventionaliseerd 
met ontlasting van een normale C57/B6 J muis en vervolgens gedurende 30 dagen bestudeerd.
Uit deze studie is gebleken dat de diversiteit van de darmbacteriën na conventionalisering in de 
tijd toeneemt. Al na een dag was het effect van deze conventionalisering te zien in jejunum en 
urine, waar  specifieke metabolieten werden gemeten, alsook in de transcriptionele respons van 
het jejunum epitheel. Daarentegen werd de transciptoom response in de ileum en colon pas na 
vier dagen waargenomen, die vervolgens tot een stabiele maar locatie-specifieke moleculaire 
situatie leiden vanaf dag 16. De belangrijkste moleculaire reacties op conventionalisering waren 
een sterke inductie van het niet-specifieke immuunsysteem die vervolgens gevolgd werden 
door adaptieve en regulerende immuunreacties en een verandering van vet-, suiker-, en anabole 
metabole routes. Convenionalisering werd verder gekenmerkt door twee fasen, die gescheiden 
worden door een korte intermediaire fase op dag 4 waarop een ontstekingsreactie plaatsvond 
die waargenomen kon worden in zowel de transcriptoom als specifieke histologische en plasma 
markers.  Tegelijkertijd vond een verschuiving in de samenstelling van de darmbacteriën plaats 
waarbij vooral bacteriën domineerden die als pathobiont bekend staan, wat aangeeft dat het hier 
waarschijnlijk een tijdelijke dysbiosis betreft. Extensieve karakterisering van de transcriptoomdata 
over alle tijdstippen en locaties resulteerde in de identificatie van specifieke centrale genregulatie 
netwerken die het proces van conventionalisering reguleren en daarmee als genetische signaturen 
voor controle van homeostase in muizen kunnen worden beschouwd. Veel van deze genetische 
signaturen hebben ook homologen die in de genoom van de mens zijn gevonden wat suggereert 
dat deze observaties in muizen ook relevant kunnen zijn voor de darmbiologie van de mens. 
Deze hypothese wordt verstrekt door het feit dat het genetische regulatore netwerk in 
het jejunum sterk geassocieerd is met metabole ziekten in mensen, wat suggereert dat de 
proximale dunne darm een belangrijke rol speelt bij de systemische metabole controle.
Dit proefschrift illustreert de centrale rol van dynamische moleculaire interacties tussen 
darmbacteriën en darmepitheel in de ontwikkeling en behoud van mucosale homeostase in 
gezonde muizen. De moleculaire signaturen die in dit proefschrift beschreven staan zouden 
uiteindelijk kunnen leiden tot nieuwe therapeutische targets en diagnostische  toepassingen 
voor specifieke ziekten die het gevolg zijn van dysbiosis of verlies van homeostase in de darm.
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 اﻟﻌرﺒﻲ اﻟﻤﻠﺨص
 
وﺘﺄﺜﻴرﻩ ﻋﻠﻲ  اﻟﻤﺨﺎطﻲﺎ( واﻟﻐﺸﺎء وﺘ)اﻟﻤﻴﻛروﺒﺎﻴﺒﻴن اﻟﺒﻛﺘرﻴﺎ اﻟﻤﻌوﻴﺔ اﻟﻨﺎﻓﻌﺔ  اﻟدﻴﻨﺎﻤﻴﻛﻲﻝ  اﻟﺘﻔﺎﻋ
ﺒﺎﻟﺒﻛﺘرﻴﺎ ران  اﻟﻤطﻌﻤﺔاﻻﺘزان اﻟﺒﻴوﻟوﺠﻲ ﻟﻠﻔﺌﺘﺤﻘﻴق 
أﻫﻤﻴــﺔ ﺠوﻫرﻴــﺔ ﻓــﻲ ﺘﻌرﻴــف  ﻓق اﻟﻐــذاﺌﻲ ذىﻴوﺘــﺎ واﻟﻌﺎﺌــﻝ واﻟﺘــدﻔﺎﻋــﻝ اﻟوﺜﻴــق ﺒــﻴن ﻛــﻝ ﻤــن اﻟﻤﻴﻛروﺒﺎﻴﻌــد اﻟﺘ
 , ﺎﻟﺒﻛﺘرﻴـﺎ اﻟﻤﻌوﻴـﺔ اﻟﻨﺎﻓﻌـﺔﻤـن اﻟﻤﻴﻛروﺒـﺎت ﺒ ﺎﻟﻴـﺔاﻟﺨران ﺒﺘطﻌﻴم اﻟﻔﺌـم ﻘﻴﺎﻴﺔ اﻟﻤﻠﻋ ﻝﺨﻼﻤن و .اﻟﺤﺎﻟﺔ اﻟﺼﺤﻴﺔ ﻟﻠﻌﺎﺌﻝ 
ء اإز  اﻟﻤﻨﺎﻋﻴﺔ  وﻟوﺠﻲ وﺘﻔﻌﻴﻝ اﻟﻤﻘﺎوﻤﺔﻴاﻟﺒ اﻻﺘزانق ﻴﺘﺤﻘ ﻓﻲ ﺸدﻴدة اﻟﺘﻨظﻴم ﻟﺠزﻴﺌﻴﺔا تﻻﺴﺘﺠﺎﺒﺎاأﻤﻛن دراﺴﺔ ﺘﺄﺜﻴر 
  .وﺘﺎاﻟﻤﻴﻛروﺒﺎﻴ
اﻟﻤﻴﻛروﺒﺎﻴوﺘ ـــﺎ واﻟﻌﺎﺌـــﻝ ﺨـــﻼﻝ ﻋﻤﻠﻴـــﺔ  ﺒـــﻴن ﻟﻠﺘﻔﺎﻋـــﻝ ﻌﻴﺔواﻟﻤوﻀـــ اﻟزﻤﻨﻴـــﺔ دﻴﻨﺎﻤﻴﻛﻴـــﺔاﻟ ﻛﺘﺸـــﺎف اﻟﻌﻤﻠﻴـــﺎتوﻻ
ﻴـﺔ إﻀـﺎﻓﺔ )اﻟﺘراﻨﺴـﻛرﻴﺒﺘوم( واﻟﺨﻼﻴـﺎ واﻷﻨﺴـﺠﺔ اﻟﻤﻨﺎﻋ دراﺴـﺔ ﻤـزﻴﺞ ﻤـن اﻟﻌﻨﺎﺼـر اﻟﺠﻴﻨﻴـﺔﺘـم ﺒﺎﻟﺒﻛﺘرﻴـﺎ  رانﻔﺌـاﻟﺘطﻌـﻴم 
 ﺘــم . وﻋﻘــب ذﻟــكﺎ( ﻋــﻼوة ﻋﻠــﻰ ﺘﻌرﻴــف اﻟﻤﻴﻛروﺒﺎﻴوﺘــ واﻟﺒــوﻝ واﻟــدم ﻨﺴــﺠﺔﻓــﻲ اﻷ ) ﻋــن اﻻﻴــض إﻟــﻰ اﻟﻤــواد اﻟﻨﺎﺸــﺌﺔ
ر ﺘﻠـك اﻟﺘﺠـﺎرب ﻋﻠـﻰ ﻤـداﺎﺌﺞ ﺘـﻤﺘﺎﺒﻌـﺔ ﻨوﻗـد ﺘﻤـت  .ن اﻟﺨﺎﻟﻴـﺔ ﻤـن اﻟﻤﻴﻛروﺒـﺎت ﺒﺎﻟﺒﻛﺘرﻴـﺎ اﻟﻤﻌوﻴـﺔ اﻟﻨﺎﻓﻌـﺔار ﺌـاﻟﻔ ﻴمﺘطﻌـ
اﻟﻤﺴـﺘوطﻨﺔ ﺒﺘﻐﻴـر ﻤﺴـﺘوى اﻟﺘﻨـوع ﻤـن اﻷﻗـﻝ إﻟـﻰ اﻷﻛﺜـر  ت اﻟﺒﻛﺘرﻴـﺎﻓﺘـرة زﻤﻨﻴـﺔ ﺘﺒﻠـﻎ ﺜﻼﺜـون ﻴوﻤـﺎ ﻤﺘﻘطﻌـﺔ وﻗـد اﺘﺴـﻤ
ﻋﻠــﻰ ﻨﻤــو ﺴــرﻴﻊ ﻤــن ﺨــﻼﻝ ارﺘﻔــﺎع  اﻟﺒﻛﺘرﻴــﺎ ﻴطﺎنﺒﺎﻹﻀــﺎﻓﺔ إﻟــﻰ ذﻟــك أﻨﻌﻛــس اﺴــﺘوﻋــﺎ ﻋﻠــﻰ ﻤــدار ﻓﺘــرة اﻟﺘطﻌــﻴم. ﺘﻨ
ﺠﻴﻨـﺎت ﺔ ﻓـﻲ وﻟوﺠﻴـﺔ اﻟﻤﻬﻤـوﻛـذا اﻟﺘﻐﻴـرات اﻟﺒﻴ ﺔاﻟدﻗﻴﻘـاﻷﻤﻌـﺎء ﻓـﻲ اﻟﺒـوﻝ واﻟﺠـزء اﻷوﺴـط ﻤـن  اﻷﻴـض ﺘرﻛﻴـزات ﻤـواد
ﻓـﻲ اﻟﺠـزء  ﻨـﺎت اﻟﺠﻴاﺴـﺘﺠﺎﺒﺔ  ﻗﻴـﺎس ﻤـدىن أﻤﻛـﻋﻠـﻰ اﻟﻌﻛـس ﻤـن ذﻟـك و  .اﻷﻤﻌـﺎء اﻟدﻗﻴﻘـﺔ ﻨﺴـﻴﺞ اﻟﺠـزء اﻷوﺴـط ﻤـن
وﻗــد ﻷﻤﻌــﺎء اﻟدﻗﻴﻘــﺔ اأﻛﺒــر ﻤﻘﺎرﻨــﺔ ﺒــﺎﻟﺠزء اﻷوﺴــط ﻤــن  زﻤﻨﻴــﺔ واﻟﻘوﻟــون وﻟﻛــن ﻓــﻲ ﻓﺘــرةﻷﻤﻌــﺎء اﻟدﻗﻴﻘــﺔ ااﻷﺴــﻔﻝ ﻤــن 
اﺴــﺘﺜﺎرة  ﺒﻌﻬــﺎﺒﺘﺔ اﻟﻤﺘﺨﺼﺼــ ﻏﻴــر اﻻﺴــﺘﺠﺎﺒﺔ اﻟﻤﻨﺎﻋﻴــﺔ ﺔ ﻋﻠــﻰ زﻴــﺎدة ﺤــﺎدة ﻓــﻲﻴــاﻻﺴــﺘﺠﺎﺒﺎت اﻟﺠزﻴﺌ ﻏﺎﻟﺒﻴــﺔ اﺸــﺘﻤﻠت
ﻫون اﻟـد اﻟﻤﺸـﺘﻤﻠﺔ ﻋﻠـﻰ اﻴـض  ﻴضﻻأﻓﻲ ﻤﺴﺎرات ﺘﻌدﻴﻼت اﻟ  ﻋنﻟﻠوظﺎﺌف اﻟﻤﻨﺎﻋﻴﺔ اﻟﻤﻨظﻤﺔ واﻟﻤﺘﺨﺼﺼﺔ ﻓﻀﻼ
ﻤرﺤﻠـﺔ وﺴـطﻴﺔ ﻠﺘﻴن ﻤﻨﻔﺼـﻠﺘﻴن ﻴﺘﺨﻠﻠﻬﻤـﺎ ﺤﻤـر ﺨـﻼﻝ اﻟﺘطﻌـﻴم   وﻋﻠـﻰ ﺼـﻌﻴد ﻤﺘﺼـﻝ اﺸـﺘﻤﻠت ﻋﻤﻠﻴـﺔ .واﻟﻛرﺒوﻫﻴـدرات
ﺘﻠـك اﻟﻤرﺤﻠـﺔ إﻟـﻰ ﺤـد ﺒﻌﻴـد ﻤرﺤﻠـﺔ  ﻴـث ﺘﺸـﺒﻪﺤ - ﺔ اﻟﻘوﻟـونﻓـﻲ ﻤﻨطﻘـوﻋﻠﻲ وﺠﺔ اﻟﺨﺼوص  – ﺘﻤدد ﻟﻔﺘرة ﻴوم واﺤد
 ﺤددات ﻤﻌﻴﻨﺔ ﺒﺎﻟدم.ﻟﻤﺔ اﻟﻤرﺘﻔﻌ اﻻﻨﺘﻘﺎﻟﻴﺔﻟﺘﻬﺎﺒﺎت وذﻟك وﻓﻘﺎ ﻟﻠﻤﻌدﻻت ﻼاﻨﺘﻘﺎﻟﻴﺔ ﻟ
اﻟﺘﺤﻠﻴــﻝ اﻟﻤﻛﺜـــف  أﺘـــﺎحوﻗــد  اﻟﺒﻛﺘرﻴـــﺎ. ﻌﻴﻨﻬـــﺎ ﻤــنﻟﻤﺠﻤوﻋــﺔ ﺒ ﻤؤﻗﺘـــﺔﺴــﻴﺎدة  ﻤﻨــت ﺘﻠـــك اﻟﻤرﺤﻠــﺔ ﻤـــﻊوﻗــد ﺘزا
ﺘﻌﻤــﻝ ﻋﻠــﻰ اﻟــﺘﺤﻛم ﻓــﻲ اﻻﺴــﺘﺠﺎﺒﺎت  ﻤﻨظﻤــﺔ ﺠﻴﻨﻴــﺔ ﻤرﻛزﻴــﺔﻛﺎت ﻲ ﻤﻨطﻘــﺔ اﻷﻤﻌــﺎء اﻟﻔرﺼــﺔ ﻟﺘﻌرﻴــف ﺸــﺒﻟﻠﺠﻴﻨــﺎت ﻓــ
 ﻌﻴم.ﺨﻼﻝ ﻋﻤﻠﻴﺔ اﻟﺘطاﻟﺠزﻴﺌﻴﺔ 
اﻟﻤﻌوﻴـﺔ  اﻟﺘﻔﺎﻋﻼت اﻟدﻴﻨﺎﻤﻴﻛﻴﺔ ﻓﻴﻤﺎ ﺒـﻴن اﻟﺒﻛﺘرﻴـﺎ ﺘﻠﻌﺒﻪ اﻟذي اﻟﺤﻴوياﻟدور  اﻟﺒﺤث ﻴوﻀﺢ ﻓﺎن ﻫذا وأﺨﻴرا 
اﻟﺠزﻴﺌﻴـﺔ اﻻﺴـﺘﺠﺎﺒﺎت ﻗـد ﺘـوﻓر و  .اﻟﺴـﻠﻴﻤﺔ  رانﺘﺤﻘﻴق اﻻﺘزان اﻟﺒﻴوﻟوﺠﻲ ﻓﻲ اﻟﻔﺌ ﻤن ﺤﻴث ﺸﺎء اﻟﻤﺨﺎطﻲاﻟﻨﺎﻓﻌﺔ واﻟﻐ
أدوات ﺘﺸﺨﻴﺼـــﻴﺔ ﻤوﻀـــﻌﻴﺔ وأﻫـــداف ﻋﻼﺠﻴـــﺔ  رانﻟﻔﺌـــا ﻋﻠـــﻰ ﻤـــن ﺨـــﻼﻝ ﺘﻠـــك اﻟدراﺴـــﺎت اﻟﺒﺤـــث إﻟﻴﻬـــﺎﺘوﺼـــﻝ  اﻟﺘـــﻲ
ﻝ اﻷﻤﻌﺎء واﻟﻐﺸﺎء اﻟﻤﺨﺎطﻲ.ﻼﺔ واﻟﻤﺘﻌﻠﻘﺔ ﺒﺎﻋﺘوﻴاﻟﻤﻌ اﻻﻀطراﺒﺎتﺒﻌض ﻋﻨد ﺤدوث ﻟﻺﻨﺴﺎن 
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